Browse through one of our latest Open Access articles: Alopecia areata-associated white hair growth can occur independent of follicular cycling by Zhang et al. 2026. Free to read! doi.org/10.1093/bjd/ljag303 #dermtwitter #alopeciaareata #openaccess #bjd #dermatology #research
British Journal of Dermatology
The British Journal of Dermatology is a monthly peer-reviewed medical journal that covers the field of dermatology. It is published by Wiley-Blackwell on behalf of the British Association of Dermatologists. The journal was established in 1888 and the editor-in-chief is John Ingram. According to the Journal Citation Reports, the journal has a 2020 impact factor of 9.3., ranked third within the dermatology subject category. More on Wikipedia
-
BJD
@BrJDermatol
-
BJD
@BrJDermatol
Read one of our latest Open Access accepted articles: High-risk basal cell carcinomas, severe ocular anomalies and meningioma in SMO mosaicism: expanding the mosaic hedgehog spectrum by Hortemo et al. 2026, here: doi.org/10.1093/bjd/ljag494 #dermtwitter #basalcellcarcinoma #research
-
BJD
@BrJDermatol
Read @BrJDermatol's newest Editor's Choice article: Views and experiences of young people and their parents of managing acne: qualitative interview study by Easton et al. 2026, here: doi.org/10.1093/bjd/ljag284 #dermtwitter #research #dermatology #acne
-
BJD
@BrJDermatol
In this episode of @BJDTalks, we discuss ‘Trends in keratinocyte cancers in England, 2013–22: basal cell carcinoma incidence, cutaneous squamous cell carcinoma incidence and nonmelanoma skin cancer mortality’ by Mistry et al. Read the article here: doi.org/10.1093/bjd/ljag071
-
BJD
@BrJDermatol
We are looking for a Section Editor for our Global Health and Equity Section!
Think you'd like to be a part of our 135+ year old journal? Explore the opportunity here: academic.oup.com/bjd/pages/vacancy-section-editor
#bjd #dermatology #vacancy #globalhealth -
BJD
@BrJDermatol
We are looking for a Section Editor for our Global Health and Equity Section!
Think you'd like to be a part of our 135+ year old journal? Explore the opportunity here: academic.oup.com/bjd/pages/vacancy-section-editor
#bjd #dermatology #vacancy #globalhealth -
BJD
@BrJDermatol
#bjdtalks Episode 54: Subcutaneous efgartigimod in pemphigus: phase III ADDRESS trial, is out now! www.buzzsprout.com/2615997/episodes/20007848-episode-54-s… #dermtwitter #brjdermatol #podcast
-
BJD
@BrJDermatol
We are looking for a Section Editor for our Global Health and Equity Section!
Think you'd like to be a part of our 135+ year old journal? Explore the opportunity here: academic.oup.com/bjd/pages/vacancy-section-editor
#bjd #dermatology #vacancy #globalhealth -
BJD
@BrJDermatol
We are looking for a Section Editor for our Global Health and Equity Section!
Think you'd like to be a part of our 135+ year old journal? Explore the opportunity here: academic.oup.com/bjd/pages/vacancy-section-editor
#bjd #dermatology #vacancy #globalhealth -
BJD
@BrJDermatol
On the closing day of #eadv, read our recent commentary "Metabolic reprogramming of fibroblasts: a new paradigm for striae gravidarum?" here: doi.org/10.1093/bjd/ljag207 #dermtwitter #fibroblasts #dermatology
-
BJD
@BrJDermatol
To coincide with some of the topics highlighted at #eadv, read: Dermatopathology in 4D: in situ spatial transcriptomics maps the cellular and molecular architecture of skin here: doi.org/10.1093/bjd/ljag246 #technology #dermtwitter #dermatology
-
BJD
@BrJDermatol
In honour of #eadv Congress this week, we're sharing a few of our recent articles.
"Skin cancer mortality in Australian and New Zealand kidney transplant recipients'' here: doi.org/10.1093/bjd/ljag232 #skincancer #dermtwitter -
BJD
@BrJDermatol
Listen to the newest BJD Talks Podcast Episode #50 - Reducing infant bathing: a randomized controlled feasibility trial here: www.buzzsprout.com/2615997/episodes or wherever you get you podcasts. #bjdtalks #podcast #dermtwitter #research
-
BJD
@BrJDermatol
As we close out #peerreviewweek - one last thank you to our Peer Reviewers for all that you do! Your work is very much appreciated. #prw2026
-
BJD
@BrJDermatol
What’s the most valuable feedback you've received during peer review? #peerreviewweek #prw2026 #peerreview
-
BJD
@BrJDermatol
As part of #peerreviewweek, we'd like to know: What motivates you to be a #peerreviewer?
Leave us an answer in the comments!
#prw2026 -
BJD
@BrJDermatol
What is the biggest challenge facing peer review today? #peerreviewweek #prw2026
-
BJD
@BrJDermatol
In the spirit of #peerreviewweek, and this year's theme of 'Peer Review Capacity: Volume, Speed, and Quality" - Thank you to all of our dedicated, hardworking, Peer Reviewers! #prw2026
-
BJD
@BrJDermatol
Listen to the most recent episode of the BJD Talks podcast - Episode 49. Quality of life in patients with BCNS., which can be found on Buzzsprout here: www.buzzsprout.com/2615997/episodes/19680452-episode-49-q…
#brjdermatol #bjdtalks #dermatology #dermtwitter -
BJD reposted
Healio Dermatology
@HealioDerm
🆕 from @BrJDermatol: Many families were willing to participate in a larger trial that evaluated whether fewer baths could help prevent infant #eczema.
📈 High adherence and retention in the trial may suggest bigger studies on this topic are possible.
vist.ly/5gr66 -
BJD reposted
Dermatology Advisor
@DermAdvisor
From @BrJDermatol: Treatment with the highest dose of #delgocitinib cream, 20 mg/g, was associated with a mean change in #eczema Area and Severity Index scores of -7.6 at 8 weeks compared with -1.9 with cream vehicle.
www.dermatologyadvisor.com/news/delgocitinib-cream-demons… -
BJD
@BrJDermatol
Does prior atopic dermatitis influence outcomes in cutaneous T-cell lymphoma?
In this study, AD was associated with longer diagnostic delay, more advanced CTCL at presentation, increased disease progression and reduced overall survival.
👇 Read more: doi.org/10.1093/bjd/ljag143 -
BJD
@BrJDermatol
Can genetics improve melanoma risk prediction?
A polygenic risk score was the strongest single predictor compared with individual self-reported clinical risk factors. Adding it to clinical models improved melanoma risk prediction.
👇 Read more: doi.org/10.1093/bjd/ljag126 -
BJD
@BrJDermatol
New insights into keloid inflammation.
Collagen I-DDR1 signalling promotes inflammation, with ARF6 enhancing DDR1 activity and downstream STAT3 phosphorylation. Combined DDR1 and ARF6 inhibition synergistically suppressed this pathway.
👇 Read more: doi.org/10.1093/bjd/ljag105 -
BJD
@BrJDermatol
Building better evidence for pyoderma gangrenosum.
An international multidisciplinary consensus established the minimum dataset for a new international PG registry, spanning 26 domains and 118 items across baseline and follow-up visits.
👇 Read more: doi.org/10.1093/bjd/ljag084 -
BJD
@BrJDermatol
How does infection risk vary across systemic psoriasis treatments?
In 46,770 BADBIR treatment episodes, serious infections occurred at a rate of 27.7 per 1000 person-years. Recurrent-event analysis found lower risk with risankizumab.
👇 Read more: doi.org/10.1093/bjd/ljag174 -
BJD
@BrJDermatol
The largest European study of lentigo maligna (LM) and lentigo maligna melanoma (LMM) to date, covering >40,000 tumours in England, finds incidence stabilized before COVID-19 before rising thereafter.
👇 Read more: doi.org/10.1093/bjd/ljag177 -
BJD
@BrJDermatol
Could TYK2/JAK1 inhibition offer a new option for chronic spontaneous urticaria?
In this phase Ib trial, oral TLL-018 was well tolerated and effective in patients with moderate-to-severe CSU who had inadequate response to H1 antihistamines.
👇 Read more: doi.org/10.1093/bjd/ljag092 -
BJD
@BrJDermatol
Can TYK2 inhibition treat alopecia areata?
In this phase II randomized trial, deucravacitinib did not significantly improve Severity of Alopecia Tool (SALT) scores vs placebo. No new safety signals were identified.
👇 Read more: doi.org/10.1093/bjd/ljag109 -
BJD
@BrJDermatol
🚨 The August 2026 issue of the BJD is here! 🚨
Issue highlights include deucravacitinib in patients with alopecia areata, infection risk with systemic treatments for psoriasis, and genetics versus clinical risk scores in melanoma.
Read more: academic.oup.com/bjd/issue -
BJD
@BrJDermatol
Virtual Roundtable: Acne unfiltered
Acne is a common skin disease affecting millions globally. Find expert discussion on stigma and solutions in a new virtual roundtable from the British Journal of Dermatology.
doi.org/10.1093/bjd/ljaf506 -
BJD
@BrJDermatol
What regulates naevus growth?
Transcriptomic profiling identified HRK as a key regulator of acquired melanocytic naevi. Reduced HRK expression impaired proliferation and promoted senescence, providing insight into melanoma-related pathways.
👇 Read more: doi.org/10.1093/bjd/ljag063 -
BJD
@BrJDermatol
How long should photoallergens remain occluded during photopatch testing?
In a European study, a 48-hour occlusion period detected substantially more sunscreen and NSAID photoallergy than 24 hours, supporting updated testing protocols.
👇 Read more: doi.org/10.1093/bjd/ljag085 -
BJD
@BrJDermatol
Interferon-γ and mechanical stress work together to weaken melanocyte adhesion to the basement membrane.
This study provides new mechanistic insight into vitiligo and the Koebner phenomenon, identifying a potential new therapeutic target.
👇 Read more: doi.org/10.1093/bjd/ljag113 -
BJD
@BrJDermatol
What does a BCC diagnosis feel like from the patient's perspective?
This piece highlights the emotional impact of the word "cancer" and the value of prevention, compassionate communication, and shared decision making in dermatology care.
👇 Read more: doi.org/10.1093/bjd/ljag110 -
BJD
@BrJDermatol
📢 We're recruiting a BJD Editorial Trainee!
Interested in medical publishing, peer review, social media, and dermatology? Join our editorial team to gain hands-on editorial experience and help shape the future of dermatology publishing.
👇 Apply here: academic.oup.com/bjd/pages/british-journal-editorial-trai… -
BJD
@BrJDermatol
Does MGUS increase skin cancer risk?
Using nationwide data from the iStopMM study and the Icelandic Cancer Registry, researchers found no association between MGUS and skin cancer incidence or survival.
👇 Read more: doi.org/10.1093/bjd/ljag119 -
BJD
@BrJDermatol
Insights into Rowell syndrome.
This cohort study defines clinicopathological and immunological features of RS, identifying a dominant interferon–JAK/STAT activation signature and evidence supporting JAKi as a targeted treatment approach.
👇 Read more: doi.org/10.1093/bjd/ljag132 -
BJD
@BrJDermatol
Mental health disorders are common in lichen simplex chronicus.
Across a racially and ethnically diverse cohort, patients with LSC had nearly 2× higher odds of psychiatric diagnoses, extending beyond mood and anxiety disorders.
👇 Read more: doi.org/10.1093/bjd/ljag125 -
BJD
@BrJDermatol
How does SJS/TEN affect pregnancy outcomes?
In 2.6 million pregnancies, pre-pregnancy SJS/TEN was associated with severe maternal morbidity at delivery, while SJS/TEN during pregnancy was linked to preterm birth and caesarean delivery.
👇 Read more: doi.org/10.1093/bjd/ljag128 -
BJD
@BrJDermatol
What does the metabolome reveal about psoriasis?
In a cross-sectional study of 470,352 participants, researchers identified metabolic signatures linked to psoriasis, disease severity, and shared pathways with other immune-mediated diseases.
👇 Read more: doi.org/10.1093/bjd/ljag116 -
BJD
@BrJDermatol
Should biologics be used earlier for psoriasis?
Using BADBIR data, first-line biologic therapy was associated with better long-term skin clearance, improved QoL, and fewer incident comorbidities than the traditional stepwise approach.
👇 Read more: doi.org/10.1093/bjd/ljag098 -
BJD
@BrJDermatol
Who is most likely to develop another cSCC?
Using nationwide data from 11,737 patients, this prognostic model found marked differences in metachronous cSCC risk, supporting more personalized, risk-stratified follow-up after a first tumour.
👇 Read more: doi.org/10.1093/bjd/ljag076 -
BJD
@BrJDermatol
New data for primary cutaneous angiosarcoma.
In the JCOG1605 trial, pazopanib did not prolong progression-free survival after prior paclitaxel but showed encouraging response rates and overall survival, with no new safety concerns.
👇 Read more: doi.org/10.1093/bjd/ljag071 -
BJD
@BrJDermatol
This review highlights how mitochondrial metabolism regulates neutrophil recruitment, activation, and cell death, shaping inflammatory skin diseases (e.g., psoriasis, lupus, Behçet's), as well as identifies new therapeutic opportunities.
👇 Read more: doi.org/10.1093/bjd/ljag060 -
BJD
@BrJDermatol
🚨 The July 2026 issue of the BJD is here! 🚨
Issue highlights include methotrexate and topical corticosteroids in bullous pemphigoid, biologics as first-line systemic treatment for psoriasis, and genome-wide meta-analysis of lichen sclerosus.
Read more: academic.oup.com/bjd/issue -
BJD
@BrJDermatol
📢 Are you at #bad2026?
Join us on 1 July, 10:30-11:00 for "Publication ethics: Why it matters?" with Shehnaz Ahmed, Ewan Langan, and Adam Daunton.
We'll discuss publication ethics, AI in publishing, and case studies on common ethical challenges.
See you there! -
BJD
@BrJDermatol
Kicking off the British Association of Dermatologists Annual Meeting in Manchester this week with a pre-conference session on how to peer review, featuring our Editor-in-Chief Professor John McGrath (@BJDEditor). Come say hi! #bad2026
-
BJD
@BrJDermatol
Can AI reduce skin cancer waiting times?
Using data from 24 NHS trusts, this real-world analysis found no consistent improvement in Faster Diagnosis Standard breaches after AI-assisted lesion triage.
👇 Read more: doi.org/10.1093/bjd/ljag120 -
BJD
@BrJDermatol
How do Merkel cells communicate touch signals?
Merkel cells release ATP in response to mechanical stimulation, activating neighbouring cells via purinergic signalling. This newly identified mechanism may help shape tactile sensitivity.
👇 Read more: doi.org/10.1093/bjd/ljag067 -
BJD
@BrJDermatol
Can sublingual THC/CBD help chronic pain in epidermolysis bullosa?
In a randomized crossover trial, 75% of participants achieved ≥30% global pain reduction, while analgesic use halved during active treatment.
👇 Read more: doi.org/10.1093/bjd/ljag072 -
BJD
@BrJDermatol
Who benefits from dermatology AI?
This perspective examines the ethics of developing AI tools using data from low- and middle-income countries without ensuring access to resulting technologies.
👇 Read more: doi.org/10.1093/bjd/ljag087 -
BJD
@BrJDermatol
How common are airway allergic diseases in atopic dermatitis?
In the first globally standardized estimates, among people with AD, asthma affects 20.1%, rhinitis 45.1%, allergic rhinitis 41.4%, and coexisting asthma + rhinitis 10.4%.
👇 Read more: doi.org/10.1093/bjd/ljag025 -
BJD
@BrJDermatol
Can melanoma prognostication be improved beyond TNM staging?
Using machine learning in 111,871 patients, this study found that age, sex, race/origin, histology, and mitotic rate add prognostic value beyond the 8th edition TNM system.
👇 Read more: doi.org/10.1093/bjd/ljag018 -
BJD
@BrJDermatol
Phase III data for adolescents with moderate-to-severe AD.
The anti-IL-4Rα antibody stapokibart significantly improved disease signs, symptoms, and quality of life, with favourable safety and no conjunctivitis reported through week 18.
👇 Read more: doi.org/10.1093/bjd/ljag052 -
BJD
@BrJDermatol
How should we interpret the BE HEARD I and II trials of bimekizumab for hidradenitis suppurativa?
This critical appraisal reviews efficacy, safety, strengths, and limitations of 2 pivotal 48-week phase III studies in moderate-to-severe HS.
👇 Read more: doi.org/10.1093/bjd/ljag051 -
BJD
@BrJDermatol
B cells are emerging as key players in melanoma.
Mature and memory B cells, and class-switched antibodies, are linked to improved survival and better immunotherapy responses. B-cell signatures may predict treatment response and toxicity.
👇 Read more: doi.org/10.1093/bjd/ljag074 -
BJD
@BrJDermatol
“Cosmeceutical” remains a regulatory paradox: widely used in marketing, but not formally recognized by law.
As evidence for topical products grows more sophisticated, dermatology must define what level of data warrants clinical endorsement.
👇 Read more: doi.org/10.1093/bjd/ljag095 -
BJD
@BrJDermatol
Could microbiota-fibroblast crosstalk be the missing link between barrier dysfunction and skin fibrosis?
This review highlights fibroblasts as active interpreters of microbial signals, with certain pathways emerging as therapeutic targets.
👇 Read more: doi.org/10.1093/bjd/ljag068 -
BJD
@BrJDermatol
New review on clinical and molecular markers in vitiligo.
Integrating biomarkers across multiple sample types, this review highlights emerging translational signals for disease staging, treatment response, and future monitoring strategies.
👇 Read more: doi.org/10.1093/bjd/ljag058 -
BJD
@BrJDermatol
New 2025 BAD living guideline for nodular prurigo (prurigo nodularis).
Evidence-based recommendations for managing adults, children, and young people with nodular prurigo, designed to evolve alongside emerging evidence and therapies.
👇 Read more: doi.org/10.1093/bjd/ljag070 -
BJD
@BrJDermatol
🚨 The June 2026 issue of the BJD is here! 🚨
Issue highlights include the BAD living guideline for management of prurigo nodularis, an AI-based smartphone app for skin cancer detection, and global estimates of asthma and rhinitis in AD.
Read more: academic.oup.com/bjd/issue -
BJD
@BrJDermatol
A recurrent de novo EMP2 variant was identified in 2 patients with EMP2-nEDD.
The mutation disrupted lipid raft integrity and triggered ligand-independent EGFR activation. One patient showed marked improvement after 1 month of erlotinib.
👇 Read more: doi.org/10.1093/bjd/ljag045 -
BJD
@BrJDermatol
A plant flavonoid shows promise for acne and scars.
In a split-face RCT, topical icariin (from Epimedium) reduced acne and atrophic scar severity without adverse events, targeting inflammation, keratinization, and ECM repair.
👇 Read more: doi.org/10.1093/bjd/ljag062 -
BJD
@BrJDermatol
Real-world BADBIR data on severe psoriasis treatments.
Infliximab was linked to higher serious infection risk vs adalimumab, secukinumab, ustekinumab, and standard care using weighted recurrent Cox models.
👇 Read more: doi.org/10.1093/bjd/ljag032 -
BJD reposted
Skin Health and Disease
@SkinHealthDis
Next up is another great article from @BrJDermatol - public health advice on sun exposure and sunbed use should not be disregarded - read it here doi.org/10.1093/bjd/ljaf434 #sunawarenessweek #bad #sunbeds #sunawareness #skincancer
-
BJD
@BrJDermatol
Racial disparities in autoimmune blistering disease outcomes.
At Emory University, Black patients presented younger, with higher comorbidity and deprivation, and had >2× risk of AIBD hospitalization vs White patients (RR 2.34).
👇 Read more: doi.org/10.1093/bjd/ljaf504
BJD
@BrJDermatol
Racial gaps in AIBD care persist despite similar severity at presentation.
Black patients had higher ED use, hospitalizations, and comorbidity burden vs White patients, highlighting the need for more equitable AIBD care.
👇 Read more: doi.org/10.1093/bjd/ljaf530 -
BJD
@BrJDermatol
Sun Awareness Week (11-17 May 2026) reminds us that all UV exposure causes skin damage and increases skin-cancer risk.
Protect your skin with SPF, shade, and checks for new or changing moles. 📆 #sunawarenessweek #thinkbeforeyoutan
👇 Read more: blog.oup.com/2026/05/think-before-you-tan-why-sun-awarene… -
BJD
@BrJDermatol
Extensive dermal melanocytosis (EDM) has newly identified mosaic causes.
Variants in HRAS, ACTB, PIK3CA, and GNA11 challenge current mosaic disorder concepts. Differentiate from common blue spots and consider routine ophthalmology review.
👇 Read more: doi.org/10.1093/bjd/ljaf481 -
BJD
@BrJDermatol
What shapes the infant skin microbiome in year 1?
In the Enquiring About Tolerance (EAT) trial, microbiome patterns were driven by body site and age. Changes tracked with barrier dysfunction and early AD; S. aureus was rarely detected.
👇 Read more: doi.org/10.1093/bjd/ljaf524 -
BJD
@BrJDermatol
Koilocytes in actinic keratosis may flag higher cancer risk. HPV8-associated AKs (koilocyte-positive) were more likely to progress to SCC and BCC, often with multiple tumours, supporting earlier intervention and closer follow-up.
👇 Read more: doi.org/10.1093/bjd/ljag016 -
BJD
@BrJDermatol
Spatial proteomics links tertiary lymphoid structures to ICI response in Merkel cell carcinoma.
TLS number, immune makeup, and spatial arrangement differed between responders/non-responders, offering insights into patient stratification.
👇 Read more: doi.org/10.1093/bjd/ljaf525 -
BJD
@BrJDermatol
UVB drives early ATG7 loss in melanocytes, before full senescence.
Metformin preserved ATG7, maintained autophagy, reduced oxidative stress, and delayed melanocyte ageing, suggesting a pathway to prevent hypopigmentation.
👇 Read more: doi.org/10.1093/bjd/ljaf529 -
BJD
@BrJDermatol
Why does nonsegmental vitiligo relapse after successful repigmentation?
In a cohort of 809 patients, independent predictors of recurrence/relapse included acral distribution, thyroid disease, and other autoimmune comorbidities.
👇 Read more: doi.org/10.1093/bjd/ljaf531 -
BJD
@BrJDermatol
Melanoma of unknown primary (MUP) may arise from sun-exposed skin ☀️
In this cohort study, MUP had similar overall survival to melanoma with known primary. Genomics showed UV mutation signatures and high TMB, mirroring sun-exposed melanoma.
👇 Read more: doi.org/10.1093/bjd/ljaf499 -
BJD
@BrJDermatol
Nationwide Dutch study of lentigo maligna 🇳🇱
Most diagnosed by punch biopsy and treated surgically. 14% upstaged to LM melanoma after excision. Recurrence 7%; median time 2.4 years. Implications for biopsy choice, margins, and follow-up.
👇 Read more: doi.org/10.1093/bjd/ljag011 -
BJD
@BrJDermatol
Could the cGAS–STING DNA-sensing pathway be a therapeutic target in cutaneous autoimmunity? This review examines evidence in SLE and systemic sclerosis, and the potential for pathway-directed treatment. 👇 Read more below:
doi.org/10.1093/bjd/ljaf526 -
BJD
@BrJDermatol
From propranolol for haemangiomas to minoxidil for hair loss, dermatology’s breakthroughs often begin with sharp clinical observation. Here, @BJDEditor explores how serendipity can evolve into a strategic path for drug repositioning. 👇 Read more below:
doi.org/10.1093/bjd/ljag039 -
BJD
@BrJDermatol
🚨 The May 2026 issue of the BJD is here! 🚨
Issue highlights include treatment of lentigo maligna, QoL outcome measures for SJS/TEN, and plant-derived icariin in acne vulgaris and atrophic acne scars.
Read more: academic.oup.com/bjd/issue -
BJD
@BrJDermatol
In 37,193 adults from the Lifelines cohort, atopic dermatitis was linked to increased odds of non-atopic multimorbidity, with distinct orofacial and cardiometabolic patterns. Findings support coordinated, multidisciplinary care. 👇 Read more below:
doi.org/10.1093/bjd/ljaf475 -
BJD
@BrJDermatol
Sunscreen recalls in Australia expose limits in SPF testing and oversight. Inaccurate labels are a patient-safety issue, not cosmetic, calling for stronger standards and post-market surveillance to protect trust in photoprotection. 👇 Read more below:
doi.org/10.1093/bjd/ljag009 -
BJD
@BrJDermatol
When ICD-10-CM lacks key dermatology subcodes, rare skin diseases vanish from US real-world datasets, skewing evidence as real-world data shapes research and guidance. Practical fixes can improve phenotypic resolution. 👇 Read more below:
doi.org/10.1093/bjd/ljag019 -
BJD
@BrJDermatol
Many survivors of epidermal necrolysis face lasting functional decline. In a 7-year cohort (n=43), worse function was associated with disease severity, not age/comorbidities, and improved with proactive inpatient rehab. 👇 Read more below:
doi.org/10.1093/bjd/ljaf495 -
BJD
@BrJDermatol
Cuticle width may reflect nail growth rate. This study in healthy adults found a significant positive correlation, suggesting a simple clinical marker for nail growth dynamics. 👇 Read more below:
doi.org/10.1093/bjd/ljag001 -
BJD
@BrJDermatol
Facial microbiota differ in adolescents with acne. Beyond C. acnes, this study links C. granulosum and S. epidermidis to acne, while Streptococcus species were seen in acne-free skin. 👇 Read more below:
doi.org/10.1093/bjd/ljaf508 -
BJD
@BrJDermatol
Topical retinoid exposure in early pregnancy was not linked to a substantial increase in major congenital malformations in a large Nordic cohort. Findings may reassure women after inadvertent exposure, though caution remains advised. 👇 Read more below:
doi.org/10.1093/bjd/ljaf500 -
BJD
@BrJDermatol
A new patient-reported outcome tool, cNF-PUSH-D, measures stigma related to cutaneous neurofibromas in neurofibromatosis 1. This validated instrument supports better assessment of disease burden and future clinical trials. 👇 Read more below:
doi.org/10.1093/bjd/ljaf479 -
BJD
@BrJDermatol
Ivarmacitinib ointment improved skin clearance and itch in adults with mild-to-moderate atopic dermatitis in a randomized trial. Responses were seen by week 8, and benefits sustained to week 52 with good tolerability. 👇 Read more below:
doi.org/10.1093/bjd/ljaf482 -
BJD
@BrJDermatol
Stapokibart (anti-IL-4Rα) shows promise in children 6-11 with moderate-to-severe atopic dermatitis. In this phase Ib/IIa trial, weight-tiered dosing was well tolerated and associated with improved disease outcomes. 👇 Read more below:
doi.org/10.1093/bjd/ljaf455 -
BJD
@BrJDermatol
🚨 The April 2026 issue of the BJD is here! 🚨
Issue highlights include ivarmacitinib for mild-to-moderate atopic dermatitis, topical retinoid use and risk of congenital malformations, and Delphi criteria for topical steroid withdrawal.
Read more: academic.oup.com/bjd/issue -
BJD
@BrJDermatol
Meet the faces behind the research at AAD Annual Meeting!
Join British Journal of Dermatology for “Meet the Deputy Editor” with Aaron Drucker.
📍 Booth #859 (@oxunipress)
🗓️ Sat, Mar 28 | 11–12
Stop by to chat publishing and special issues!
#aad2026 -
BJD
@BrJDermatol
A visual clue to VEXAS syndrome: this image set highlights key diagnostic findings in this somatic mutation–driven autoinflammatory disorder and aims to improve clinical recognition. 👇 Read more below:
doi.org/10.1093/bjd/ljaf470 -
BJD
@BrJDermatol
Netherton syndrome (SPINK5-sEDD) is associated with significant endocrine complications in children, including growth hormone resistance, corticotropic insufficiency and rickets. Findings highlight the need for systematic screening. 👇 Read more below:
doi.org/10.1093/bjd/ljaf467 -
BJD
@BrJDermatol
The Inflammatory Skin Disease map is a new interactive resource mapping molecular mechanisms in psoriasis and atopic dermatitis. It enables visualization of omics data, supports hypothesis testing, and facilitates data interpretation. 👇 Read more below:
doi.org/10.1093/bjd/ljaf491 -
BJD
@BrJDermatol
Lentigo maligna has excellent disease-specific survival, but overall survival in patients ≥80 is low, reflecting comorbidity and frailty. Findings highlight the need for individualized, shared decision making and consideration of nonsurgical management.
doi.org/10.1093/bjd/ljaf489 -
BJD
@BrJDermatol
Editor’s Choice: Early- vs late-onset hidradenitis suppurativa shows distinct patterns. Late-onset HS is linked to more smoking and metabolic comorbidities, with less axillary/nuchal involvement, despite similar disease severity. 👇 Read more below:
doi.org/10.1093/bjd/ljaf476 -
BJD
@BrJDermatol
When science meets the algorithm: how dermatology research can be distorted on social media.
This perspective highlights impact on public trust and sun safety, and calls for proactive, accurate communication from clinicians and researchers. Read more 👇
doi.org/10.1093/bjd/ljaf474 -
BJD
@BrJDermatol
A new entity – disseminated myofibroblastic papulosis (DMP) – is described in young patients, presenting with multiple papules and characteristic dermal fibroblastic proliferation. The condition appears benign with potential for spontaneous regression.
doi.org/10.1093/bjd/ljaf509 -
BJD
@BrJDermatol
New research characterizes germline and somatic “second-hit” changes in #porokeratosis, identifying novel variants and genotype–phenotype correlations across 572 cases. Findings may support future molecular risk-stratified management. #dermatology
doi.org/10.1093/bjd/ljaf461 -
BJD
@BrJDermatol
Three-dimensional total body photography reveals distinct cutaneous phenotypes linked to risk of late-onset invasive melanoma in high-risk adults age >50. These findings highlight the potential of imaging to refine #melanoma risk assessment.
doi.org/10.1093/bjd/ljaf440 -
BJD
@BrJDermatol
Early diagnosis of cutaneous T-cell lymphoma (CTCL), particularly mycosis fungoides, remains challenging. Multiharmonic imaging combined with AI-driven lymphocyte detection may enable earlier and more precise identification of disease. #dermatology #ctcl
doi.org/10.1093/bjd/ljaf345 -
BJD
@BrJDermatol
Psychological distress is common among melanoma survivors and individuals at high risk. This study identifies optimal Distress Thermometer cutoffs to aid screening and highlights distinct psycho-oncological needs in these groups. #melanoma #dermatology
doi.org/10.1093/bjd/ljaf439 -
BJD
@BrJDermatol
Unfavourable sleep patterns are linked to increased risk of psoriatic disease, particularly in those with genetic susceptibility. Inflammatory and metabolic biomarkers may partly mediate this association. #psoriasis #dermatology
doi.org/10.1093/bjd/ljaf463 -
BJD reposted
Werth Lab
@werthlab
Erythema and scale in cutaneous #lupus erythematosus significantly impacts patient quality of life #qol and disease course impression @BrJDermatol academic.oup.com/bjd/article-abstract/193/3/558/8123945
-
BJD
@BrJDermatol
Outcome measures in bullous pemphigoid research remain highly heterogeneous, with minimal use of patient-reported outcomes.
This scoping review highlights the need for harmonized outcome measures to strengthen evidence and guide future treatments.
🔗 doi.org/10.1093/bjd/ljaf471 -
BJD
@BrJDermatol
Can early-life infections shape long-term skin health?
New research in the BJD shows childhood infections may predispose to psoriasis into early adulthood, highlighting the role of adaptive immune development in formative years. #psoriasis #immunology
doi.org/10.1093/bjd/ljaf416 -
BJD
@BrJDermatol
🚨 The March 2026 issue of the BJD is here! 🚨
Issue highlights include childhood infections as a risk factor for psoriasis, weekly vs daily bathing for eczema, and 3D-total body photography to characterize late-onset invasive melanoma risk.
Read more: academic.oup.com/bjd/issue -
BJD
@BrJDermatol
Celebrating #rarediseaseday 🌍 today! Rare diseases affect millions globally, yet treatment options remain limited. This editorial from @derm_scientist calls for accelerated innovation and optimism in rare disease therapy development. Read more 👉
doi.org/10.1093/bjd/ljaf432 -
BJD
@BrJDermatol
Atopic dermatitis shares a distinct T helper 2 subset with mycosis fungoides that exhibits autonomous proliferative potential
doi.org/10.1093/bjd/ljaf362 -
BJD
@BrJDermatol
This spatial epidemiological study examines the association between sarcoidosis period prevalence and environmental exposures in Massachusetts.
doi.org/10.1093/bjd/ljaf402 -
BJD
@BrJDermatol
From flare to freedom: a young woman’s guttate psoriasis journey
This patient narrative describes the psychosocial impact of guttate psoriasis in a young woman, including its progression to plaque psoriasis and the role of stress and alcohol as triggers.
doi.org/10.1093/bjd/ljaf433 -
BJD
@BrJDermatol
Psoriasis is usually managed via a ‘staircase’ approach, slowly escalating treatment from topicals to biologics, often delaying effective intervention for years. Recent evidence supports an ‘elevator’ approach, advocating early use of systemic therapies.
doi.org/10.1093/bjd/ljaf403 -
BJD
@BrJDermatol
Therapeutic efficacy of cannabidiol on pruritus and pain in children with recessive dystrophic epidermolysis bullosa: a pilot study
doi.org/10.1093/bjd/ljaf400 -
BJD
@BrJDermatol
A multiple-methods study of the SKCIN Sun Safe Schools international programme 2012–23: promoting sun safety and empowering behavioural change in primary education
doi.org/10.1093/bjd/ljaf425 -
BJD
@BrJDermatol
Skin cancer does not affect all communities equally. This #worldcancerday, explore new national data from England (2013-2020) on ethnicity and skin cancer incidence, highlighting the importance of equitable prevention, awareness and early diagnosis.
doi.org/10.1093/bjd/ljaf352 -
BJD
@BrJDermatol
‘A treatment should be here in 5 years’: has the time come for rare diseases?
doi.org/10.1093/bjd/ljaf432 -
BJD
@BrJDermatol
📢 We are seeking applications for the Section Editor role in Evidence-Based Dermatology. If you’re passionate about evidence synthesis and dermatology research, we’d love to hear from you!👇
academic.oup.com/bjd/pages/evidence-based-dermatology-rec… -
BJD
@BrJDermatol
Psoriasis and risk of 26 cancers: pooled population-based cohort studies from Denmark, England, Israel and Taiwan
doi.org/10.1093/bjd/ljaf399 -
BJD
@BrJDermatol
Psoriasis is associated with cardiometabolic comorbidity. GLP-1RAs have been shown to reduce cardiometabolic risk. In this matched cohort study, the authors found lower risk of major adverse cardiac events in psoriasis patients treated with GLP-1RAs.
doi.org/10.1093/bjd/ljaf346 -
BJD
@BrJDermatol
Psoriasis and risk of 26 cancers: pooled population-based cohort studies from Denmark, England, Israel and Taiwan
doi.org/10.1093/bjd/ljaf399 -
BJD
@BrJDermatol
Rademikibart (CBP-201) is a next-generation human monoclonal antibody targeting IL-4 receptor subunit alpha. Rademikibart was investigated in a phase II trial in Chinese adults and adolescents with moderate-to-severe atopic dermatitis. Read more:
doi.org/10.1093/bjd/ljaf347 -
BJD
@BrJDermatol
This 48-week double-blind, randomized, placebo-controlled phase II/III trial (RAAINBOW) is the first to evaluate the efficacy and safety of Cinainu, a botanical drug candidate, in children and adolescents with moderate-to-severe alopecia areata.
doi.org/10.1093/bjd/ljaf279 -
BJD
@BrJDermatol
Listen to BJD Talks, the official podcast of British Journal of Dermatology! You can browse all episodes and stream the podcast series on Soundcloud or Apple Podcasts. Check us out at the link below!
academic.oup.com/bjd/pages/podcast -
BJD
@BrJDermatol
Alloknesis refers to itch caused by stimuli that does not normally induce itch, and differs from mechanical pruritus because it is linked to sensitization to pruritus, and therefore occurs in pathological conditions. Read more at the link below:
doi.org/10.1093/bjd/ljaf337 -
BJD
@BrJDermatol
Anti-p200 pemphigoid is an autoimmune bullous disorder. In this review, the authors summarize the current knowledge about the epidemiology, clinical presentation, diagnosis, target antigens, pathophysiology and treatment of this pemphigoid disease.
doi.org/10.1093/bjd/ljaf324 -
BJD
@BrJDermatol
SPECTREM phase IIIb clinical trial results through week 16: guselkumab efficacy and safety for the treatment of low body surface area, moderate psoriasis with high-impact site involvement
doi.org/10.1093/bjd/ljaf327 -
BJD
@BrJDermatol
Quality of life, psychosocial difficulties and bullying in paediatric patients with alopecia areata: a European cross-sectional study
doi.org/10.1093/bjd/ljaf318 -
BJD
@BrJDermatol
Authorship dynamics: a bibliometric analysis of low- and middle-income country author representation in high-impact dermatology journals
doi.org/10.1093/bjd/ljaf335 -
BJD
@BrJDermatol
A national cohort study of melanoma BRAF status, testing patterns, patient and tumour characteristics, treatment and survival in England from 2016 to 2021
doi.org/10.1093/bjd/ljaf351 -
BJD
@BrJDermatol
Validation of CXCL9 as a biomarker of morphoea disease state and severity through longitudinal analysis
doi.org/10.1093/bjd/ljaf267 -
BJD
@BrJDermatol
The Hidradenitis Suppurativa Symptom and Impact Diary: Development and psychometric evaluation of a novel set of patient-reported outcomes for hidradenitis suppurativa
doi.org/10.1093/bjd/ljaf317 -
BJD
@BrJDermatol
Effect of daily sunscreen application on vitamin D: findings from the open-label randomized controlled Sun-D Trial
doi.org/10.1093/bjd/ljaf310 -
BJD
@BrJDermatol
Comparative efficacy of topical tofacitinib versus topical tacrolimus in the treatment of localized vitiligo: a randomized investigator-blinded intraindividual trial
doi.org/10.1093/bjd/ljaf306 -
BJD
@BrJDermatol
Beneath the surface: delineating the subtypes of Dowling–Degos disease
doi.org/10.1093/bjd/ljaf286 -
BJD
@BrJDermatol
European Organisation for Research and Treatment of Cancer, United States Cutaneous Lymphoma Consortium and International Society for Cutaneous Lymphomas consensus recommendations for management and treatment of cutaneous lymphoproliferative disorders
doi.org/10.1093/bjd/ljaf312 -
BJD
@BrJDermatol
The rise of new targets in melanoma
doi.org/10.1093/bjd/ljaf251 -
BJD
@BrJDermatol
Mosaic disorders affecting pigmentation – part 2: how to make a genetic diagnosis
doi.org/10.1093/bjd/ljaf224 -
BJD
@BrJDermatol
🚨 The December 2025 issue of the BJD is here! 🚨
Issue highlights include upadacitinib in adults with atopic dermatitis, QoL and bullying in paediatric alopecia areata, and TYK2 inhibition in cutaneous lupus.
Read more: academic.oup.com/bjd/issue -
BJD
@BrJDermatol
The impact of vitiligo on pregnancy and perinatal outcome: a systematic review and meta-analysis
doi.org/10.1093/bjd/ljaf266 -
BJD
@BrJDermatol
Skin picking in Down syndrome: a patient speaks out
doi.org/10.1093/bjd/ljaf264 -
BJD
@BrJDermatol
Segmental macular hyperpigmentation: new genes, new clinical implications
doi.org/10.1093/bjd/ljaf254 -
BJD
@BrJDermatol
Genetic, immunological and clinical assessment of isolated chronic recalcitrant dermatophytosis: a prospective study
doi.org/10.1093/bjd/ljaf269 -
BJD
@BrJDermatol
Genomic loci and molecular genetic mechanisms for hidradenitis suppurativa
doi.org/10.1093/bjd/ljaf277 -
BJD
@BrJDermatol
Incidence rates of bullous pemphigoid, herpes zoster and urticaria following the start of the COVID-19 vaccination programme in the UK: a population-based cohort study
doi.org/10.1093/bjd/ljaf237 -
BJD
@BrJDermatol
Avelumab plus cetuximab in patients with unresectable stage III or IV cutaneous squamous cell carcinoma: clinical activity and safety results from AliCe, a single-arm multicentre phase II DeCOG trial
doi.org/10.1093/bjd/ljaf303 -
BJD
@BrJDermatol
Mosaic disorders affecting pigmentation – part 1: how to make a clinical diagnosis
doi.org/10.1093/bjd/ljaf262 -
BJD
@BrJDermatol
Assessing the performance of artificial intelligence models in evaluating inflammatory skin disease severity: a systematic review and meta-analysis
doi.org/10.1093/bjd/ljaf250 -
BJD
@BrJDermatol
Atopic dermatitis epidemiological research methodology: a global scoping review
doi.org/10.1093/bjd/ljaf238 -
BJD
@BrJDermatol
New gene therapies for dystrophic epidermolysis bullosa: progress, promise and persistent gaps
Read the latest from @BJDEditor at the link below!
doi.org/10.1093/bjd/ljaf321 -
BJD
@BrJDermatol
We are soliciting applications for Section Editor for Artificial Intelligence and Emerging Technologies!
The closing date for applications is 11/7/2025. Applications (CV, cover letter) should be sent to Shehnaz Ahmed (shehnaz@bad.org.uk).
More info here: academic.oup.com/bjd/pages/vacancy-british-journal -
BJD
@BrJDermatol
🚨 The November 2025 issue of the BJD is here! 🚨
Issue highlights include AI accuracy in assessing inflammatory skin disease severity, outcomes for delusional infestation in multidisciplinary clinics, and genetics of hidradenitis suppurativa.
Read more: academic.oup.com/bjd/issue -
BJD
@BrJDermatol
Microbiome network: a robust biomarker of skin health
doi.org/10.1093/bjd/ljaf230 -
BJD
@BrJDermatol
Unpredictable interdependence of invasive and in situ melanoma
doi.org/10.1093/bjd/ljaf235 -
BJD
@BrJDermatol
Mechanistic in vivo studies of secondary skin-to-skin peanut allergen transfer to determine the impact of hand washing in reducing the risk of cutaneous sensitization
doi.org/10.1093/bjd/ljaf214 -
BJD
@BrJDermatol
Residential ambient ultraviolet B and ultraviolet A and incidence of keratinocyte carcinoma in the nationwide US Radiologic Technologists cohort
doi.org/10.1093/bjd/ljaf206 -
BJD
@BrJDermatol
Safety and efficacy of the selective tyrosine kinase 2/Janus kinase 1 inhibitor TLL-018 in moderate-to-severe plaque psoriasis: a phase Ib, randomized, double-blind, placebo-controlled study
doi.org/10.1093/bjd/ljaf185 -
BJD
@BrJDermatol
Citations of BJD publications contributing to the 2024 Journal Impact Factor
doi.org/10.1093/bjd/ljaf272 -
BJD
@BrJDermatol
In this episode of BJD Talks, Sam and Meera discuss the article "Mutation burden of narrowband ultraviolet B phototherapy (NB-UVB) in human skin: relevance to NB-UVB lifetime exposures and skin cancer surveillance" by Fowler et al.
soundcloud.com/bjd_talks/episode-17-mutation-burden-of-na…
BJD
@BrJDermatol
The full article can be accessed here: doi.org/10.1093/bjd/ljaf173
*This podcast was generated by an AI tool created by 67Bricks for the British Association of Dermatologists* -
BJD
@BrJDermatol
Impact of Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) on the health-related quality of life (HRQoL) experiences of adults with SJS/TEN: a mixed-methods systematic review
doi.org/10.1093/bjd/ljaf229 -
BJD
@BrJDermatol
Nonsyndromic epidermal differentiation disorders: a new classification toward pathogenesis-based therapy
The authors highlight progress in elucidating the molecular and genetic basis of nonsyndromic epidermal differentiation disorders (nEDDs).
Read more: doi.org/10.1093/bjd/ljaf154 -
BJD
@BrJDermatol
Prurigo nodularis: disease burden, clinical features and approach to management
doi.org/10.1093/bjd/ljaf213 -
BJD
@BrJDermatol
Syndromic epidermal differentiation disorders: a new classification toward pathogenesis-based therapy
The authors present a new gene- and protein product function-based classification for the group of disorders formerly called ichthyosis.
Read more: doi.org/10.1093/bjd/ljaf123 -
BJD
@BrJDermatol
🚨 The October 2025 issue of the BJD is here! 🚨
Issue highlights include quality of life experiences of adults with SJS/TEN, epidemiology of melanoma in England, and a phase I trial of TLL-018 in psoriasis.
Read more: academic.oup.com/bjd/issue -
BJD
@BrJDermatol
A to F Think MF! A Memory Aid for the Early Recognition of Mycosis Fungoides/Sézary syndrome
doi.org/10.1093/bjd/ljaf367 -
BJD
@BrJDermatol
Day 2 at the EADV Congress. Today, we highlight a study looking beyond the physical symptoms of alopecia areata.
The Alopecia + Me study reveals alopecia areata's significant psychosocial burden and its impacts on patient quality of life.
Read more: doi.org/10.1093/bjd/ljaf189 -
BJD
@BrJDermatol
Day 1 at the EADV Congress and we're focusing on psoriasis!
This study of over 8 million women revealed a link between hormone therapy and increased risk of developing psoriasis in both younger and post-menopausal women. Read more at the link below!
doi.org/10.1093/bjd/ljaf179 -
BJD
@BrJDermatol
Happy Peer Review Week 2025! 📝
Artificial intelligence is revolutionizing research and publishing, but how will it impact peer review? We’re eager to hear your thoughts!
Join the discussion with our polls running all week. Share your perspectives below!
BJD
@BrJDermatol
Do you think artificial intelligence could be used in peer review?
BJD
@BrJDermatol
What are your views about the use of artificial intelligence in peer review?
BJD
@BrJDermatol
How do you currently use artificial intelligence in your academic work? How do you think artificial intelligence might help with the future of research, publishing, and peer review? Let us know in the replies!
-
BJD
@BrJDermatol
Efficacy and safety of tildrakizumab in patients with early- vs. late-onset psoriasis
doi.org/10.1093/bjd/ljaf171 -
BJD
@BrJDermatol
Outcome measures for interdisciplinary care in immune-mediated inflammatory skin diseases: a scoping review
doi.org/10.1093/bjd/ljaf153 -
BJD
@BrJDermatol
Palmoplantar epidermal differentiation disorders: a new classification toward pathogenesis-based therapy
doi.org/10.1093/bjd/ljaf054 -
BJD
@BrJDermatol
Psychosocial burden and the impact of illness perceptions and stigma on quality of life, anxiety and depression in alopecia areata: results from the Alopecia + Me study
doi.org/10.1093/bjd/ljaf189 -
BJD
@BrJDermatol
Management of oesophageal strictures in inherited epidermolysis bullosa: a clinical practice guideline
doi.org/10.1093/bjd/ljaf191 -
BJD
@BrJDermatol
Targeting the MAPK pathway for NRAS mutant melanoma: from mechanism to clinic
doi.org/10.1093/bjd/ljaf178 -
BJD
@BrJDermatol
🚨 The September 2025 issue of the BJD is here! 🚨
Issue highlights include a review of palmoplantar epidermal differentiation disorders, tirabrutinib in systemic sclerosis, and psychosocial burden in alopecia areata.
Read more: academic.oup.com/bjd/issue -
BJD
@BrJDermatol
Treatment of bullous pemphigoid with methotrexate is associated with a decreased mortality risk
doi.org/10.1093/bjd/ljaf172 -
BJD
@BrJDermatol
In this episode of BJD Talks, Sam and Meera discuss the article "Janus kinase/signal transducer and activator of transcription signalling pathway is involved in the immune mechanism of bullous pemphigoid" by H-Y Chung et al.
soundcloud.com/bjd_talks/jakstat-signalling-in-bullous-pe…
BJD
@BrJDermatol
The full article can be accessed here: doi.org/10.1093/bjd/ljaf219
*This podcast was generated by an AI tool created by 67Bricks for the British Association of Dermatologists* -
BJD
@BrJDermatol
In this episode of BJD Talks, Sam and Meera discuss the article "Added value of pathology consultations in cutaneous lymphomas: a 2-year review from the Dutch national referral and expertise centre" by Doeleman et al.
soundcloud.com/bjd_talks/added-value-of-pathology-consult…
BJD
@BrJDermatol
The full article can be accessed here: doi.org/10.1093/bjd/ljaf184
*This podcast was generated by an AI tool created by 67Bricks for the British Association of Dermatologists* -
BJD reposted
British Geriatrics Society
@GeriSoc
BGS President Jugdeep Dhesi has co-authored an article in the @BrJDermatol on how we can work together to support patients living with frailty/Multiple Long-Term Conditions make the best treatment decisions about skin cancers and avoid overtreatment. academic.oup.com/bjd/article/193/3/551/8133179?login=false
-
BJD
@BrJDermatol
In this episode of BJD Talks, Sam and Meera discuss the article "Psychosocial burden and the impact of illness perceptions and stigma on quality of life, anxiety and depression in alopecia areata: results from the Alopecia + Me study" by Christou et al.
soundcloud.com/bjd_talks/psychosocial-burden-impact-of-il…
BJD
@BrJDermatol
The full article can be accessed here: doi.org/10.1093/bjd/ljaf189
*This podcast was generated by an AI tool created by 67Bricks for the British Association of Dermatologists* -
BJD
@BrJDermatol
Tonsillar microbiota alterations contribute to immune responses in psoriasis by skewing aged neutrophils
doi.org/10.1093/bjd/ljaf134 -
BJD
@BrJDermatol
Performance of deep learning algorithm based on Xception in evaluating morphological characteristics reflecting the activity of vitiligo
doi.org/10.1093/bjd/ljaf133 -
BJD
@BrJDermatol
Transcriptomic skin niches in systemic sclerosis underpin a role for mitochondrial dysfunction
doi.org/10.1093/bjd/ljaf119 -
BJD
@BrJDermatol
Measurement properties of the Comprehensive Quality-of-Life Measure for Acne (CompAQ): a cohort study at three international sites
doi.org/10.1093/bjd/ljaf127 -
BJD
@BrJDermatol
We are seeking a new BJD Associate Editor for the Outcomes and Qualitative Research section!
If you feel you would be a good fit, please email a brief (2 page), focused CV and separate cover letter to shehnaz@bad.org.uk.
More info at the link below!
academic.oup.com/bjd/pages/british-journal-associate-editor -
BJD
@BrJDermatol
Interleukin (IL)-34 promotes the inflammatory role of IL-1β-producing myeloid cells in pemphigus lesions
doi.org/10.1093/bjd/ljaf130 -
BJD
@BrJDermatol
Hormone therapy and increased risk of psoriasis in reproductive-age and postmenopausal women: a nationwide cohort study and target trial emulation
doi.org/10.1093/bjd/ljaf179 -
BJD
@BrJDermatol
Low-grade systemic inflammation is associated with risk of psoriasis in a general population study of more than 100 000 individuals
doi.org/10.1093/bjd/ljaf147 -
BJD
@BrJDermatol
Measurement properties of the Comprehensive Quality-of-Life Measure for Acne (CompAQ): a cohort study at three international sites
doi.org/10.1093/bjd/ljaf127 -
BJD
@BrJDermatol
Congenital melanocytic naevi initiated by BRAF fusion oncogene with firmness, pruritus and desmoplastic stroma
doi.org/10.1093/bjd/ljaf061 -
BJD
@BrJDermatol
Childhood mastocytosis: challenges and potential shortfalls in current disease classification
doi.org/10.1093/bjd/ljaf141 -
BJD
@BrJDermatol
🚨 The August 2025 issue of the BJD is here! 🚨
Issue highlights include HS and psychiatric disease, eyebrow and eyelash involvement with baricitinib in patients with AA, and low-grade systemic inflammation and psoriasis.
Read more: academic.oup.com/bjd/issue -
BJD
@BrJDermatol
We are delighted to announce the relaunch of the BJD Talks podcast!
The new episodes are AI-generated and designed to provide clear, concise and engaging summaries of selected articles.
Be sure to subscribe via your podcast app of choice or visit: soundcloud.com/bjd_talks
BJD
@BrJDermatol
In this episode of BJD Talks, Sam and Meera discuss the article "Understanding eyebrow and eyelash involvement in patients with alopecia areata and responsiveness to treatment with baricitinib" by Mostaghimi et al.
Listen here: soundcloud.com/bjd_talks/eyebrow-and-eyelash-involvement-…
BJD
@BrJDermatol
Sam and Meera discuss the article "Evidence of immunogenic cell death (ICD) and ICD-dependent dendritic cell activation induced by extracorporeal photopheresis in patients with leukaemic forms of cutaneous T-cell lymphoma" by Lackner et al.
Listen here: soundcloud.com/bjd_talks/immunogenic-cell-death-in-ecp-tr… -
BJD
@BrJDermatol
Risk of herpes zoster and postherpetic neuralgia in patients with psoriasis treated with biologics: a nationwide study using a target trial emulation framework
doi.org/10.1093/bjd/ljaf101 -
BJD
@BrJDermatol
A qualitative interview study exploring patients’ views and experiences of treatment for hidradenitis suppurativa in the UK
doi.org/10.1093/bjd/ljaf046 -
BJD
@BrJDermatol
Sodium–glucose cotransporter 2 inhibitors and inverse risk of new-onset atopic dermatitis in a cohort with diabetes: a nationwide active-comparator study
doi.org/10.1093/bjd/ljaf086 -
BJD
@BrJDermatol
Incidence, stage and outcome of malignant melanoma, keratinocyte and other cancers in individuals with vitiligo or alopecia: intraindividual or familial risks?
doi.org/10.1093/bjd/ljaf074 -
BJD
@BrJDermatol
Management of congenital ichthyoses: guidelines of care
In Part 2 of the 2024 update to these guidelines, the authors discuss managing complications, neonatal considerations, and specific conditions such as Netherton syndrome.
Read more: doi.org/10.1093/bjd/ljaf077 -
BJD
@BrJDermatol
Therapeutic advances for cutaneous T-cell lymphoma
doi.org/10.1093/bjd/ljaf105 -
BJD
@BrJDermatol
Long-term (68 weeks) administration of nemolizumab and topical corticosteroids for prurigo nodularis in patients aged ≥ 13 years: efficacy and safety data from a phase II/III study
doi.org/10.1093/bjd/ljaf045 -
BJD
@BrJDermatol
Management of congenital ichthyoses: guidelines of care
In Part 1 of the 2024 update to these guidelines, the authors discuss treatment options, managing the psychosocial impacts of disease, telemedicine, and genetic testing.
Read more: doi.org/10.1093/bjd/ljaf076 -
BJD
@BrJDermatol
🚨 The July 2025 issue of the BJD is here! 🚨
Issue highlights include an update to guidelines for management of congenital ichthyoses, long-term nemolizumab in prurigo nodularis, and skin cancer risk in vitiligo and alopecia areata.
Read more: academic.oup.com/bjd/issue -
BJD
@BrJDermatol
Come stop by and say hi in the exhibition hall!
-
BJD reposted
Oxford Journals
@OxfordJournals
📢Calling all attendees of the British Association of Dermatologists Annual Meeting!📢 Are you looking for more information about @BrJDermatol, @ced_journal, and @SkinHealthDis? Visit the BAD stand for the Meet the Editors sessions this week!
-
BJD
@BrJDermatol
Come say hi at BAD 2025! Looking forward to seeing you all there!
-
BJD
@BrJDermatol
Leading the field for impact: the BJD maintains its #1 dermatology journal ranking with CiteScore
doi.org/10.1093/bjd/ljaf129 -
BJD
@BrJDermatol
Maternal Janus kinase inhibitor use is associated with increased risk of aborted pregnancy: a systematic review and meta-analysis
doi.org/10.1093/bjd/ljaf113 -
BJD
@BrJDermatol
Diagnosis and management of Mohs surgery complications by large language models using preconstructed written scenarios
doi.org/10.1093/bjd/ljaf100 -
BJD
@BrJDermatol
Upadacitinib outperforms dupilumab in restoring the fungal microbiome in atopic dermatitis
doi.org/10.1093/bjd/ljaf095 -
BJD
@BrJDermatol
Characteristics of patients seeking skin-related minor ailment pharmacy services in Ontario, Canada: a population-based cross-sectional study
doi.org/10.1093/bjd/ljaf092 -
BJD
@BrJDermatol
St Andrews Referral Delay in Skin Cancer (StARDISC): a study of keratinocyte skin cancer time to treatment, growth, invasiveness, British Association of Dermatologists risk factors and excision adequacy
doi.org/10.1093/bjd/ljaf097 -
BJD reposted
Belinda Campbell
@belinda_campbe
Delighted to see our work in print! 🇦🇺
With thanks to my brilliant co-authors and to @BrJDermatol 🙏
Free to read ➡️ academic.oup.com/bjd/article/192/6/1018/7917659
#ctcl #geospatial #rarecancers #equityofcare
@PeterMacCC @UniMelb @PeterMacRes @PeterMacHSR @CCQld @PeterBaade @MACHAustralia -
BJD reposted
CED
@ced_journal
Join us for the How to Peer Review Course, an in-person 3-hour course held in Glasgow on Monday 30 June.
This is taking place during the pre-conference sessions of the British Association of Dermatologists’ Annual Meeting. -
BJD
@BrJDermatol
Prevalence of chronic hand eczema in adults: a cross-sectional survey of over 60 000 respondents from the general population of Canada, France, Germany, Italy, Spain and the UK
doi.org/10.1093/bjd/ljaf020 -
BJD
@BrJDermatol
Prenatal and postnatal exposure to fine particulate matter (PM2.5) are associated with later development of atopic dermatitis. Vulnerable periods might be late gestation and soon after birth.
Read more: doi.org/10.1093/bjd/ljaf075 -
BJD
@BrJDermatol
EASE was a phase III randomized controlled trial of Oleogel-S10 (birch bark extract) in patients with epidermolysis bullosa, demonstrating favorable long-term safety and sustained reductions in wound burden (affected BSA from 12.1% to 6.1%).
Read more: doi.org/10.1093/bjd/ljaf022 -
BJD
@BrJDermatol
Geospatial analyses reveal heterogeneity in CTCL incidence across Australia, with lower diagnosis rates in rural/remote and socioeconomically disadvantaged areas, and differing from that of all rare cancers.
doi.org/10.1093/bjd/ljae476 -
BJD
@BrJDermatol
Cutaneous granulomas: mechanisms, cellular interactions and therapeutic insights
doi.org/10.1093/bjd/ljaf096 -
BJD
@BrJDermatol
Causal association between polyunsaturated fatty acids and acne: a two-sample Mendelian randomization study
doi.org/10.1093/bjd/ljaf052 -
BJD
@BrJDermatol
The efficacy and safety of first-line metastatic melanoma treatment with ipilimumab + nivolumab vs. nivolumab in a real-world setting
doi.org/10.1093/bjd/ljae470 -
BJD reposted
Werth Lab
@werthlab
Erythema variation in #dermatomyositis across subtypes and racial groups: importance of outcome measure for dermatomyositis clinical trials in @BrJDermatol academic.oup.com/bjd/article-abstract/192/5/943/7945316
-
BJD
@BrJDermatol
Prevalence of chronic hand eczema in adults: a cross-sectional survey of over 60 000 respondents from the general population of Canada, France, Germany, Italy, Spain and the UK
doi.org/10.1093/bjd/ljaf020 -
BJD
@BrJDermatol
Skin cancer risk in more than 200 000 patients with haematological malignancies over 30 years: a nationwide population-based study in the Netherlands
doi.org/10.1093/bjd/ljaf027 -
BJD
@BrJDermatol
Orismilast, a phosphodiesterase 4B/D inhibitor, in moderate-to-severe atopic dermatitis: efficacy and safety from a multicentre randomized placebo-controlled phase IIb dose-ranging study (ADESOS)
doi.org/10.1093/bjd/ljae507 -
BJD
@BrJDermatol
🚨 The June 2025 issue of the BJD is here! 🚨
Issue highlights include fine particulate matter exposure and AD, patient research priorities in melanoma, and novel translational research showing that human scalp hair follicles can "taste."
Read more: academic.oup.com/bjd/issue/192/6 -
BJD
@BrJDermatol
Clinical practices and educational interests of dermatologists in Caribbean countries
doi.org/10.1093/bjd/ljaf030 -
BJD
@BrJDermatol
Real-world melanoma miss rate in an NHS hospital dermatology service: a retrospective study
doi.org/10.1093/bjd/ljaf024 -
BJD
@BrJDermatol
Under-representation of climate change and sustainability manuscripts in high-impact dermatology journals
doi.org/10.1093/bjd/ljaf037 -
BJD
@BrJDermatol
Pilot study of topical ruxolitinib demonstrates efficacy and blunting of heterogeneous inflammatory processes in mild hidradenitis suppurativa
doi.org/10.1093/bjd/ljae495 -
BJD
@BrJDermatol
Happy Sun Awareness Week! ☀️
#sunawarenessweek is the BAD’s annual campaign to encourage everyone to protect their skin from sun damage and to promote @HealthySkin4All.
Read more in @OUPAcademic’s blog highlighting recent skin cancer-related research!
blog.oup.com/2025/05/shining-light-on-sun-safety-for-sun-…Post not available here, view on X
BJD
@BrJDermatol
In this study from the Netherlands, Eggermont et al. found that patients with blood cancers have a higher risk of skin cancers across the lifetime, underscoring the importance of targeted awareness campaigns for sun protection in this patient population.
doi.org/10.1093/bjd/ljaf027
BJD
@BrJDermatol
In the last of three BJD article highlights from #sunawarenessweek, Simpson et al. found that drugs for type 2 diabetes, especially metformin, may lower risk of non-melanoma skin cancer.
doi.org/10.1093/bjd/ljae341 -
BJD
@BrJDermatol
Grover disease shows type 2 immune activation and improves with dupilumab @billdamsky
doi.org/10.1093/bjd/ljaf005 -
BJD
@BrJDermatol
Long-term (68 weeks) administration of nemolizumab in paediatric patients aged 6–12 years with atopic dermatitis with moderate-to-severe pruritus: efficacy and safety data from a phase III study
doi.org/10.1093/bjd/ljae458 -
BJD
@BrJDermatol
A novel three-dimensional model of infantile haemangioma
doi.org/10.1093/bjd/ljae483 -
BJD
@BrJDermatol
Efficacy and safety of the ustekinumab biosimilar ABP 654 in patients with moderate-to-severe plaque psoriasis: a randomized double-blinded active-controlled comparative clinical study over 52 weeks
doi.org/10.1093/bjd/ljae402 -
BJD
@BrJDermatol
Differences in mean age at diagnosis of invasive melanoma for men and women by anatomical site, thickness and subtype
doi.org/10.1093/bjd/ljae482 -
BJD
@BrJDermatol
Reporting of concomitant and rescue topical therapies in randomized controlled trials evaluating a systemic treatment in atopic dermatitis: a scoping review
doi.org/10.1093/bjd/ljaf031 -
BJD
@BrJDermatol
Melanoma: assessment and management summary of the 2022 update of the National Institute for Health and Care Excellence guidelines
doi.org/10.1093/bjd/ljaf016 -
BJD
@BrJDermatol
Emerging role of regulatory T cells in the immunopathogenesis of vitiligo and implications for treatment
doi.org/10.1093/bjd/ljae472 -
BJD
@BrJDermatol
Press play for impact: enhancing BJD article appeal through video
Read more from @BJDEditor on how the BJD is advancing our digital footprint through video!
doi.org/10.1093/bjd/ljaf044 -
BJD
@BrJDermatol
🚨 The May 2025 issue of the BJD is here! 🚨
Issue highlights include a trial of long-term nemolizumab for AD with pruritus in children, geospatial variation of CTCLs across Australia, and novel instruments to assess AD in skin of colour.
Read more: academic.oup.com/bjd/issue/192/5 -
BJD
@BrJDermatol
Global Delphi consensus on treatment goals for generalized pustular psoriasis
doi.org/10.1093/bjd/ljae491 -
BJD
@BrJDermatol
Caffeine-induced fixed drug eruption: evidence from a positive patch test
doi.org/10.1093/bjd/ljae463 -
BJD
@BrJDermatol
Integrating artificial intelligence into skin cancer pathways: the opportunities and obstacles
doi.org/10.1093/bjd/ljae480 -
BJD
@BrJDermatol
R(+) propranolol decreases lipid accumulation in haemangioma-derived stem cells
doi.org/10.1093/bjd/ljae452 -
BJD
@BrJDermatol
Changes in skin research funding: the emergence of environmental sustainability criteria in the research competition assessment process
doi.org/10.1093/bjd/ljae503 -
BJD
@BrJDermatol
Multitranscriptome analysis reveals stromal cells in the papillary dermis to promote angiogenesis in psoriasis vulgaris
doi.org/10.1093/bjd/ljae459 -
BJD
@BrJDermatol
The roles of interleukin (IL)-17A and IL-17F in hidradenitis suppurativa pathogenesis: evidence from human in vitro preclinical experiments and clinical samples
doi.org/10.1093/bjd/ljae442 -
BJD
@BrJDermatol
Topical application of the Hedgehog inhibitor patidegib in patients with Gorlin syndrome: a phase II trial
doi.org/10.1093/bjd/ljae444 -
BJD
@BrJDermatol
Disabling pansclerotic morphoea: a century of discovery
doi.org/10.1093/bjd/ljae443 -
BJD
@BrJDermatol
Incidence and patterns of newly developed pigmented lesions in adults at high risk for melanoma
doi.org/10.1093/bjd/ljae467 -
BJD
@BrJDermatol
A personalized and systematically designed adherence intervention improves photoprotection in adults with xeroderma pigmentosum (XP): results of the XPAND randomized controlled trial
doi.org/10.1093/bjd/ljae393 -
BJD
@BrJDermatol
Association of proprotein convertase subtilisin/kexin type-9 inhibitors with risk of nonmelanoma skin cancer: a retrospective cohort study
doi.org/10.1093/bjd/ljae438 -
BJD
@BrJDermatol
The allergen that causes polymorphic light eruption (PLE) remains unknown. Here, the authors show that the microbiome composition is transiently scrambled upon photoprovocation in patients with PLE, favouring overgrowth of dysbiotic members.
Read more: doi.org/10.1093/bjd/ljae464 -
BJD
@BrJDermatol
Patient preferences for the treatment of Bowen disease
doi.org/10.1093/bjd/ljae477 -
BJD
@BrJDermatol
Long-term efficacy and safety of secukinumab in patients with moderate-to-severe hidradenitis suppurativa: week 104 results from the SUNSHINE and SUNRISE extension trial
doi.org/10.1093/bjd/ljae469 -
BJD
@BrJDermatol
Long-term management of moderate-to-severe atopic dermatitis with lebrikizumab and concomitant topical corticosteroids: a 68-week randomized double-blind placebo-controlled phase III trial in Japan (ADhere-J)
doi.org/10.1093/bjd/ljae394 -
BJD
@BrJDermatol
In this review, the authors propose a model of hair cycle progression in and out of the active growth phase being controlled by evolutionary malleable molecular checkpoints, summarizing the evidence for their hypothesis.
Read more: doi.org/10.1093/bjd/ljae456 -
BJD
@BrJDermatol
🚨 The April 2025 issue of the BJD is here! 🚨
Learn about PCSK9 inhibitors and skin cancer risk, lebrikizumab for atopic dermatitis, drug survival and safety of adalimumab biosimilars for psoriasis, and more!
Read more: academic.oup.com/bjd/issue/192/4 -
BJD
@BrJDermatol
Ultraviolet radiation is not the major cause of melanoma mortality in the UK and sun exposure advice should be revised
doi.org/10.1093/bjd/ljae426 -
BJD
@BrJDermatol
Integrating artificial intelligence into skin cancer pathways: the opportunities and obstacles
doi.org/10.1093/bjd/ljae480 -
BJD reposted
sk(in depth)
@skindepthderm
Are drugs commonly given to older patients putting them at risk of bullous pemphigoid? Read about it in our latest issue courtesy of @BrJDermatol
-
BJD
@BrJDermatol
Real-world evaluation of the effectiveness and safety of dupilumab in bullous pemphigoid: an ambispective multicentre case series
doi.org/10.1093/bjd/ljae403 -
BJD
@BrJDermatol
Circular RNA circASH1L(4,5) protects microRNA-129-5p from target-directed microRNA degradation in human skin wound healing
Read more: doi.org/10.1093/bjd/ljae405 -
BJD
@BrJDermatol
New research published in the BJD has found that applying a common food additive to hair follicles can activate taste receptors and prevent hair growth in lab tests.
Per senior author Ralf Paus, "Is this the bittersweet end of unwanted hair?”
Read more: www.bad.org.uk/tastebuds-in-hair-follicles-could-unlock-n…
BJD
@BrJDermatol
Link to article below!
doi.org/10.1093/bjd/ljaf060 -
BJD
@BrJDermatol
In this clinical trial, the authors find that tralokinumab every 4 weeks is an effective dosing regimen for most patients with atopic dermatitis who have achieved stable disease control with tralokinumab every 2 weeks.
Read more: doi.org/10.1093/bjd/ljae439 -
BJD
@BrJDermatol
We hope everyone had as great of a time at #aad2025 as we did. See you all next year in Denver!
-
BJD
@BrJDermatol
Novel therapeutic strategy for intractable keloids: suppression of intracellular mechanotransduction and actin polymerization via Rho-kinase pathway inhibition
doi.org/10.1093/bjd/ljae384 -
BJD
@BrJDermatol
Longitudinal validity of the Hyperhidrosis Quality of Life Index (HidroQoL©) in a phase IIIb clinical trial population with hyperhidrosis: responsiveness and meaningful change
doi.org/10.1093/bjd/ljae415 -
BJD
@BrJDermatol
Association of childhood obesity or weight change with early-onset follicular occlusion triad in children
doi.org/10.1093/bjd/ljae414 -
BJD
@BrJDermatol
We'll be attending AAD 2025 in Orlando, FL. Come say hi!
In conjunction with the annual meeting, the BAD has assembled a joint virtual issue highlighting papers from North America. The issue includes 3 papers from each of our journals.
Read more: academic.oup.com/bjd/pages/highlights-from-north-american… -
BJD
@BrJDermatol
Deucravacitinib, an oral selective allosteric tyrosine kinase 2 inhibitor, in patients from China mainland, Taiwan and South Korea with moderate-to-severe plaque psoriasis: a phase III randomized clinical trial
doi.org/10.1093/bjd/ljae406 -
BJD
@BrJDermatol
In a UK Biobank analysis, higher air pollution exposure levels significantly increased risk of psoriasis, especially in those at high genetic risk. These findings highlight the importance of reducing air pollution for psoriasis prevention.
Read more: doi.org/10.1093/bjd/ljae391 -
BJD
@BrJDermatol
Tailored bioengineering and nanomedicine strategies for sex-specific healing of chronic wounds
doi.org/10.1093/bjd/ljae457 -
BJD
@BrJDermatol
In the March 2025 issue of the BJD, @BJDEditor shares his perspective on recently discovered roles for macrophages in human skin development.
Read more: doi.org/10.1093/bjd/ljae473 -
BJD
@BrJDermatol
🚨 The March 2025 issue of the BJD is here! 🚨
Learn more about real-world efficacy and safety of dupilumab, air pollution and psoriasis, insights gained from spatial proteomics of the human melanoma tumor microenvironment, and more!
Read more: academic.oup.com/bjd/issue/192/3 -
BJD
@BrJDermatol
An evolutionary tale on clinical trials in hidradenitis suppurativa
doi.org/10.1093/bjd/ljae318 -
BJD
@BrJDermatol
Information encoded in hidradenitis suppurativa (HS) genotypes/phenotypes suggests the presence of clinically relevant disease subtypes. Investment in genetic research will create opportunities to improve health outcomes for patients with HS.
Read more: doi.org/10.1093/bjd/ljae399 -
BJD
@BrJDermatol
The pathophysiology of hidradenitis suppurativa is complex and ever-evolving. A more nuanced understanding of the disease is leading to the identification of novel therapeutic targets and biomarkers directing therapeutic selection.
Read more: doi.org/10.1093/bjd/ljae238 -
BJD
@BrJDermatol
In the February 2025 issue supplement, we present the BJD state-of-the-art review series.
Curated by former EIC John Ingram, these articles delve into genetics of, and precision medicine and clinical trial design for hidradenitis suppurativa.
Read more: doi.org/10.1093/bjd/ljae455 -
BJD
@BrJDermatol
Comprehensive mutational profiling identifies new driver events in cutaneous leiomyosarcoma
doi.org/10.1093/bjd/ljae386 -
BJD
@BrJDermatol
Single-cell RNA sequencing comparison of CD4+, CD8+ and T-cell receptor γδ+ cutaneous T-cell lymphomas reveals subset-specific molecular phenotypes
doi.org/10.1093/bjd/ljae313 -
BJD
@BrJDermatol
A new study published in the BJD found that various skin conditions, including acne and rosacea, are more common in women with irregular periods than those with regular periods.
Read more: www.linkedin.com/posts/british-association-of-dermatologi… -
BJD
@BrJDermatol
Polarization of circulating follicular helper T cells correlates with bullous pemphigoid severity
doi.org/10.1093/bjd/ljae355 -
BJD reposted
John Barbieri, MD, MBA
@DrJohnBarbieri
Just out in @BrJDermatol, interesting MR study lending further support to the potential role of Omega-3 being helpful in acne. These findings align with small trials and observational studies suggesting Omega-3 may be useful. 1/2
pubmed.ncbi.nlm.nih.gov/39936505/ -
BJD
@BrJDermatol
Combined programmed cell death protein 1 and cytotoxic T-lymphocyte associated protein 4 blockade in an international cohort of patients with acral lentiginous melanoma
@McgillivrayErin @Gino_K_In_USC
doi.org/10.1093/bjd/ljae401 -
BJD
@BrJDermatol
Biologics in congenital ichthyosis: are they effective?
Here, the authors report real-life effects of biologics in 98 patients with congenital ichthyosis and perform a parallel literature review, identifying a subset of patients most likely to respond.
doi.org/10.1093/bjd/ljae420 -
BJD
@BrJDermatol
CCR8/CCL1 and CXCR3/CXCL10 axis-mediated memory T-cell activation in patients with recalcitrant drug-induced hypersensitivity
Read more: doi.org/10.1093/bjd/ljae375 -
BJD
@BrJDermatol
Living with epidermolysis bullosa: daily challenges and coping strategies
doi.org/10.1093/bjd/ljae373 -
BJD
@BrJDermatol
Do large language model chatbots perform better than established patient information resources in answering patient questions? A comparative study on melanoma
doi.org/10.1093/bjd/ljae377 -
BJD
@BrJDermatol
Validation of the real-world application of the Hidradenitis Suppurativa Quality of Life (HiSQOL) score to adults with hidradenitis suppurativa
doi.org/10.1093/bjd/ljae367 -
BJD
@BrJDermatol
Global, regional and national burdens of acne vulgaris in adolescents and young adults aged 10–24 years from 1990 to 2021: a trend analysis
doi.org/10.1093/bjd/ljae352 -
BJD
@BrJDermatol
Reflectance confocal microscopy in diagnosing basal cell carcinoma in the UK: a prospective observational single-centre trial
doi.org/10.1093/bjd/ljae356 -
BJD
@BrJDermatol
British Association of Dermatologists living guideline for managing people with alopecia areata 2024
Read more: doi.org/10.1093/bjd/ljae385 -
BJD
@BrJDermatol
🚨 The February 2025 issue of the BJD is here! 🚨
Learn about treatment of patients with alopecia areata, diagnostic accuracy of reflectance confocal microscopy in diagnosis of basal cell carcinoma, epidemiology of acne vulgaris, and more!
Read more: academic.oup.com/bjd/issue/192/2 -
BJD
@BrJDermatol
January 30 marks World NTD Day, the annual rallying point for the global movement to eliminate neglected tropical diseases.
Read more: worldntdday.org
#worldntdday
#beatntds
#uniteacteliminate
BJD
@BrJDermatol
Call for Papers: Special Issue on Neglected Tropical Diseases
Submit your work on neglected tropical diseases to @ced_journal! Deadline is Friday, February 28.
academic.oup.com/ced/pages/call-for-papers-special-issue-… -
BJD
@BrJDermatol
A practical guide to using oral Janus kinase inhibitors for atopic dermatitis from the International Eczema Council
doi.org/10.1093/bjd/ljae342 -
BJD
@BrJDermatol
Artificial intelligence and machine learning in dermatological research and healthcare: British Society for Investigative Dermatology Skin Club Report, Southampton, April 2024
Read more: doi.org/10.1093/bjd/ljae395 -
BJD
@BrJDermatol
Downregulation of lysine 2-hydroxyisobutyrylation of ErbB3 binding protein 1 at amino acid 210 promotes keratinocyte proliferation via induction of transcription initiation factor IA-mediated rRNA synthesis
doi.org/10.1093/bjd/ljae194 -
BJD
@BrJDermatol
Development and psychometric properties of the Functional Assessment of Cancer Therapy–Cutaneous T-Cell Lymphoma (FACT-CTCL) instrument
doi.org/10.1093/bjd/ljae308 -
BJD
@BrJDermatol
Germline amelanotic/hypopigmented melanoma (AHM)-related gene variants were identified in 70% of patients with AHM compared to 8% in pigmented melanoma. Sturm et al. propose that a "second hit" to the corresponding gene results in amelanogenesis in AHM.
doi.org/10.1093/bjd/ljae336 -
BJD
@BrJDermatol
Small interfering RNA microneedle patches versus silicone sheets in reducing postoperative scars: a randomized single-blinded intraindividually controlled clinical trial
doi.org/10.1093/bjd/ljae347 -
BJD reposted
David Zheng (郑夏喆), MD
@davidxzheng
Excited to share our invited editorial in @BrJDermatol on McGillivray et al.'s analysis of real-world outcomes for combined PD-1 and CTLA-4 immune checkpoint blockade in acral lentiginous melanoma. Link below!
doi.org/10.1093/bjd/ljae445 -
BJD
@BrJDermatol
Efficacy and safety of upadacitinib versus dupilumab in adults and adolescents with moderate-to-severe atopic dermatitis: week 16 results of an open-label randomized efficacy assessor-blinded head-to-head phase IIIb/IV study (Level Up)
doi.org/10.1093/bjd/ljae404 -
BJD
@BrJDermatol
‘Psycholag’: a new term to describe the delay between physical and psychological improvement in patients with skin disease
doi.org/10.1093/bjd/ljae333 -
BJD
@BrJDermatol
In this retrospective cohort study, the authors identify disparities in diagnosis and access to care for Black and Hispanic infants with atopic dermatitis compared with non-Hispanic White infants.
Read more: doi.org/10.1093/bjd/ljae322 -
BJD
@BrJDermatol
Prevalence of abdominal aortic aneurysm in patients with hidradenitis suppurativa in the Veterans Affairs Health Care System
doi.org/10.1093/bjd/ljae325 -
BJD
@BrJDermatol
Skin bleaching: a socioecological perspective
doi.org/10.1093/bjd/ljae368 -
BJD
@BrJDermatol
Mycosis fungoides: an unwelcome guest in my life
This patient's perspective highlights the significant impact that mycosis fungoides has had on his quality of life, specifically the psychological impact associated with his diagnosis.
Read more: doi.org/10.1093/bjd/ljae349 -
BJD
@BrJDermatol
The quality-of-life impact of Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) on patients’ lives: an interpretative descriptive qualitative study
doi.org/10.1093/bjd/ljae334 -
BJD
@BrJDermatol
Is seborrhoeic dermatitis of infancy and childhood related to maternal history of seborrhoeic dermatitis? A large population-based cohort study from the UK
doi.org/10.1093/bjd/ljae331 -
BJD
@BrJDermatol
The lifetime risk and impact of vitiligo across sociodemographic groups: a UK population-based cohort study
Lifetime incidence of vitiligo in the UK is 0.92%, with 5x higher incidence in people of Asian ethnicity than those of White ethnicity.
Read more: doi.org/10.1093/bjd/ljae282 -
BJD
@BrJDermatol
Wishing everyone a Happy New Year from the BJD!
-
BJD
@BrJDermatol
Reflectance confocal microscopy to diagnose malignant melanoma and lentigo maligna in the UK: a single-centre prospective observational trial
doi.org/10.1093/bjd/ljae354 -
BJD
@BrJDermatol
Recent progress in Stevens–Johnson syndrome/toxic epidermal necrolysis: diagnostic criteria, pathogenesis and treatment
doi.org/10.1093/bjd/ljae321 -
BJD
@BrJDermatol
Check out the January 2025 issue of the BJD!
Featuring articles on tips for using JAK inhibitors in atopic dermatitis, lifetime risk and healthcare disparities in vitiligo, and the quality-of-life impact of SJS/TEN on patients' lives. Link below! 👇🏻
academic.oup.com/bjd/issue/192/1 -
BJD
@BrJDermatol
Inflammatory dermatoses and an era of new diagnostic dermatopathology
In this editorial, @BJDEditor discusses the potential of -omic profiling and precision diagnostics to transform the landscape of dermatopathology diagnostic practice.
doi.org/10.1093/bjd/ljae306 -
BJD reposted
Prof Andrew R Thompson 💙
@ProfARThompson
Delighted to see our article on the front of the BJD - The incidence and impact of AA on mental health & work outcomes is highest in ethnic groups other than White. Clinicians should be aware of this possibility, and provide assessment and targetted support as required.
BJD
@BrJDermatol
Overall lifetime incidence of alopecia areata (AA) in the UK is 2.1%, with marked variation across ethnic groups. Additionally, lifetime risk of AA is higher for people from more deprived and urban areas.
Read more in the BJD at the link below!
doi.org/10.1093/bjd/ljae307 -
BJD
@BrJDermatol
Hear from @BJDEditor as he discusses the values, changes, and editorial developments of the journal.
www.youtube.com/watch?v=fBq69Ld6g_w -
BJD
@BrJDermatol
Management of scabies in children under 15 kg and pregnant or breastfeeding women: recommendations supported by the Centre of Evidence of the French Society of Dermatology
doi.org/10.1093/bjd/ljae288 -
BJD
@BrJDermatol
Clinically mild hidradenitis suppurativa: mild for whom?
doi.org/10.1093/bjd/ljae310 -
BJD
@BrJDermatol
Duration of smoking cessation for the prevention of psoriasis vulgaris and palmoplantar pustulosis
doi.org/10.1093/bjd/ljae317 -
BJD
@BrJDermatol
Fish-oil supplementation protects skin from yellowness induced by fine particulate matter through an anti-inflammatory mechanism: a randomized, double-blind, placebo-controlled clinical trial
doi.org/10.1093/bjd/ljae311 -
BJD
@BrJDermatol
VEXAS syndrome was in front of us for decades
doi.org/10.1093/bjd/ljae309 -
BJD
@BrJDermatol
High prevalence of undiagnosed and undertreated psoriasis in a UK urban population: results from the observational COPPACA study
doi.org/10.1093/bjd/ljae292 -
BJD
@BrJDermatol
Photodynamic therapy reduces the burden of small ultraviolet-induced epidermal clones in human and mouse skin
doi.org/10.1093/bjd/ljae314 -
BJD
@BrJDermatol
Dupilumab-associated (hyper)eosinophilia in patients with atopic dermatitis: a single-centre cohort study of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry
doi.org/10.1093/bjd/ljae289 -
BJD
@BrJDermatol
Sensitization against medical hyaluronidase in patients with confirmed hypersensitivity against hymenoptera species and its clinical implications
doi.org/10.1093/bjd/ljae290 -
BJD reposted
BJD
@BrJDermatol
The BJD is seeking a Patient Associate Editor (PAE) to support our journal’s reach to patients and the lay public!
More information at the link below. The application includes a cover letter and a short CV (2 pages) by January 6, 2025.
academic.oup.com/bjd/pages/call-for-pae -
BJD
@BrJDermatol
Cytokeratin 17 expression is commonly observed in keratinocytic skin tumours and controls tissue homeostasis impacting human papillomavirus protein expression
doi.org/10.1093/bjd/ljae255 -
BJD
@BrJDermatol
Overall lifetime incidence of alopecia areata (AA) in the UK is 2.1%, with marked variation across ethnic groups. Additionally, lifetime risk of AA is higher for people from more deprived and urban areas.
Read more in the BJD at the link below!
doi.org/10.1093/bjd/ljae307 -
BJD
@BrJDermatol
High-dose vitamin D supplementation does not improve outcome in a cutaneous melanoma population: results of a randomized double-blind placebo-controlled study (ViDMe trial)
doi.org/10.1093/bjd/ljae257 -
BJD
@BrJDermatol
Atypical chemokine receptor 1-positive endothelial cells mediate leukocyte infiltration and synergize with secreted frizzled-related protein 2/asporin-positive fibroblasts to promote skin fibrosis in systemic sclerosis
doi.org/10.1093/bjd/ljae286 -
BJD
@BrJDermatol
The BJD is seeking a Patient Associate Editor (PAE) to support our journal’s reach to patients and the lay public!
More information at the link below. The application includes a cover letter and a short CV (2 pages) by January 6, 2025.
academic.oup.com/bjd/pages/call-for-pae -
BJD reposted
AADmember
@AADmember
A study published in the @BrJDermatol assessed outcomes in 488 adult and pediatric #dermatology patients with #atopicdermatitis receiving treatment with cyclosporine, dupilumab, or methotrexate.
www.aad.org/dw/weekly/september-25-2024 -
BJD
@BrJDermatol
An expert consensus on managing dupilumab-related ocular surface disorders in people with atopic dermatitis 2024
doi.org/10.1093/bjd/ljae344 -
BJD
@BrJDermatol
🚨 The December 2024 issue of the BJD is here! 🚨
In this issue, learn more about dupilumab-related ocular surface disorders in atopic dermatitis, high-dose vitamin D supplementation in melanoma, and epidemiology of alopecia areata. Link below! 👇🏻
academic.oup.com/bjd/issue/191/6 -
BJD
@BrJDermatol
A gain-of-function variant in SREBF1 causes generalized skin hyperpigmentation with congenital cataracts
doi.org/10.1093/bjd/ljae291 -
BJD reposted
Morteza Mahmoudi, PhD
@MoriMahmoudi
A follow-up review paper to our earlier comment in @natrevbioeng (www.nature.com/articles/s44222-024-00191-4) on the need for tailoring #bioengineering and #nanomedicine strategies for #sex-specific healing of #chronic wounds (academic.oup.com/bjd/advance-article/doi/10.1093/bjd/ljae…).
@BrJDermatol @MatooriSimon @A_Shahbazi_UMCG -
BJD
@BrJDermatol
Clinical characteristics associated with joint pain in hidradenitis suppurativa
doi.org/10.1093/bjd/ljae251 -
BJD
@BrJDermatol
The effects of ciclosporin and methotrexate on kidney function in the treatment of severe atopic dermatitis in children: results from the TREAT trial
doi.org/10.1093/bjd/ljae276 -
BJD reposted
Danny Johnston
@DannyJohnston2
Delighted that our infographic has made the COVER of the November edition of the @BrJDermatol!
Well done to Ciara and all the other authors, we hope our piece in the potential of inflammasome inhibition in #hidradenitissuppurativa is stimulating!
@hsireland1 @Skin_Research
BJD
@BrJDermatol
🚨 The November 2024 issue of the BJD is here! 🚨
Read more about secukinumab in lichen planus, epidemiology of itch, outcome measures for vascular malformations, and more. Link below! 👇🏻
academic.oup.com/bjd/issue/191/5 -
BJD
@BrJDermatol
Predictive features for effectiveness of dupilumab in elderly patients with atopic dermatitis: a real-world study
doi.org/10.1093/bjd/ljae278 -
BJD
@BrJDermatol
Prediction of melanoma metastasis using dermatoscopy deep features: an international multicentre cohort study
doi.org/10.1093/bjd/ljae281 -
BJD
@BrJDermatol
‘When you do not feel comfortable in your skin, you cannot get out of it’; a qualitative interview study exploring psychosocial impact and coping strategies among patients with prurigo nodularis
doi.org/10.1093/bjd/ljae274 -
BJD
@BrJDermatol
Urticaria and the risk of cancer: a Danish population-based cohort study
doi.org/10.1093/bjd/ljae264 -
BJD
@BrJDermatol
A phase II multicentre study of plasminogen activator inhibitor-1 inhibitor (TM5614) plus nivolumab for treating anti-programmed cell death 1 antibody-refractory malignant melanoma: TM5614-MM trial
doi.org/10.1093/bjd/ljae231 -
BJD
@BrJDermatol
The impact of irritant challenge on the skin barrier and myeloid-resident immune cells in women who are postmenopausal is modulated by hormone replacement therapy
doi.org/10.1093/bjd/ljae226 -
BJD
@BrJDermatol
In this translational study, @BencomoTomas and @CarolynLeeMDPhD reanalysed RNA sequencing data from cutaneous squamous cell carcinoma and its precursor lesions to define the transcriptome landscape at different stages of tumorigenesis.
doi.org/10.1093/bjd/ljae249 -
BJD
@BrJDermatol
Social, disease and diagnostic factors associated with diagnostic delays in dermatomyositis: a retrospective cohort study
doi.org/10.1093/bjd/ljae247 -
BJD
@BrJDermatol
Through semi-structured interviews, this qualitative study explores the lived experience and needs of adult patients and parents of paediatric patients with epidermolysis bullosa along the diagnostic trajectory.
doi.org/10.1093/bjd/ljae242 -
BJD
@BrJDermatol
Responsiveness of the condition-specific Outcome measures for VAscular MAlformations (OVAMA) questionnaire to measure symptoms and appearance in patients with vascular malformations
doi.org/10.1093/bjd/ljae213 -
BJD
@BrJDermatol
International study on prevalence of itch: examining the role of itch as a major global public health problem
doi.org/10.1093/bjd/ljae260 -
BJD
@BrJDermatol
Comparison of incidence, causes and prognosis of adult and paediatric epidermal necrolysis: a French population-based study
doi.org/10.1093/bjd/ljae240 -
BJD
@BrJDermatol
Secukinumab in adult patients with lichen planus: efficacy and safety results from the randomized placebo-controlled proof-of-concept PRELUDE study
doi.org/10.1093/bjd/ljae181 -
BJD
@BrJDermatol
🚨 The November 2024 issue of the BJD is here! 🚨
Read more about secukinumab in lichen planus, epidemiology of itch, outcome measures for vascular malformations, and more. Link below! 👇🏻
academic.oup.com/bjd/issue/191/5 -
BJD
@BrJDermatol
Semaglutide for weight loss in people with obesity as an adjunctive treatment for hidradenitis suppurativa: its impact on disease control and quality of life
doi.org/10.1093/bjd/ljae216 -
BJD
@BrJDermatol
Incidence and trends of first basal cell carcinomas in France between 1980 and 2019: a regional population-based registry study
doi.org/10.1093/bjd/ljae201 -
BJD
@BrJDermatol
Mutational landscape and tumour mutational burden in adults with malignant melanoma arising from congenital naevi
doi.org/10.1093/bjd/ljae214 -
BJD
@BrJDermatol
Analysing common topics of secure patient messages in hidradenitis suppurativa: a text-embedding and natural language-processing approach
doi.org/10.1093/bjd/ljae222 -
BJD
@BrJDermatol
Spatial transcriptomic analysis of amelanotic acral melanoma versus pigmented acral melanoma reveals distinct molecular determinants
doi.org/10.1093/bjd/ljae224 -
BJD
@BrJDermatol
In this editorial, @BJDEditor discusses the BJD's aim of publishing the best clinically relevant science, advances in dermatology and items of clinical or practical value and interest to dermatologists and other colleagues working in related disciplines.
doi.org/10.1093/bjd/ljae273 -
BJD reposted
Jacqueline Marcia Boccacino
@jmboccacino
So happy to see the first DERMATLAS paper out in @BrJDermatol! 🎉🙏🏻
Profoundly grateful to @David_J_Adams for the opportunity to be part of this amazing team 🧬🔬💪🏻
Check out below our manuscript on the events driving cutaneous leiomyosarcoma:
academic.oup.com/bjd/article-abstract/doi/10.1093/bjd/lja… -
BJD
@BrJDermatol
In this translational study, the authors found that rituximab use in pemphigus vulgaris is associated with the emergence of follicular regulatory autoreactive Dsg-specific T cells in patients with sustained complete remission.
doi.org/10.1093/bjd/ljae220 -
BJD
@BrJDermatol
BJD Editor-in-Chief John McGrath (@BJDEditor) leading a workshop on tips for structuring research manuscripts with a group of Chinese dermatologists at EADV 2024.
-
BJD
@BrJDermatol
Insulin resistance impairs biologic agent response in moderate-to-severe plaque psoriasis: insights from a prospective cohort study in China
doi.org/10.1093/bjd/ljae147 -
BJD
@BrJDermatol
Progressive fibrosis is secondary to lack of type VII collagen in recessive dystrophic epidermolysis bullosa (RDEB). Histone deacetylase inhibitors reduce TGF-β levels, mitigating fibrosis progression and the development of disabling RDEB complications.
doi.org/10.1093/bjd/ljae225 -
BJD
@BrJDermatol
In this qualitative study, the authors explore the experiences and care needs of adult women with lichen sclerosus since childhood, identifying a need for age-appropriate, life phase-adjusted, individually tailored care for these individuals.
doi.org/10.1093/bjd/ljae203 -
BJD
@BrJDermatol
The Dermatology Life Quality Index as the primary outcome in randomized clinical trials: a systematic review
doi.org/10.1093/bjd/ljae228 -
BJD
@BrJDermatol
This review outlines what is known about the causes of atopic dermatitis (AD), specifically including the OX40 ligand (OX40L)/OX40 signaling axis. This review also discusses new treatments being developed that target OX40 and OX40L for treatment of AD.
doi.org/10.1093/bjd/ljae230 -
BJD
@BrJDermatol
The authors trialed spesolimab in patients with moderate-to-severe hidradenitis suppurativa. They found that patients on spesolimab had improvements in draining tunnels and IHS4 score compared to those who received placebo, with favorable safety profile.
doi.org/10.1093/bjd/ljae144 -
BJD
@BrJDermatol
🚨 The October 2024 issue of the BJD is here! 🚨
Read more about spesolimab in hidradenitis suppurativa, lived experiences of women with lichen sclerosus, and network pharmacology as a platform for drug discovery for hypertrophic scars. Link below! 👇🏻
academic.oup.com/bjd/issue/191/4 -
BJD
@BrJDermatol
🚨 HOT OFF THE PRESS 🚨
In this analysis of Global Burden of Disease Study data from 1990-2021, the authors found that, among adolescents and young adults, acne diagnosis rates are rising globally and within the UK.
Read more at the link below!
doi.org/10.1093/bjd/ljae352 -
BJD
@BrJDermatol
Peer Review Week is an annual global virtual event celebrating the role peer review plays in maintaining research quality. This year's theme is "Innovation and Technology in Peer Review."
Learn more about peer reviewing for the BJD at the link below!
academic.oup.com/bjd/pages/peer-reviewer-toolkit
BJD
@BrJDermatol
Most importantly, we want to thank all of our wonderful peer reviewers this #peerreviewweek!
For those interested in learning more about the peer review process at the BJD, please read our reviewer guidelines at the link below!
academic.oup.com/bjd/pages/reviewer-guidelines -
BJD
@BrJDermatol
Patients with Darier disease have an increased risk of depression and anxiety, which aligns with patterns of increased prescription of antidepressants and anxiolytics in individuals living with the disease.
doi.org/10.1093/bjd/ljae195 -
BJD
@BrJDermatol
Mutational profiling of primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder does not resemble nodal peripheral T-cell lymphomas with a follicular helper T-cell phenotype
doi.org/10.1093/bjd/ljae192 -
BJD
@BrJDermatol
Filling the prescription gap: the value of community support in psoriasis management
Read this patient perspectives piece highlighting the importance of community support networks for those living with psoriasis.
doi.org/10.1093/bjd/ljae168 -
BJD
@BrJDermatol
Interested in seeing which BJD papers have been the most downloaded, cited, and talked-about within the past year?
Read more at the link below!
academic.oup.com/bjd/pages/high-impact -
BJD
@BrJDermatol
In this translational study, the authors found that TNF-α-induced gasdermin E-mediated keratinocyte pyroptosis is crucial in the pathogenesis of psoriasis.
Targeting the gasdermin E-mediated pathway may be a novel strategy in the treatment of psoriasis.
doi.org/10.1093/bjd/ljae179 -
BJD
@BrJDermatol
Incidence of anxiety disorder in adults with hidradenitis suppurativa
In this analysis of a U.S. electronic health records database, the authors found that hidradenitis suppurativa is independently associated with an increased risk of anxiety disorders.
doi.org/10.1093/bjd/ljae139 -
BJD
@BrJDermatol
🚨 HOT OFF THE PRESS 🚨
Just published in the BJD is the 2024 British Association of Dermatologists and British Society for Rheumatology living guideline for the management of Behçets disease.
Read more at the link below!
doi.org/10.1093/bjd/ljae263 -
BJD
@BrJDermatol
In this systematic review of 88 studies from 28 countries, the authors characterize the global, regional, and national epidemiology of alopecia areata.
doi.org/10.1093/bjd/ljae058 -
BJD
@BrJDermatol
Increasing melanoma incidence with unchanged mortality: more sunshine, better treatment, increased diagnostic activity, overdiagnosis or lowered diagnostic threshold?
doi.org/10.1093/bjd/ljae175 -
BJD
@BrJDermatol
Fibroblasts with high matrix metalloproteinase 2 expression regulate CD8+ T-cell residency and inflammation via CD100 in psoriasis
doi.org/10.1093/bjd/ljae205 -
BJD
@BrJDermatol
🚨 The September 2024 issue of the BJD is here! 🚨
Learn more about the epidemiology of melanoma and alopecia areata, xeligekimab in moderate-to-severe plaque psoriasis, and patient-reported outcomes in dialysis-associated pruritus. Link below! 👇🏻
academic.oup.com/bjd/issue/191/3 -
BJD
@BrJDermatol
Elevated BMI is known to be associated with hidradenitis suppurativa (HS). In this Mendelian randomization analysis, the authors demonstrated that patients had 2.62 higher odds of developing HS for each 1 SD increase in genetically predicted BMI levels.
doi.org/10.1093/bjd/ljad380 -
BJD
@BrJDermatol
Expanding global health dermatology leadership: launching the GLODERM international mentorship programme @DrEstherFreeman @alexisgstrahan
doi.org/10.1093/bjd/ljae164 -
BJD
@BrJDermatol
A qualitative study of psychological morbidity in paediatric survivors of Stevens–Johnson syndrome/toxic epidermal necrolysis
doi.org/10.1093/bjd/ljae154 -
BJD
@BrJDermatol
This mixed-methods study indicates that "as needed" biologic therapy for psoriasis is acceptable from both the patient and clinician perspectives. Such an approach may address the substantial long-term burden of indefinitely continuing biologic therapy.
doi.org/10.1093/bjd/ljae068 -
BJD
@BrJDermatol
Cumulative methotrexate dose is not associated with liver fibrosis in patients with a history of moderate-to-severe psoriasis
doi.org/10.1093/bjd/ljae069 -
BJD
@BrJDermatol
Dominant dystrophic epidermolysis bullosa is associated with glycolytically active GATA3+ T helper 2 cells which may contribute to pruritus in lesional skin
doi.org/10.1093/bjd/ljae110 -
BJD
@BrJDermatol
In this trial, the authors found that gentamicin induced type VII collagen production in patients with recessive dystrophic epidermolysis bullosa carrying nonsense mutations, suggesting it may provide a safe, efficacious therapy for these patients.
doi.org/10.1093/bjd/ljae063 -
BJD
@BrJDermatol
Paediatric-onset lymphomatoid papulosis: results of a multicentre retrospective cohort study on behalf of the EORTC Cutaneous Lymphoma Tumours Group (CLTG)
doi.org/10.1093/bjd/ljae150 -
BJD
@BrJDermatol
ARROYO was a 24-week randomized clinical trial comparing benralizumab with placebo in adults with chronic spontaneous urticaria currently taking antihistamines. Benralizumab depleted eosinophil levels, but there was no clinical benefit over placebo.
doi.org/10.1093/bjd/ljae067 -
BJD
@BrJDermatol
Efficacy and safety of nemolizumab and topical corticosteroids for prurigo nodularis: results from a randomized double-blind placebo-controlled phase II/III clinical study in patients aged ≥ 13 years
doi.org/10.1093/bjd/ljae131 -
BJD
@BrJDermatol
In this cohort study of the Korean National Health Insurance Service database, the authors found that smoking cessation was associated with reduced risk of developing psoriasis, with a more pronounced effect in those who sustained cessation.
doi.org/10.1093/bjd/ljae130 -
BJD
@BrJDermatol
Effectiveness of a nurse-led one-to-one education programme in addition to standard care in children with atopic dermatitis: a multicentre randomized control trial
doi.org/10.1093/bjd/ljae111 -
BJD
@BrJDermatol
Pemphigus vulgaris (PV) is an autoimmune bullous disease causing skin and mucous membrane blistering. This review explores the multifaceted roles of B-cells in PV, and how they contribute to disease pathogenesis and therapeutic interventions.
doi.org/10.1093/bjd/ljae107 -
BJD
@BrJDermatol
🚨 The August 2024 issue of the BJD is here! 🚨
Learn more about B-cells in pemphigus vulgaris, efficacy of nemolizumab for prurigo nodularis, and epidemiology of vitiligo in the UK. Link below! 👇🏻
academic.oup.com/bjd/issue/191/2 -
BJD
@BrJDermatol
Several definitions of an #atopicdermatitis (AD) flare exist, but it is unclear what AD flares mean from the patient perspective.
In this qualitative study, patients from a National Eczema Association focus group describe what AD flares mean to them.
doi.org/10.1093/bjd/ljae037 -
BJD reposted
GlobalSkin
@IADPO
We are thrilled to announce that our #research paper, "Measurement Properties and Interpretability of the Patient-Reported Impact of Dermatological Diseases (#pridd) Measure," was recently accepted for publication in @BrJDermatol. Read it here: academic.oup.com/bjd/article/191/6/936/7699819
#prom -
BJD
@BrJDermatol
In a general population cohort, 2153 infants with frequent oil baths from 2 weeks of age had reduced skin barrier function through infancy compared to controls. Dry skin at 3 and 6 months, however, was less common in infants subjected to the intervention.
doi.org/10.1093/bjd/ljae091 -
BJD
@BrJDermatol
In recently published study findings from the POLARIS trial, the authors found that guselkumab showed higher efficacy and a more tolerable safety profile than fumaric acid esters in patients with moderate-to-severe psoriasis.
doi.org/10.1093/bjd/ljad523 -
BJD reposted
Paediatric & Population-Based Dermatology
@PPopDerm
We are delighted to present the first ‘real world’ treatment effectiveness analysis comparing dupilumab with ciclosporin and methotrexate in atopic dermatitis, which has just gone online @BrJDermatol .
doi.org/10.1093/bjd/ljae287
(To be continued in next post...) -
BJD
@BrJDermatol
🚨 Hot off the press 🚨
In the video below, senior author Prof. Carsten Flohr discusses the first "real world" treatment effectiveness analysis of ciclosporin, dupilumab, and methotrexate in atopic dermatitis with the UK-Irish A-STAR register.
Article 👇
academic.oup.com/bjd/advance-article/doi/10.1093/bjd/ljae…
Paediatric & Population-Based Dermatology
@PPopDerm
We are grateful to all A-STAR sites and their teams and for the continued support of the British Association of Dermatologists @HealthySkin4All , in particular Shehnaz Ahmed, Zin Mon, and Simon Morrison.
www.instagram.com/reel/C9zf3Uhqrsx/
Interviewed by @StJ_DermAcademy -
BJD
@BrJDermatol
In this meta-analysis, the authors found that anxiety and depression are prevalent in patients with cutaneous malignant melanoma. Significant peaks occur during treatment, particularly in women, younger individuals, and those with lower education levels.
doi.org/10.1093/bjd/ljae011 -
BJD
@BrJDermatol
Cancer type and histology influence cutaneous immunotherapy toxicities: a multi-institutional cohort study
doi.org/10.1093/bjd/ljae053 -
BJD
@BrJDermatol
There are few studies on the importance of early nutrition in development of psoriasis. In this analysis of the All Babies in Southeast Sweden birth cohort, the authors found breastfeeding to decrease risk of developing psoriasis through early adulthood.
doi.org/10.1093/bjd/ljae043 -
BJD
@BrJDermatol
Prediction, screening and characterization of novel bioactive tetrapeptide matrikines for skin rejuvenation
doi.org/10.1093/bjd/ljae061 -
BJD
@BrJDermatol
Evaluation of an artificial intelligence-based decision support for the detection of cutaneous melanoma in primary care: a prospective real-life clinical trial
doi.org/10.1093/bjd/ljae021 -
BJD
@BrJDermatol
Discovery of severity biomarkers is crucial for the management of inflammatory skin disease. In this review, the authors describe challenges in defining disease severity in the context of biomarker research for atopic dermatitis and psoriasis.
doi.org/10.1093/bjd/ljae080 -
BJD
@BrJDermatol
🚨 Check out the July 2024 issue of the BJD! 🚨
Focusing on inflammatory skin disease, this issue delves into atopic dermatitis (AD) and psoriasis biomarkers, association of antibiotics with AD development, and patient-centered definitions of AD flares.
academic.oup.com/bjd/issue/191/1 -
BJD reposted
Jonny Guckian
@JonnyGucks
Time for plenaries at #bad2024!
First up, we heard from editors at @BrJDermatol @ced_journal & @SkinHealthDis about the articles they love & future direction.
Take homes: look out for trending topics & check if your institution will cover open access! -
BJD
@BrJDermatol
We're excited to see everyone at BAD 2024!
Don't miss your chance to meet editors of the BJD, @ced_journal, and @SkinHealthDis at the BAD stand, today from 2:30-3:00 PM. Discuss submitting your manuscript, becoming a peer reviewer, and more! -
BJD
@BrJDermatol
We are pleased to announce that, after a year as Editor-Elect working alongside Dr. John Ingram (@BJDEditor), Professor John McGrath begins his tenure as 31st Editor-in-Chief of the BJD.
Read Professor McGrath’s first editorial in this month’s BJD: doi.org/10.1093/bjd/ljae169 -
BJD reposted
John McGrath
@BJDEditor
Results of the phase IIa RCT of Izuforant, a selective oral histamine 4 receptor (H4R) antagonist, for cholinergic #urticaria are in this months’ @BrJDermatol academic.oup.com/bjd/article-abstract/190/6/825/7599651
-
BJD reposted
John McGrath
@BJDEditor
Korean study demonstrates risk of death with Behcet disease is 1.28 X the general population and is 2.66 X greater in the 1st year after diagnosis: academic.oup.com/bjd/article-abstract/190/6/858/7601980?l…
-
BJD reposted
John McGrath
@BJDEditor
Dermatology services can be supported by #artificialintelligence, however there are multiple ethical considerations as highlighted in this BJD review: academic.oup.com/bjd/article-abstract/190/6/789/7603706?l…
-
BJD
@BrJDermatol
Secukinumab in patients with moderate-to-severe hidradenitis suppurativa based on prior biologic exposure: an efficacy and safety analysis from the SUNSHINE and SUNRISE phase III trials
doi.org/10.1093/bjd/ljae098 -
BJD reposted
John McGrath
@BJDEditor
Cooling agents acting via transient receptor potential melastatin 8 (TRPM8) agonism can reduce #itch, as demonstrated in a trial of a topical TRPM8 agonist: academic.oup.com/bjd/article-abstract/190/6/885/7606551
-
BJD reposted
John McGrath
@BJDEditor
Population data from Norway show individuals with higher BMI and lower 25-hydroxyvitamin D levels have 92% higher odds for active #psoriasis: academic.oup.com/bjd/article/190/5/680/7453345?login=false
-
BJD
@BrJDermatol
Melanoma tumour-infiltrating T-lymphocyte therapy heralds the era of cell-based immunotherapies for solid tumours
doi.org/10.1093/bjd/ljae126 -
BJD reposted
John McGrath
@BJDEditor
Could “gene creams” using lipid nanoparticles to deliver gene editing allow topical therapy for genodermatoses? academic.oup.com/bjd/article/190/5/617/7501389
-
BJD reposted
John McGrath
@BJDEditor
Randomized control trial of adjuvant immunoadsorption in pemphigus did not show clear clinical benefit and there was a higher rate of severe infections. Check it out! academic.oup.com/bjd/article/190/5/657/7491160
-
BJD
@BrJDermatol
In this cohort study, the authors investigated the association between atopic dermatitis (AD) and eating disorders among US adults in the All of Us Research Program, finding that AD was significantly associated with all eating disorders tested.
doi.org/10.1093/bjd/ljae103 -
BJD
@BrJDermatol
Burden of atopic dermatitis in paediatric patients: an international cross-sectional study
Increasing AD severity was progressively associated with more itch, skin pain, sleep problems, impaired health-related quality of life, and missed school days.
doi.org/10.1093/bjd/ljad449 -
BJD
@BrJDermatol
Here, the authors trialed izofurant, a selective oral histamine 4 receptor antagonist, in patients with cholinergic urticaria. Izuforant was well tolerated, but did not demonstrate significant improvements in change from baseline Urticaria Activity Score.
doi.org/10.1093/bjd/ljae038 -
BJD
@BrJDermatol
Prurigo nodularis (PN) is an inflammatory skin condition characterized by intensely pruritic skin nodules. In this review, the authors discuss its pathophysiology, as well as novel therapeutics in various stages of development for treating PN.
doi.org/10.1093/bjd/ljae052 -
BJD
@BrJDermatol
Click the link below to read the June 2024 issue of the BJD! 👇🧬
academic.oup.com/bjd/issue/190/6 -
BJD
@BrJDermatol
Ethical considerations for artificial intelligence in dermatology: a scoping review
There are numerous benefits of AI integration into dermatologic clinical practice, but safeguards must be put in place to ensure ethically sound application of AI.
doi.org/10.1093/bjd/ljae040 -
BJD
@BrJDermatol
Initial steps towards developing a predictive algorithm of disease progression for hidradenitis suppurativa (HS): results from a Cox proportional hazard regression analysis on disease progression among a cohort of 335 Danish patients with HS
doi.org/10.1093/bjd/ljad530 -
BJD
@BrJDermatol
Contact allergy to dental materials is rare. In this retrospective study, the authors found that patients with contact allergy are predominantly middle-aged or older women. Sensitization is caused primarily by metals, additives, and (meth)acrylates.
doi.org/10.1093/bjd/ljad525 -
BJD
@BrJDermatol
In this study, the authors found that TRPM8 agonist gel significantly reduces itch intensity compared with vehicle-only gel for all pruritogens. Cooling agents like TRPM8 agonists may be promising treatments for different types of itch stimuli.
doi.org/10.1093/bjd/ljae054 -
BJD
@BrJDermatol
Using data from the BADBIR and BSTOP registries, the authors of this study found that HLA-C*06:02 status, but not age at psoriasis onset, predicts biologic survival in patients with psoriasis. #dermtwitter
doi.org/10.1093/bjd/ljad481 -
BJD
@BrJDermatol
Applications are now open for the position of Deputy Editor to assist the Editor in Chief in leading the editorial team of the BJD! Applications are due by June 3rd.
Read more at the link below: 👇
academic.oup.com/bjd/pages/deputy-editor -
BJD
@BrJDermatol
The sialic acid–Siglec immune checkpoint: an opportunity to enhance immune responses and therapy effectiveness in melanoma
doi.org/10.1093/bjd/ljad517 -
BJD
@BrJDermatol
There are limited data on oncogenicity of alpha (α)-human papillomaviruses (HPVs) in the skin. In this case series, the authors explore characteristics of three α-HPV infection-associated cutaneous squamous cell carcinomas occurring in patients with HIV.
doi.org/10.1093/bjd/ljae047 -
BJD reposted
Neil Rajan
Redefine “benign”: A misnomer in the context of patients with genetic skin tumour syndromes academic.oup.com/bjd/article-abstract/doi/10.1093/bjd/lja…
-
BJD
@BrJDermatol
According to new research published in the BJD, patients with chronic itch are twice as likely to have fatigue compared to the general population, significantly impacting their quality of life.
Read more about the authors’ findings at the link below! 👇
doi.org/10.1093/bjd/ljae173
BJD
@BrJDermatol
Read the full press release here:
www.bad.org.uk/people-with-chronic-itch-twice-as-likely-t… -
BJD
@BrJDermatol
Metals are recognized as among the most common occupational allergens known to induce contact dermatitis. Here, the authors found a significant decline in incidence of metal-related occupational contact dermatitis in the UK. #dermtwitter
doi.org/10.1093/bjd/ljad488 -
BJD reposted
Skin Health and Disease
@SkinHealthDis
Check out this new collection of key research studies in the fields of #melanoma and #nmsc in honour of #sunawarenessweek @HealthySkin4All @BrJDermatol @ced_journal
blog.oup.com/2024/05/the-importance-of-sun-safety-sun-awa… -
BJD
@BrJDermatol
In this large population-based cohort study based out of Norway, the authors found no significant relationship between serum 25-hydroxyvitamin D [25(OH)D] levels and psoriasis. #dermtwitter
doi.org/10.1093/bjd/ljad472 -
BJD
@BrJDermatol
Check out the @HealthySkin4All press release for #sunawarenessweek, where you can learn more about signs of and protective factors against non-melanoma skin cancer! ☀️
www.bad.org.uk/non-melanoma-skin-cancer-deaths-will-overt… -
BJD
@BrJDermatol
Happy #sunawarenessweek! ☀️
In the link below, read more about tips from @HealthySkin4All on how best to protect your skin from UV rays and to spot the signs of non-melanoma skin cancer!
www.skinhealthinfo.org.uk/sun-awareness/ -
BJD
@BrJDermatol
Efficacy and safety of adjuvant immunoadsorption in pemphigus vulgaris and pemphigus foliaceus (IA-Pem Study): a multicentre randomized controlled trial
doi.org/10.1093/bjd/ljad489 -
BJD
@BrJDermatol
Topical gene editing therapeutics using lipid nanoparticles: ‘gene creams’ for genetic skin diseases?
Here, the authors review how liquid nanoparticle delivery vehicles synergized with gene editing technologies may influence treatment of genodermatoses.
doi.org/10.1093/bjd/ljad528 -
BJD
@BrJDermatol
The May 2024 issue of the BJD is here! 🧬🔬
Click the link below to read more about the latest in clinical and translational research on skin disease! 👇
academic.oup.com/bjd/issue/190/5 -
BJD reposted
Esther Freeman MD PhD
@DrEstherFreeman
New paper 📢! We share the journey of developing #globalhealth #mentorship program for leadership for emerging changemakers in #dermatology from resource limited countries. Proud our 1st cohort of grads are authors! @glodermalliance @ILDSDerm @BrJDermatol academic.oup.com/bjd/advance-article/doi/10.1093/bjd/ljae…
-
BJD
@BrJDermatol
Global epidemiology of actinic keratosis in the general population: a systematic review and meta-analysis
doi.org/10.1093/bjd/ljad371 -
BJD
@BrJDermatol
In this cohort study, the authors evaluate the incidence and risk factors of anti-TNFα treatment cessation owing to liver, blood, and renal side-effects, and estimate the cost-effectiveness of alternate intervals between monitoring blood tests.
doi.org/10.1093/bjd/ljad430 -
BJD
@BrJDermatol
In this analysis of pooled safety data from three phase III trials of bimekizumab (BKZ) in moderate-to-severe plaque psoriasis, the authors found no new safety signals compared with 2-year reports, and adverse events decreased with longer exposure to BKZ.
doi.org/10.1093/bjd/ljad429 -
BJD
@BrJDermatol
Digital biobanks are routinely used to discover genes, biomarkers, gene-environment interactions, and pharmacogenetic relationships. Here, the authors describe the potential of digital biobanks to further our understanding of skin disease. @LynnPetukhova
doi.org/10.1093/bjd/ljad439 -
BJD
@BrJDermatol
Mycophenolate mofetil inhibits Merkel cell carcinoma growth
doi.org/10.1093/bjd/ljae018 -
BJD
@BrJDermatol
In this translational study, the authors identify a novel pathway involving formylpeptide receptor (FPR)1-NOD-like receptor (NLR)C4 inflammasome activation to drive proinflammatory responses in barrier-disrupted skin.
doi.org/10.1093/bjd/ljad455 -
BJD
@BrJDermatol
What do Hyperhidrosis Quality of Life Index (HidroQoL©) scores mean? Transferring science into practice by establishing a score banding system
doi.org/10.1093/bjd/ljad444 -
BJD
@BrJDermatol
Severity, impact on quality of life and mental health burden of pruritus in prurigo nodularis: a cross-sectional study of a diverse patient cohort
doi.org/10.1093/bjd/ljad500 -
BJD
@BrJDermatol
In this cohort study, the authors examined the relationship between pediatric atopic dermatitis (AD) and intellectual ability between 1.5 and 15.5 years of age, finding no meaningful associations between AD activity or severity and general cognition.
doi.org/10.1093/bjd/ljad486 -
BJD
@BrJDermatol
Read the April 2024 issue of the BJD at the link below!
academic.oup.com/bjd/issue/190/4 -
BJD
@BrJDermatol
Guidelines for cold urticaria management established by the Centre of Evidence of Dermatology and the Urticaria Group of the French Society of Dermatology
doi.org/10.1093/bjd/ljad447 -
BJD
@BrJDermatol
In this analysis of the Korean National Health Interview Service, psoriasis was found to be most associated with cumulative metabolic syndrome burden in the oldest age group, suggesting the importance of managing metabolic syndrome in mid-life and beyond.
doi.org/10.1093/bjd/ljad441 -
BJD reposted
Dr Olivia Hughes
@DrOliviaHughes
We wrote this article in @BrJDermatol providing a commentary on recent work by Dainty et al. and highlighting the importance of supporting people experiencing flares in skin conditions @ProfARThompson
academic.oup.com/bjd/advance-article/doi/10.1093/bjd/ljae… -
BJD reposted
Christopher Thang
@cthanghealth
Excited to announce my 1st publication in the British Journal of Dermatology @BrJDermatol @OUPAcademic w/ @dagaratehealth under @DrJohnBarbieri
We investigated tetracycline use in acne patients and idiopathic intracranial hypertension risk.
Read Here: academic.oup.com/bjd/advance-article/doi/10.1093/bjd/ljae… -
BJD
@BrJDermatol
Multiple long-term conditions in people with psoriasis: a latent class and bidirectional Mendelian randomization analysis
doi.org/10.1093/bjd/ljad410 -
BJD
@BrJDermatol
In this translational study, the authors characterize the identity, origin, and functions of mononuclear phagocytes in human cutaneous graft-versus-host disease and examine how they contribute to distinct manifestations of illness.
doi.org/10.1093/bjd/ljad402 -
BJD
@BrJDermatol
With the advent of RNA-based medicine, PVT1 may be a promising molecular target for the management of inoperable or metastatic cutaneous squamous cell carcinoma (cSCC). Increased expression of PVT1 may serve as a biomarker for cSCCs.
doi.org/10.1093/bjd/ljad419 -
BJD reposted
Yale School of Medicine
@YaleMed
In a new @BrJDermatol study, researchers including @YaleDerm’s Jeffrey Cohen, MD, find people with atopic #dermatitis (#eczema) are at significantly higher risk for #eatingdisorders like #anorexia, #bulimia and #bingeeating disorder. pubmed.ncbi.nlm.nih.gov/38466772/
-
BJD
@BrJDermatol
In this international eDelphi and consensus study, the authors identify three core domains achieving criteria for inclusion in #pyodermagangrenosum clinical trials: pain, clinical signs, and quality of life. #dermtwitter
doi.org/10.1093/bjd/ljad420 -
BJD
@BrJDermatol
Epidemiology of alopecia areata and population-wide comorbidities in Germany: analysis of longitudinal claims data
doi.org/10.1093/bjd/ljad381 -
BJD
@BrJDermatol
We hope everyone had an amazing time at AAD! Here’s our Editor-in-Chief @BJDEditor with a few words on his experience at AAD, and the importance of international conferences in sharing the latest breakthrough research in dermatology.
-
BJD reposted
Oxford Academic
@OUPAcademic
Are you attending the #aad24 annual conference? Share your passion for dermatological research by publishing your work in @BrJDermatol, the home for the latest research in dermatology.
Submit your manuscript today: oxford.ly/48KB1XU -
BJD
@BrJDermatol
In this study of the BIOBADADERM registry, the authors found that combination of a biologic with methotrexate for treatment of moderate-to-severe psoriasis was not associated with significant increases in risk of adverse events in any treatment group.
doi.org/10.1093/bjd/ljad382 -
BJD
@BrJDermatol
Beremagene geperpavec (B-VEC) gene therapy for the treatment of cutaneous wounds in patients with dystrophic epidermolysis bullosa: a critically appraised research paper
doi.org/10.1093/bjd/ljad433 -
BJD
@BrJDermatol
Inflammasomes are cytoplasmic protein complexes that protect tissues against pathogenic and sterile stressors by initiating inflammation. Here, the authors explore the role of the of the NLRP1 inflammasome in skin cancer and inflammatory skin diseases.
doi.org/10.1093/bjd/ljad421 -
BJD
@BrJDermatol
Always grateful for the work our Patient Associate Editors do in putting together Plain Language Summaries of each BJD issue’s articles! @bernd_020 @DrOliviaHughes
Bernd Arents
@bernd_020
The Plain Language Summaries newsletter of the @BrJDermatol has been sent. It contains the PLSs of the February 2024 issue. Link to the newsletter: mailchi.mp/447018bf0eab/bjd-plain-language-summaries-for-….
Past issues: us4.campaign-archive.com/home/?u=e6aa83f73fd2a2d3a12611b3….
To subscribe: outlook.us4.list-manage.com/subscribe?u=e6aa83f73fd2a2d3a… -
BJD reposted
Bernd Arents
@bernd_020
The Plain Language Summaries newsletter of the @BrJDermatol has been sent. It contains the PLSs of the February 2024 issue. Link to the newsletter: mailchi.mp/447018bf0eab/bjd-plain-language-summaries-for-….
Past issues: us4.campaign-archive.com/home/?u=e6aa83f73fd2a2d3a12611b3….
To subscribe: outlook.us4.list-manage.com/subscribe?u=e6aa83f73fd2a2d3a… -
BJD
@BrJDermatol
BJD's March 2024 issue is now ready to view! Read up on all the latest in dermatologic research at the link below! 👇 #dermtwitter
academic.oup.com/bjd/issue/190/3 -
BJD
@BrJDermatol
In this retrospective case series, off-label Janus kinase inhibitor use rapidly and significantly improved active cutaneous disease in patients with anti-transcription intermediary factor 1-γ positive cancer-associated dermatomyositis. #dermtwitter
doi.org/10.1093/bjd/ljad396 -
BJD
@BrJDermatol
In this cohort study, the authors report the largest series of patients with corticosteroid-dependent/resistant #bullouspemphigoid treated with omalizumab, finding that omalizumab yielded fast control of disease activity and low relapse rate. #dermtwitter
doi.org/10.1093/bjd/ljad369 -
BJD
@BrJDermatol
Disseminated juvenile xanthogranulomas with underlying neurotrophic tyrosine receptor kinase fusion and response to larotrectinib
doi.org/10.1093/bjd/ljad427 -
BJD
@BrJDermatol
Interventions for bullous pemphigoid: summary of a Cochrane Review
doi.org/10.1093/bjd/ljad386 -
BJD
@BrJDermatol
Check us out on Instagram for important BJD updates, video summaries of published articles, and much more! Link below! 👇
instagram.com/brjdermatology -
BJD
@BrJDermatol
Cutaneous neurofibromas (cNF) are considered among the highest burdens of neurofibromatosis type 1. In this Delphi consensus study, the authors offer four outcome domains, comprising 19 outcome subdomains, that should be reported in all trials of cNF.
doi.org/10.1093/bjd/ljad397 -
BJD
@BrJDermatol
In this systematic review, @aaron_drucker et al. found that upadacitinib 30mg daily and abrocitinib 200mg daily are most efficacious with regard to binary efficacy endpoints up to 16 weeks in adults with moderate-to-severe #atopicdermatitis.
doi.org/10.1093/bjd/ljad393 -
BJD
@BrJDermatol
Possible relation of cathepsin C activity and seasonal fluctuation of skin lesions in Papillon–Lefèvre syndrome
doi.org/10.1093/bjd/ljad373 -
BJD
@BrJDermatol
Risk factors for subsequent primary melanoma in patients with previous melanoma: a systematic review and meta-analysis
doi.org/10.1093/bjd/ljad275 -
BJD
@BrJDermatol
In this comprehensive review of hidradenitis suppurativa (HS), the authors present new insights into disease pathophysiology, outline promising new therapeutic targets, and identify future areas of focus to improve management for patients with HS.
doi.org/10.1093/bjd/ljad345 -
BJD reposted
Ali Fakih
@AliFaki93712585
Stigma in Vitiligo: associated factors and severity strata of the PUSH-D score academic.oup.com/bjd/article-abstract/doi/10.1093/bjd/lja…
@BrJDermatol -
BJD
@BrJDermatol
Annual BJD Editorial Team Day 2024!
Coordinating a team spanning several time zones is a challenge, but we are grateful for over 40 members of our editorial board coming together for our annual team meeting. Here are a few of the faces behind the BJD! -
BJD
@BrJDermatol
Check out the February 2024 issue of the BJD! 👇🏼
Read about the genetic risks of nodular melanoma, potential genetic modifiers of neurofibromatosis type 1, scabies treatment failure, and omalizumab for bullous pemphigoid resistant to first-line therapy.
academic.oup.com/bjd/issue/190/2 -
BJD reposted
Bernd Arents
@bernd_020
The Plain Language Summaries newsletter of the @BrJDermatol has been sent. It contains the PLSs of the January 2024 issue. Link to the newsletter: mailchi.mp/1ea49b8c57e1/bjd-plain-language-summaries-for-….
Past issues: us4.campaign-archive.com/home/?u=e6aa83f73fd2a2d3a12611b3….
To subscribe: outlook.us4.list-manage.com/subscribe?u=e6aa83f73fd2a2d3a… -
BJD
@BrJDermatol
MicroRNA-200b-mediated reversion of a spectrum of epithelial-to-mesenchymal transition states in recessive dystrophic epidermolysis bullosa squamous cell carcinomas
doi.org/10.1093/bjd/ljad335 -
BJD reposted
Dr Olivia Hughes
@DrOliviaHughes
It’s a pleasure to be a Patient Associate Editor for the @BrJDermatol with @bernd_020
Thank you for highlighting the work we do as part of the team!
BJD
@BrJDermatol
MEET OUR PATIENT ASSOCIATE EDITORS 📝
@DrOliviaHughes and @bernd_020 serve as PAEs, a role unique to the BJD. They write our Plain Language Summaries, distribute these among patient support groups, and recruit perspective pieces from patients living with skin conditions. -
BJD
@BrJDermatol
MEET OUR PATIENT ASSOCIATE EDITORS 📝
@DrOliviaHughes and @bernd_020 serve as PAEs, a role unique to the BJD. They write our Plain Language Summaries, distribute these among patient support groups, and recruit perspective pieces from patients living with skin conditions.
BJD
@BrJDermatol
Read more about how the BJD's Patient Associate Editors advocate for patient involvement in research in the editorial below! 👇
doi.org/10.1111/bjd.19389 -
BJD
@BrJDermatol
Nemolizumab, a monoclonal antibody against IL-31A, was recently approved in Japan for treatment of atopic dermatitis (AD)-associated itch in patients aged ≥13 years. This study assessed efficacy of nemolizumab plus topicals in children ages 6-12 with AD.
doi.org/10.1093/bjd/ljad268 -
BJD
@BrJDermatol
Enhancers are regulatory DNA sequences that activate gene expression. Here, the authors review the roles of enhancers in psoriasis and atopic dermatitis, and how they may present an opportunity for new therapeutic approaches for these conditions.
doi.org/10.1093/bjd/ljad321 -
BJD
@BrJDermatol
Lymphatic filariasis (LF) is a neglected tropical disease presenting as lower-limb lymphedema. Here, the authors assess the effectiveness of Indian integrative medicine treatment combining biomedicine, traditional Ayurveda, and yoga in management of LF.
doi.org/10.1093/bjd/ljad310 -
BJD
@BrJDermatol
Machine learning analysis of pretreatment skin biopsies predicts nonresponse to dupilumab in patients with eczematous dermatitis @billdamsky
doi.org/10.1093/bjd/ljad389 -
BJD
@BrJDermatol
Does genetic risk modify the effect of skin screening on melanoma detection rates? doi.org/10.1093/bjd/ljad333
-
BJD reposted
Psoriasis UK
@PsoriasisUK
December 2023's @BrJDermatol Plain Language Summaries are now available.
The summaries aim to make #dermatology research findings accessible to those without formal medical training. We've linked to the summary that has a focus on #psoriasis below -
BJD
@BrJDermatol
There are few studies on the drug survival of metformin in patients with #hidradenitissuppurativa (HS). Here, the authors found that 50% of HS patients were still on metformin after 1 year, and 25% were still on metformin after 2 years of treatment.
doi.org/10.1093/bjd/ljad364 -
BJD
@BrJDermatol
Reliability and agreement testing of a new automated measurement method to determine facial vitiligo extent using standardized ultraviolet images and a dedicated algorithm
doi.org/10.1093/bjd/ljad304 -
BJD
@BrJDermatol
Epidemiological data on atopic dermatitis are lacking in 41.5% of countries worldwide. This study quantifies global, regional, and country-specific estimates of the incidence and prevalence of atopic dermatitis.
doi.org/10.1093/bjd/ljad339 -
BJD
@BrJDermatol
The January 2024 issue of the BJD is here!
Read more about the latest dermatologic advances in clinical and translational science at the link below! 👇
academic.oup.com/bjd/issue/190/1 -
BJD
@BrJDermatol
Wishing everyone a Happy New Year from the BJD! 🎉
-
BJD
@BrJDermatol
Sleep disturbance is common in patients with atopic dermatitis (AD) and has a significant impact on QoL.
Compared to placebo, dupilumab significantly improved overall sleep, itch, and QoL in adults with moderate-to-severe AD.
doi.org/10.1093/bjd/ljad284 -
BJD
@BrJDermatol
This study provides evidence that autoimmunity may play a key role in sustaining chronic inflammation and the coexistence of celiac disease, which in turn could exacerbate anemia/malnutrition and progression in recessive dystrophic epidermolysis bullosa.
doi.org/10.1093/bjd/ljad313 -
BJD
@BrJDermatol
In their analysis of patient serum proteomics, the authors found that erythrodermic psoriasis harboured a blended immune milieu with distinct Th17/Th1 skewing and mild Th2 activation, with substantial up-regulation in atherosclerosis signalling pathways.
doi.org/10.1093/bjd/ljad283 -
BJD
@BrJDermatol
Nicotinamide for skin cancer chemoprevention in transplant recipients: a critically appraised topic
doi.org/10.1093/bjd/ljad318 -
BJD
@BrJDermatol
Short anagen hair syndrome: association with mono- and biallelic variants in WNT10A and a genetic overlap with male pattern hair loss
doi.org/10.1093/bjd/ljad314 -
BJD
@BrJDermatol
In this translational study, the authors provide insight into how metformin may provide therapeutic benefit for #hidradenitissuppurativa, focusing on its effects against inflammation and on immunometabolism.
doi.org/10.1093/bjd/ljad305 -
BJD
@BrJDermatol
Increasing melanoma incidence and survival trend shifts with improved melanoma-specific survival between 1990 and 2020 in Sweden
doi.org/10.1093/bjd/ljad244 -
BJD reposted
NCA Research NHS
@NCAresearchNHS
Useful analysis of a large cohort here by @OrasAlabas & colleagues @SalfordCO_NHS @FBMH_UoM @BADBIR :
The association of age at psoriasis onset & HLA-C*06:02 with biologic survival in patients with moderate/severe psoriasis
Just published in @BrJDermatol doi.org/10.1093/bjd/ljad481 -
BJD
@BrJDermatol
In this study, the authors analyse data from patients with severe #alopeciaareata treated with baricitinib in two phase III trials, finding that responders clustered into three patterns: early, gradual, and late response.
Read more below! 👇
doi.org/10.1093/bjd/ljad253 -
BJD reposted
Nottingham Eczema
@eczemasupport
Research needed to give accurate picture of how eczema affects different world populations : the Global Atopic Dermatitis Atlas (GADA) #eczema by @OliviaHughes___ @bernd_020 @Ezzoef @Carsten_F_Derm academic.oup.com/bjd/article/doi/10.1093/bjd/ljad286/7241479
-
BJD
@BrJDermatol
Endothelial cells differentiated from patient dermal fibroblast-derived induced pluripotent stem cells resemble vascular malformations of port-wine birthmark
-
BJD
@BrJDermatol
The future is now: the Global Atopic Dermatitis Atlas (GADA)
Led by our @bernd_020, the authors describe how the GADA will provide a "go to" hub for atopic dermatitis burden data via systematic evidence syntheses and fieldwork in unstudied populations.
doi.org/10.1093/bjd/ljad286 -
BJD reposted
Alex G Ortega Loayza
@ThePGguy
We are working together in #upgrade paving a way forward to elevate the standards of #pyodermagangrenosum clinical trials; the core domain set for PG trials include now clinical signs, quality of life and pain @BrJDermatol @MedDermSoc #dermtwitter
academic.oup.com/bjd/advance-article/doi/10.1093/bjd/ljad… -
BJD
@BrJDermatol
This review summarizes the current understanding of mechanisms underlying the development and survival of resident cutaneous T memory cells in inflammatory skin disease and reports of the effect of current therapeutics upon their survival and function.
doi.org/10.1093/bjd/ljad303 -
BJD
@BrJDermatol
The December 2023 issue of the BJD is here!
Read more about the latest clinical, translational, and qualitative research pertaining to skin disease at the link below! 👇
academic.oup.com/bjd/issue/189/6?login=false -
BJD reposted
Psoriasis UK
@PsoriasisUK
November 2023's @BrJDermatol Plain Language Summaries are now available to view.
The summaries aim to make #dermatology research findings accessible to those without formal medical training.
We've linked to the summary that has a focus on #psoriasis below ⬇️ -
BJD reposted
John McGrath
@BJDEditor
Data from Taiwan show that Stevens–Johnson syndrome and toxic epidermal necrolysis on average reduce life expectancy by more than 9 years: rebrand.ly/6rdx8hy
-
BJD
@BrJDermatol
Exploring the natural and treatment history of vitiligo: perceptions of patients and healthcare professionals from the global VALIANT study
doi.org/10.1093/bjd/ljad245 -
BJD
@BrJDermatol
The authors carried out a randomized controlled trial to assess efficacy and safety of a novel rapamycin cream to treat facial angiofibromas.
Topical rapamycin improved appearance of angiofibromas over a 26-week treatment period and was well tolerated. doi.org/10.1093/bjd/ljad243
BJD
@BrJDermatol
In the corresponding editorial, Hong and Lee discuss how the study's findings may impact clinical practice. doi.org/10.1093/bjd/ljad334
-
BJD reposted
John McGrath
@BJDEditor
Score severity bands and minimal important change for the key RECAP instrument measuring long term #atopicdermatitis control now available: rebrand.ly/l4l59mc
-
BJD
@BrJDermatol
Hair follicle naevus (HFN) is a rare benign hamartoma predominantly affecting the face and neck. The genetic basis of HFN remains unclear.
Here, the authors report on two cases of HFN caused by pathozygotic gain-of-function variants in FGFR2.
doi.org/10.1093/bjd/ljad267 -
BJD
@BrJDermatol
Spatial transcriptomic profiling reveals the pathophysiology of early-stage hidradenitis suppurativa
doi.org/10.1093/bjd/ljad274 -
BJD
@BrJDermatol
In this trial, risankizumab was found to result in ≥90% improvement in Psoriasis Area and Severity Index and static Physician’s Global Assessment at 16 weeks in patients with moderate psoriasis when compared to apremilast, with no new safety signals.
doi.org/10.1093/bjd/ljad252 -
BJD reposted
Dr Olivia Hughes
@DrOliviaHughes
Do you have experience of a skin condition?
If you have a unique perspective or new point of view to share, the @BrJDermatol are looking for submissions from dermatology patients
For more information, email: bjd@bad.org -
BJD
@BrJDermatol
In this study, the authors found that neither pictorial nor textual descriptions of the Fitzpatrick Scale represent how individuals consider their own skin. How might we adapt skin colour scales to be more sensitive to the lived experience of skin colour?
doi.org/10.1093/bjd/ljad189 -
BJD
@BrJDermatol
In this phase II clinical trial, the authors assessed the safety and efficacy of amlitelimab, an anti-OX40 ligand monoclonal antibody, in adults with atopic dermatitis. They found it to be well tolerated and lead to clinically meaningful improvement.
doi.org/10.1093/bjd/ljad240 -
BJD
@BrJDermatol
Time to reconsider skin cancer-related follow-up visits?
Firm evidence regarding the effectiveness of current skin cancer follow-up schedules is lacking. Here, the authors debate whether these visits are an efficient use of scarce healthcare resources.
doi.org/10.1093/bjd/ljad241 -
BJD reposted
Rachel Watson
@WatsonDermLab
Delighted to share our new review, published in the @BrJDermatol, on skin ageing and strategies for rejuvenation #asrl @astar_research @NCAresearchNHS @OfficialUoM
-
BJD
@BrJDermatol
Targeted anti-interleukin-17 therapy for linear porokeratosis
@CristinaHas #dermtwitter
doi.org/10.1093/bjd/ljad223 -
BJD
@BrJDermatol
In this first-in-human clinical trial, Siebenhaar et al. found lirentelimab, a monoclonal antibody that inhibits mast cell activation, to be well tolerated and improve symptoms and quality of life in patients with indolent systemic mastocytosis.
doi.org/10.1093/bjd/ljad191
BJD
@BrJDermatol
In the corresponding editorial, Barete and Arock discuss the study's findings, and whether lirentelimab may be the "magic bullet" in fighting pathological mast-cell activation in systemic mastocytosis.
doi.org/10.1093/bjd/ljad227 -
BJD
@BrJDermatol
Comparative analysis of immune-related adverse events among patients with melanoma on immune checkpoint inhibitors: a retrospective cohort study
doi.org/10.1093/bjd/ljad271 -
BJD
@BrJDermatol
November is Hyperhidrosis Awareness Month!
Hyperhidrosis, or excessive sweating, inflicts significant quality of life burden on patients, and is associated with increased risk of depression and anxiety. #dermtwitter @WeKnowSweat
Read more in the BJD! 👇🏻
doi.org/10.1093/bjd/ljac010 -
BJD reposted
John McGrath
@BJDEditor
Survival from cutaneous #squamouscellcarcinoma is linked to the abundance of B cells in the peritumoral stroma, which is prognostic, even in immunocompetent patients: rebrand.ly/gne1xrk
-
BJD
@BrJDermatol
In this nationwide cohort of 6552 incident SJS/TEN cases, Chiu and Chiu found that patients, particularly young ones, suffer substantial loss-of-life expectancy and incur significant healthcare expenditures when compared to the general population.
doi.org/10.1093/bjd/ljad234 -
BJD reposted
Dr Olivia Hughes
@DrOliviaHughes
Our review article has been published in the Resilience in Skin Disease supplement of @BrJDermatol, discussing the psychological impact of living with acne #psychodermatology #acne #dermatology #skinconditions
academic.oup.com/bjd/article/189/Supplement_1/i11/7333863 -
BJD
@BrJDermatol
In this qualitative study, Herbert et al. explore the quality of life impact of #pyodermagangrenosum through in-depth patient interviews. #dermtwitter
doi.org/10.1093/bjd/ljad235 -
BJD
@BrJDermatol
Autoimmune, inflammatory, allergic and neuropsychiatric outcomes of offspring born to mothers with vitiligo: a nationwide Korean population-based birth cohort study
doi.org/10.1093/bjd/ljad196 -
BJD
@BrJDermatol
Bidirectional Mendelian randomization analysis did not indicate a causal relationship between atopic dermatitis and COVID-19
doi.org/10.1093/bjd/ljad208 -
BJD
@BrJDermatol
In this analysis of the National Cancer Database, @HannaKakish et al. identified high-risk tumor factors associated with sentinel lymph node metastasis in very thin (<0.8 mm) invasive melanomas.
@davidxzheng @TheNotoriousHPB @Richard_Hoehn @LukeRothermel
doi.org/10.1093/bjd/ljad195
BJD
@BrJDermatol
In the corresponding editorial, Ribero et al. detail how dermatologists may benefit from these epidemiologic data in deciding which of these patients with minimal theoretical risk of nodal positivity to refer for sentinel lymph node biopsy.
doi.org/10.1093/bjd/ljad218
BJD
@BrJDermatol
In the corresponding author video, senior author @LukeRothermel further describes his team's findings! @UHSurgOncology
www.youtube.com/watch?v=SI0-x_HzO2A -
BJD reposted
Bernd Arents
@bernd_020
The Plain Language Summaries newsletter of the @BrJDermatol has been sent. It contains the PLSs of the October 2023 issue. mailchi.mp/2977f1cd1f01/bjd-plain-language-summaries-for-….
Past issues: us4.campaign-archive.com/home/?u=e6aa83f73fd2a2d3a12611b3….
To subscribe: outlook.us4.list-manage.com/subscribe?u=e6aa83f73fd2a2d3a… -
BJD
@BrJDermatol
No evidence of isotretinoin sensitization in peanut-allergic children: a cross-sectional study
doi.org/10.1093/bjd/ljad214 -
BJD reposted
Shehnaz Ahmed
@Shehnaz27867450
So proud of this work on skin cancer survival rates- a joint partnership between @HealthySkin4All and @NHSDigital. Well done to Birgitta van Bodegraven and Zoe Venables for leading this along with our fantastic Steering Committee! Link in @BrJDermatol: academic.oup.com/bjd/article/188/6/777/7051650
-
BJD
@BrJDermatol
In this nationwide UK cohort study, Warren et al. use electronic health record data to demonstrate a small increased risk of venous thromboembolism in adults with #atopicdermatitis. #dermtwitter
doi.org/10.1093/bjd/ljad212
BJD
@BrJDermatol
In the corresponding editorial, Hong and Lee contextualize their findings relative to other cohort studies assessing risk of venous thromboembolism in atopic dermatitis.
doi.org/10.1093/bjd/ljad221
BJD
@BrJDermatol
Watch the authors describe their study findings in the video below! 👇
www.youtube.com/watch?v=X9zOm4yPMlk -
BJD reposted
John McGrath
@BJDEditor
Phase IIa RCT of amlitelimab, an anti-OX40 ligand monoclonal antibody, provides initial safety and efficacy data for moderate to severe #atopicdermatitis: rebrand.ly/iznl5f3
-
BJD
@BrJDermatol
Agreement and reliability of remote assessment of actinic keratosis: a proof-of-concept study using smartphone photographs
doi.org/10.1093/bjd/ljad209 -
BJD
@BrJDermatol
In this phase II trial, Kircik et al. evaluated once-daily roflumilast foam 0.3% in patients with scalp and body psoriasis. Roflumilast-treated patients were found to achieve greater clarity of body and scalp, decreased scalp itch, and few adverse events.
doi.org/10.1093/bjd/ljad182 -
BJD
@BrJDermatol
Gender disparity in Canadian Institutes of Health Research grant funding decisions among recipients from dermatology departments: a retrospective study
#dermtwitter @khosafaisal @brendantao
doi.org/10.1093/bjd/ljad192 -
BJD
@BrJDermatol
Incidence and prevalence of generalized pustular psoriasis in multiethnic Johor Bahru, Malaysia: a population-based cohort study using routinely captured electronic health records in the Teleprimary Care (TPC) clinical information system from 2010 to 2020
doi.org/10.1093/bjd/ljad158
BJD
@BrJDermatol
Check out the corresponding video below in which the authors describe their study findings!
www.youtube.com/watch?v=XPzk3Xnv7Dg
BJD
@BrJDermatol
In the corresponding editorial, Tsai explains the potential genetic underpinnings of the study's findings.
doi.org/10.1093/bjd/ljad197 -
BJD
@BrJDermatol
In this clinical trial, Voorberg et al. randomized patients with severe #chronichandeczema to either dupilumab or placebo. They found that, at 16 weeks, patients who received dupilumab achieved greater improvement in pruritus and severity of their eczema.
doi.org/10.1093/bjd/ljad156
BJD
@BrJDermatol
Check out the corresponding video below in which the authors describe their study findings!
www.youtube.com/watch?v=Zwo5qUO4OGg
BJD
@BrJDermatol
In the corresponding editorial, Brans summarizes the study's findings and outlines next steps for assessing the utility of dupilumab in treating the different subtypes of #chronichandeczema.
doi.org/10.1093/bjd/ljad199 -
BJD
@BrJDermatol
Barrabés-Torrella et al. present a case of a patient with locally advanced #basalcellcarcinoma that underwent sarcomatoid transformation following treatment with the sonic hedgehog inhibitor sonidegib. #dermtwitter
Read more below! 👇
doi.org/10.1093/bjd/ljad206 -
BJD reposted
Alison Wright
@_AlisonWright
Our latest @PsoriasisAtlas study on the epidemiology of #gpp in Malaysia. t.ly/mUnMv
This follows on from our study on #psoriasis in Malaysia. t.ly/VQUr7
BJD
@BrJDermatol
Incidence and prevalence of generalized pustular psoriasis in multiethnic Johor Bahru, Malaysia: a population-based cohort study using routinely captured electronic health records in the Teleprimary Care (TPC) clinical information system from 2010 to 2020
doi.org/10.1093/bjd/ljad158 -
BJD
@BrJDermatol
Has the time come to assess small-molecule/biologic drug combinations for the management of moderate-to-severe hidradenitis suppurativa?
@BJDEditor #hidradenitissuppurativa #dermtwitter
doi.org/10.1093/bjd/ljad224 -
BJD
@BrJDermatol
In this systematic review, Ertus et al. highlight rare cases of major adverse cardiovascular events in patients receiving Janus kinase inhibitors for the treatment of #atopicdermatitis.
doi.org/10.1093/bjd/ljad229 -
BJD
@BrJDermatol
As we wrap up another #peerreviewweek, we'd like to give thanks to our excellent peer reviewers. None of what we do would be possible without all your help! @OUPMedicine @WileyHealth
doi.org/10.1093/bjd/ljad066
doi.org/10.1093/ced/llad085 -
BJD reposted
Skin Research Ireland
@Skin_Research
Read below the press release for our recent publication in @BrJDermatol
Trinity College Dublin
@tcddublin
A team, led by scientists from @tcdTBSI, has unearthed a possible target for treating the debilitating skin disease hidradenitis suppurativa, which is a painful, chronic, inflammatory condition that can last decades.
Read about this #trinityresearch at: shorturl.at/eDJ48 -
BJD reposted
John McGrath
@BJDEditor
In this @BrJDermatol, analysis of BABIR data shows #psoriasis patients given adalimumab are twice as likely to be clear or nearly clear and are less likely to discontinue treatment vs methotrexate: academic.oup.com/bjd/advance-article/doi/10.1093/bjd/ljad…
-
BJD reposted
Conor Smith
@Smith96conor
Delighted to see some of my PhD work recently published in @BrJDermatol! A massive collaborative effort with my fellow first author @tcdflow, everyone in the Fletcher lab and the dermatology research team in @svuh
academic.oup.com/bjd/article/189/4/447/7181042?login=false
@Skin_Research @tcdTBSI -
BJD reposted
Bernd Arents
@bernd_020
The Plain Language Summaries newsletter of the @BrJDermatol has been sent. It contains the PLSs of the September 2023 issue. Link to the newsletter: mailchi.mp/a7aa2b2ed0d3/bjd-plain-language-summaries-for-….
Past issues: us4.campaign-archive.com/home/?u=e6aa83f73fd2a2d3a12611b3….
To subscribe: outlook.us4.list-manage.com/subscribe?u=e6aa83f73fd2a2d3a… -
BJD
@BrJDermatol
🚨🎊 PEER REVIEW WEEK IS HERE! 🎊🚨
Calling all reviewers/potential reviewers! Please consider filling out our survey to help us develop solutions and ideas to improve the peer review process: forms.office.com/e/wJgkEHn2zm
@ced_journal @SkinHealthDis @PeerRevWeek #peerreviewweek -
BJD
@BrJDermatol
Leveraging large language models in dermatology
doi.org/10.1093/bjd/ljad230 -
BJD reposted
John McGrath
@BJDEditor
In this month's @BrJDermatol, defective cathepsin Z affects EGFR expression and causes autosomal dominant palmoplantar keratoderma, raising the possibility of topical therapy with EGFR inhibitors: academic.oup.com/bjd/advance-article-abstract/doi/10.1093…
-
BJD
@BrJDermatol
In newly published results from the TREAT trial, the authors found that methotrexate was more efficacious (and cost effective) than ciclosporin for treatment and control of systemic pediatric #atopicdermatitis.
Read the full article at the link below 👇🏻
doi.org/10.1093/bjd/ljad281
BJD
@BrJDermatol
Check out the authors' YouTube video with discussion of the study's findings!
@eczemasociety @PPopDerm @tcddublin @TrinityMed1
www.youtube.com/watch?v=n1Lm_fmAEio -
BJD
@BrJDermatol
In this translational study, Malovitski et al. explore the genetic basis of #palmoplantarkeratoderma (PPK), finding that downregulation of cathepsin Z results in one form of PPK secondary to increased expression of the epidermal growth factor receptor.
doi.org/10.1093/bjd/ljad167
BJD
@BrJDermatol
In the corresponding editorial, Akiyama discusses the close links between the cathepsin protease family and cutaneous disorders of cornification and inflammation.
doi.org/10.1093/bjd/ljad190 -
BJD reposted
John McGrath
@BJDEditor
In this month's @BrJDermatol, Dutch BioDay registry study demonstrates successful dupilumab interval prolongation in more than 80% of patients in remission, with cost savings of millions of Euros: academic.oup.com/bjd/advance-article/doi/10.1093/bjd/ljad…
-
BJD
@BrJDermatol
Izokibep for the treatment of moderate-to-severe plaque psoriasis: a phase II, randomized, placebo-controlled, double-blind, dose-finding multicentre study including long-term treatment
#dermtwitter @OUPMedicine
doi.org/10.1093/bjd/ljad186 -
BJD
@BrJDermatol
In this cohort study, Lawson et al. validate SWIFT (Soreness, Whitening, urinary Incontinence, Fissures, and clitoral hood Thickening), a novel diagnostic tool for rapid and accurate diagnosis of prepubertal #lichensclerosus.
doi.org/10.1093/bjd/ljad180 -
BJD
@BrJDermatol
Moving towards structured, specialised hidradenitis suppurativa care to improve patient outcomes
doi.org/10.1093/bjd/ljad198 -
BJD
@BrJDermatol
Van Laar et al. synthesized circulating microRNA profiles from invasive #melanoma patients to develop a novel prognostic 12-microRNA signature (MEL12).
High-risk MEL12 patients were ~3x more likely to have nodal metastatic disease than low-risk patients.
doi.org/10.1093/bjd/ljad137
BJD
@BrJDermatol
In the corresponding editorial, Vergara and Stark discuss the promise of liquid biopsies in improving melanoma diagnosis and prognosis.
doi.org/10.1093/bjd/ljad185 -
BJD reposted
John McGrath
@BJDEditor
Where has our understanding reached in terms of the #monkeypox global health challenge? A cutting-edge review in this issue of @BrJDermatol: academic.oup.com/bjd/advance-article-abstract/doi/10.1093…
-
BJD reposted
Andreea Petrasca, PhD
@APetrasca
Really excited to share our study in @BrJDermatol showing the benefits & mode of action of metformin in HS. Thanks to all involved @Skin_Research, esp. my PI & mentor Dr Jean Fletcher, the patients, and our funders @IrishResearch @BSFcharity & CDSCHC
academic.oup.com/bjd/article/doi/10.1093/bjd/ljad305/7256193 -
BJD
@BrJDermatol
In this cohort study, @billdamsky et al. found increased expression of IL-4 and IL-13 in immune checkpoint inhibitor-induced #bullouspemphigoid lesional skin. #dupilumab, which blocks the IL-4 receptor alpha, showed efficacy in treating these patients.
doi.org/10.1093/bjd/ljad149 -
BJD reposted
John McGrath
@BJDEditor
Anti-IL-36 receptor treatment with imsidolimab shows promise for generalized pustular psoriasis, with 6 of 8 patients meeting the primary endpoint of this open label study in this month's @BrJDermatol: academic.oup.com/bjd/advance-article/doi/10.1093/bjd/ljad…
-
BJD
@BrJDermatol
In this epidemiologic study, Romiti et al. estimate the prevalence of psoriasis and other autoimmune skin diseases among the indigenous peoples of the Auaris region in the Yanomami Indigenous Territory, Brazil.
#dermtwitter #globalhealth @ciromgomes
doi.org/10.1093/bjd/ljad165 -
BJD
@BrJDermatol
Missing melanomas in England during the COVID-19 pandemic: 2485 fewer melanoma diagnoses in 2020 than in 2019
doi.org/10.1093/bjd/ljad117 -
BJD
@BrJDermatol
In this analysis of the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR), Alabas et al. demonstrate that patients on adalilumab were 2x as likely to clear their psoriasis than patients on methotrexate.
doi.org/10.1093/bjd/ljad179
BJD
@BrJDermatol
In the corresponding editorial, Thomas and van den Reek discuss whether we should prefer biologics over non-biological agents in psoriasis.
doi.org/10.1093/bjd/ljad231 -
BJD
@BrJDermatol
Mpox: an updated review of dermatological manifestations in the current outbreak
doi.org/10.1093/bjd/ljad151 -
BJD reposted
Bernd Arents
@bernd_020
The Plain Language Summaries newsletter of the
@BrJDermatol has been sent. It contains the PLSs of the August 2023 issue. Link to the newsletter: mailchi.mp/5739ee80a618/bjd-plain-language-summaries-for-….
Past issues: us4.campaign-archive.com/home/?u=e6aa83f73fd2a2d3a12611b3….
To subscribe: outlook.us4.list-manage.com/subscribe?u=e6aa83f73fd2a2d3a… -
BJD
@BrJDermatol
We encourage authors to submit a graphical abstract with submissions of Original and Review Articles! Read the article below for more information on how best to create graphical abstracts! #dermtwitter
@Shehnaz27867450 @BJDEditor
doi.org/10.1093/bjd/ljad181 -
BJD reposted
John McGrath
@BJDEditor
This @BrJDermatol study determines a 1.3% change in body surface area is the minimal important difference for #vitiligo and impact is 7 times greater when the face is affected: academic.oup.com/bjd/advance-article-abstract/doi/10.1093…
-
BJD
@BrJDermatol
Key issues when considering adopting a skin cancer diagnostic tool which uses artificial intelligence
doi.org/10.1093/bjd/ljad080 -
BJD
@BrJDermatol
Carter et al. demonstrate that anifrolumab (anti-type I interferon receptor) shows efficacy in treating discoid lupus and rituximab-resistant cutaneous lupus, with associated interferon-stimulated gene suppression and decline in intermediate monocytes.
doi.org/10.1093/bjd/ljad089
BJD
@BrJDermatol
In the corresponding editorial, Günther outlines how the findings from this important study extend upon those from previous #systemiclupuserythematosus clinical trials.
doi.org/10.1093/bjd/ljad111 -
BJD
@BrJDermatol
Involvement of visible areas in vitiligo is correlated with increased psychiatric morbidity.
This qualitative study by Merhi et al. showed that facial involvement has a higher impact on patients’ perception of the extent of their vitiligo. #dermtwitter
doi.org/10.1093/bjd/ljad109 -
BJD
@BrJDermatol
In this genome-wide association study, Han et al. demonstrate that the transmembrane protein 232 (TMEM232) gene was significantly increased in skin lesions of patients with #atopicdermatitis, resulting in increased inflammation.
doi.org/10.1093/bjd/ljad078
BJD
@BrJDermatol
In the corresponding editorial, Abdallah and Johansen outline the implications of these findings.
doi.org/10.1093/bjd/ljad127 -
BJD
@BrJDermatol
Check out this recently published article on the Global #atopicdermatitis Atlas, a project of the @ILDSDerm, by our Patient Associate Editors @OliviaHughes___ and @bernd_020!
@Ezzoef @zbysfedo #dermtwitter
Dr Olivia Hughes
@DrOliviaHughes
Great to see our perspectives article published in the @BrJDermatol with @bernd_020 @Ezzoef @zbysfedo and @Carsten_F_Derm on the Global Atopic Dermatitis Atlas (GADA)
academic.oup.com/bjd/advance-article/doi/10.1093/bjd/ljad… -
BJD
@BrJDermatol
Combined use of nivolumab and ipilimumab in Japanese patients with melanoma: a multicentre retrospective study of 111 cases
doi.org/10.1093/bjd/ljad114 -
BJD
@BrJDermatol
In their analysis of the National Inpatient Sample, @SiriChoragudi and Yosipovitch demonstrate the association between prurigo nodularis and neural sensitization disorders of pain, such as fibromyalgia and irritable bowel syndrome. #dermtwitter
doi.org/10.1093/bjd/ljad121 -
BJD
@BrJDermatol
Kirby et al. explore the real-world experiences and unmet needs of patients with #hidradenitissuppurativa (HS) through their analysis of social media platforms, highlighting opportunities to raise awareness of HS and improve patient quality of life.
doi.org/10.1093/bjd/ljad104 -
BJD
@BrJDermatol
Doolan et al., including our next editor-in-chief John McGrath, review genotrichoses and hair pathology associated with inherited skin diseases.
Read more below! 👇
doi.org/10.1093/bjd/ljad102 -
BJD
@BrJDermatol
Buried dermal interrupted or vertical mattress suture: which is the best for dermal layer suturing of surgical skin wounds?
doi.org/10.1093/bjd/ljad132 -
BJD reposted
John McGrath
@BJDEditor
In this month's @BrJDermatol, a potential breakthrough for cutaneous lupus: anifrolumab, a type-I IFN receptor blocker, demonstrates effectiveness when rituximab has failed. academic.oup.com/bjd/advance-article/doi/10.1093/bjd/ljad…
-
BJD
@BrJDermatol
Warren et al. present results from a phase II trial of imsidolimab, an anti-interleukin-36 receptor antibody for #generalizedpustularpsoriasis. They found that patients treated with imsidolimab after a flare showed rapid, sustained resolution of symptoms.
doi.org/10.1093/bjd/ljad083
BJD
@BrJDermatol
In the accompanying editorial, Gleeson and Mahil discuss the promise of emerging therapies targeting the interleukin-36 pathway for treatment of generalized pustular psoriasis.
doi.org/10.1093/bjd/ljad128 -
BJD reposted
John Barbieri, MD, MBA
@DrJohnBarbieri
Check out our @BrJDermatol critically appraised topic summarizing the recent SAFA trial on spironolactone for acne, nicely written by Ali Shields.
academic.oup.com/bjd/advance-article-abstract/doi/10.1093… -
BJD
@BrJDermatol
Psychosocial impact of pyoderma gangrenosum: a patient perspective
doi.org/10.1093/bjd/ljad074 -
BJD
@BrJDermatol
We caught up with @JonnyGucks, the BJD’s podcast editor, at the BAD Annual Meeting. He gave us a preview of what we can expect from the podcast in the second half of 2023!
Browse all episodes and stream the podcast series at the link below:
academic.oup.com/bjd/pages/podcast -
BJD
@BrJDermatol
Lebwohl et al. analyze pooled data from seven phase II/III studies, confirming the short- and long-term safety profile of the interleukin-23 inhibitor guselkumab in patients with #psoriasis.
doi.org/10.1093/bjd/ljad115
BJD
@BrJDermatol
In the accompanying editorial, Lloyd-Lavery discusses the importance of these findings. #dermtwitter
doi.org/10.1093/bjd/ljad161 -
BJD
@BrJDermatol
In this meta-analysis, Gupta et al. review the relative therapeutic efficacy of treatments for onychomycosis. Their findings provide guidance for appropriate antifungal selection, especially amid growing concerns about terbinafine resistance.
Read more:
doi.org/10.1093/bjd/ljad070 -
BJD
@BrJDermatol
In this translational study, Quaade et al. characterize the plasma inflammatory signature of chronic hand eczema (CHE). They found that systemic Th2-driven inflammation is shared between CHE both with and without history of atopic dermatitis.
Read more:
doi.org/10.1093/bjd/ljad110 -
BJD reposted
Hanna Kakish حنا قاقيش
@HannaKakish
Our analysis of the National Cancer Database in @BrJDermatol identified tumor factors (Lymphovascular invasion, ulceration, mitoses, nodular subtype) associated with sentinel node metastasis in very thin invasive melanomas. @LukeRothermel @Richard_Hoehn
doi.org/10.1093/bjd/ljad195 -
BJD reposted
Paediatric & Population-Based Dermatology
@PPopDerm
Dupilumab improves patient-reported symptoms and health-related quality of life in children aged 6–11 years with severe atopic dermatitis
(c) POEM
(d) CDLQI
Check out @Carsten_F_Derm's new publication via doi.org/10.1093/bjd/ljad124
@BrJDermatol -
BJD
@BrJDermatol
In this review of 30 years of clinical studies on #epidermolysisbullosa (EB), authors demonstrate the heterogeneity in reported outcomes and outcome measurement instruments over time. #dermtwitter
doi.org/10.1093/bjd/ljad077 -
BJD reposted
Bernd Arents
@bernd_020
The Plain Language Summaries newsletter of the @BrJDermatol has been sent. It contains the PLSs of the July 2023 issue. Link to the newsletter: mailchi.mp/6c3b48e36d20/bjd-plain-language-summaries-for-…. Past issues: us4.campaign-archive.com/home/?u=e6aa83f73fd2a2d3a12611b3….
To subscribe: outlook.us4.list-manage.com/subscribe?u=e6aa83f73fd2a2d3a… -
BJD
@BrJDermatol
In this editorial, @DrEstherFreeman and colleagues discuss the importance of international collaboration and the key role dermatologists have played in understanding the manifestations of COVID-19. #dermtwitter
doi.org/10.1093/bjd/ljad131 -
BJD
@BrJDermatol
We Are Not “Other” Populations: Building research, education, and clinical capacity around gender variance in dermatology
doi.org/10.1093/bjd/ljad073 -
BJD
@BrJDermatol
MEET OUR NEW EDITORIAL TRAINEES
@davidxzheng joins us from Boston. He received his medical degree from @CWRUSOM and is completing his internal medicine internship with @MGHMedicine. In his free time, David enjoys taking dance classes, playing tennis, and singing karaoke! 🕺🏻🎾🎤 -
BJD
@BrJDermatol
This single-arm trial found the JAK inhibitor abrocitinib to provide disease control and significant improvement in pruritus in patients with #lichensclerosus.
doi.org/10.1093/bjd/ljad129 -
BJD
@BrJDermatol
Does #atopicdermatitis (AD) increase risk of developing cancer?
In this population-based cohort study, the authors did not find evidence of strong overall malignancy risk in patients with AD. However, severe AD may increase risk of lymphoma. Read more:
doi.org/10.1093/bjd/ljad072
BJD
@BrJDermatol
In the accompanying editorial, Vittrup discusses the clinical implications of these epidemiological findings.
doi.org/10.1093/bjd/ljad119 -
BJD
@BrJDermatol
In this clinical trial, authors assessed the efficacy of topical brepocitinib, a dual inhibitor of TYK2 and JAK1, for plaque #psoriasis.
While brepocitinib was well tolerated, it did not result in significant changes compared to control. Read more below!
doi.org/10.1093/bjd/ljad098
BJD
@BrJDermatol
In the accompanying editorial, Cranwell and Sinclair discuss the potential of brepocitinib to be formulated into an effective topical therapy for mild-to-moderate chronic plaque psoriasis. #dermtwitter
doi.org/10.1093/bjd/ljad157 -
BJD
@BrJDermatol
Check out highlights from a great week in Liverpool at #bad2023!
All of the meeting’s accepted abstracts can now be viewed in the BJD’s BAD Annual Meeting Supplement, available at the link below:
academic.oup.com/bjd/issue/188/Supplement_4 -
BJD
@BrJDermatol
#merkelcellcarcinoma is a rare neuroendocrine skin cancer.
In this translational study, the authors identify B-cell lymphoma-extra large (Bcl-xL) protein as a promising therapeutic target for treatment of this aggressive tumour. Read more below! 👇
doi.org/10.1093/bjd/ljad099 -
BJD
@BrJDermatol
Important announcement from @BJDEditor:
John McGrath, Professor of Molecular Dermatology at St John’s Institute of Dermatology in London, has been appointed as our next editor-in-chief. Professor McGrath will serve as editor-elect for a year before taking over in July 2024! -
BJD reposted
John McGrath
@BJDEditor
Deep phenotyping of hyperlinear palms reveals 5 subtypes, 2 of which correlate more strongly with filaggrin loss of function mutations. Read more in this month's @BrJDermatol: academic.oup.com/bjd/advance-article/doi/10.1093/bjd/ljad…
-
BJD
@BrJDermatol
Follow along with Podcast Associate Editor @JonnyGucks as he livetweets from the #meded session at #bad2023! #dermtwitter
Jonny Guckian
@JonnyGucks
-
BJD
@BrJDermatol
Members of the BJD Editorial Team at our annual strategy day meeting. If you see us around #bad2023, stop by and say hi! #dermtwitter
-
BJD
@BrJDermatol
Acquired cutis laxa (ACL) is a rare dermatological condition often caused by environmental exposures, leading to wrinkled skin. Read more below about the presentations and potential triggers of ACL. #dermtwitter
@K8toconnell @DrAveryLaChance @ChoateMD
doi.org/10.1093/bjd/ljad043 -
BJD
@BrJDermatol
Homelessness is linked with increased general risk of skin conditions. Using nationwide Danish registry data, the authors examine associations between homelessness and specific skin condition diagnoses, medications prescribed, and type of consultation.
doi.org/10.1093/bjd/ljad040 -
BJD reposted
John McGrath
@BJDEditor
"Get Data Out” #skincancer registry provides incidence and survival rates for common and rare skin tumours in England, including Merkel cell carcinoma and genital cSCC in this month's @BrJDermatol: academic.oup.com/bjd/advance-article/doi/10.1093/bjd/ljad…
-
BJD
@BrJDermatol
MEET OUR NEW EDITORIAL TRAINEES
@BeckyLMcCarthy joins us from London. She received her medical degree from @UoS_Medicine and is a pachyonychia congenita research fellow with @blizard_inst. In her free time, she enjoys running, travelling, and sampling London's food scene! 🏃🏼♀️⛩🍕 -
BJD
@BrJDermatol
In this critical appraisal, @werthlab and colleagues discuss findings from a recent @NEJM clinical trial of intravenous immunoglobulin in #dermatomyositis, the first successful phase III trial of its kind. #dermtwitter
doi.org/10.1093/bjd/ljad044 -
BJD reposted
Edel O'Toole
@EdelOToole
In June issue @BrJDermatol we published our first phenotyping paper in 506 Bangladeshi children and young adults with eczema. We sequenced the filaggrin gene and examined the palms of 506 individuals. #dermtwitter #eczema academic.oup.com/bjd/article/188/6/785/7058065
-
BJD reposted
John McGrath
@BJDEditor
In this month's @BrJDermatol, the 52-week results from ADvocate1 & 2 RCTs of lebrikizumab in atopic dermatitis show comparable results for Q4W vs Q2W maintenance dosing after the induction Q2W treatment phase: academic.oup.com/bjd/advance-article/doi/10.1093/bjd/ljad…
-
BJD
@BrJDermatol
In this review, the authors describe the global epidemiology of #atopicdermatitis and the disparities that exist in various populations and regions across the globe. #dermtwitter
doi.org/10.1093/bjd/ljad042 -
BJD reposted
Hidradenitis Suppurativa (HS) Ireland
@hsireland1
Living with and/or caring for someone with a #skin condition? Are you part of a skin-related #patient organisation? Willing to share your story?
BJD
@BrJDermatol
📣Are you a dermatology patient, carer, or patient society? We want to hear your perspectives!
🖌️Submissions can encompass a variety of formats and can be on any topic relevant to dermatology.
👇Check out the poster below for more details! -
BJD
@BrJDermatol
#hidradenitissuppurativa (HS) is a chronic inflammatory skin disease that significantly impairs patient quality of life (QOL). In this survey study, the authors examine factors associated with HS-specific QOL impact. #hidradenitissuppurativaawarenessweek
doi.org/10.1093/bjd/ljad069 -
BJD
@BrJDermatol
MC1R red hair colour variants (R & r) and MITF E318K independently increase #melanoma risk. In this epidemiologic study, presence of the MC1R r allele was found not to increase melanoma risk in carriers of MITF E318K.
@WallingfordC46 @Amcinerneyleo
doi.org/10.1093/bjd/ljad041
BJD
@BrJDermatol
In the accompanying editorial, Bruno discusses the authors' findings in the context of increasing use of polygenic risk scores to risk-stratify melanoma. #dermtwitter
doi.org/10.1093/bjd/ljad097 -
BJD reposted
ISG UK
@ISG_Charity
The @BrJDermatol invites patients and/or caregivers to write for their patient perspective section. Below is a recently published piece written by @CARLEENWALGAL as Mom of a child affected by harlequin #ichthyosis.
academic.oup.com/bjd/article-abstract/188/6/797/7069845?l…
#dermtwitter -
BJD reposted
John McGrath
@BJDEditor
In the June issue of @BrJDermatol, a review series on atopic dermatitis (AD) presents guidance to help navigate the surge in #eczema therapeutics: academic.oup.com/bjd/advance-article/doi/10.1093/bjd/ljac…
-
BJD reposted
Bernd Arents
@bernd_020
The Plain Language Summaries newsletter of the @BrJDermatol has been sent. It contains the PLSs of the June 2023 issue, plus two highlighted articles. Link to the newsletter: mailchi.mp/b39eb35cf794/bjd-plain-language-summaries-for-…
Past issues: us4.campaign-archive.com/home/?u=e6aa83f73fd2a2d3a12611b3…
Subscribe: outlook.us4.list-manage.com/subscribe?u=e6aa83f73fd2a2d3a… -
BJD
@BrJDermatol
In this cohort study, psoriasis patients treated with TNF-alpha inhibitors showed faster reduction in immunity to COVID-19 vaccines relative to controls. The authors suggest that this should be considered when advising patients about COVID-19 vaccination.
doi.org/10.1093/bjd/ljad023 -
BJD reposted
AADmember
@AADmember
Authors of a @BrJDermatol study investigated the outcomes in patients with #atopicdermatitis who agreed to a dose reduction of dupilumab. Learn more in #dermworldweekly - assets.aad.org/html/ErrorPages/auth0_error.html?client_id…
-
BJD
@BrJDermatol
Neutrophils contribute to #hidradenitissuppurativa, and G-CSF is a growth factor that facilitates neutrophil development.
CSL324, a monoclonal antibody against G-CSF, inhibits neutrophil migration, showing promise as a potential novel treatment for HS.
doi.org/10.1093/bjd/ljad013 -
BJD
@BrJDermatol
Given the rise in global prevalence of anxiety and depression during the COVID-19 pandemic, the authors explore the association between mental health disorders and non-adherence to immune-modifying therapy among patients with psoriasis.
Article below! 👇🏼
doi.org/10.1093/bjd/ljac144
BJD
@BrJDermatol
In the accompanying editorial, Valenti and Costanzo explore the crucial role of doctor-patient communication in avoiding drug discontinuation.
doi.org/10.1093/bjd/ljad014 -
BJD reposted
Shehnaz Ahmed
@Shehnaz27867450
Exciting when you see an idea come together, #teamwork! @BrJDermatol now publishes graphical abstract. Read our editorial to find out how and tips to make one! We look forward to receiving them: academic.oup.com/bjd/advance-article/doi/10.1093/bjd/ljad…
-
BJD reposted
Esther Freeman MD PhD
@DrEstherFreeman
We are pleased to announce that we @BrJDermatol have joined the growing movement in global health for authorship reflexivity statements, as part of our work on authorship & collaboration equity. Curious what that means? Read our editorial here. #dermtwitter @SepSaleh @EvaHeinz7
BJD
@BrJDermatol
The BJD’s approach to global health and equity in publishing: adding author reflexivity statements
@DrEstherFreeman #dermtwitter
doi.org/10.1093/bjd/ljad058 -
BJD
@BrJDermatol
In this international consensus statement, authors from the CORALS initiative identified three key outcome domains to measure in all future lichen sclerosus (LS) clinical trials: clinical (visible) signs, symptoms, and quality of life specific to LS.
doi.org/10.1093/bjd/ljac145 -
BJD
@BrJDermatol
In this phase II clinical trial, the authors found that guselkumab provided clinical benefit in a subset of patients with hidradenitis suppurativa through inhibition of the interleukin-23/T helper 17 axis.
Read more below! 👇🏼
doi.org/10.1093/bjd/ljad010 -
BJD
@BrJDermatol
The BJD’s approach to global health and equity in publishing: adding author reflexivity statements
@DrEstherFreeman #dermtwitter
doi.org/10.1093/bjd/ljad058 -
BJD reposted
Psoriasis UK
@PsoriasisUK
📢 May 2023's @BrJDermatol Plain Language Summaries are now available to view. 📢
The summaries aim to make #dermatology research findings more accessible to those without formal medical training.
Below is the summaries that have a particular focus on #psoriasis: -
BJD
@BrJDermatol
Check out the article behind this month's cover image! Local cutaneous refractoriness to sun exposure following omalizumab injections in solar urticaria.
doi.org/10.1093/bjd/ljad012 -
BJD reposted
Alex G Ortega Loayza
@ThePGguy
Thanks to @MedDermSoc for supporting this project through the research committee. Determining the severity features of pyoderma gangrenosum are the first step to develop clinical guidelines @BrJDermatol #dermtwitter #rarediseases
academic.oup.com/bjd/article-abstract/188/4/566/6931755 -
BJD reposted
William Damsky MD, PhD
@billdamsky
Glad to be involved in @yalederm @BrJDermatol paper - dupilumab in bullous pemphigoid (conventional and PD-1 inh induced) - interesting cytokine staining compared to atopic derm - IL13 (and IL4) is dermal predominant (often right under DEJ) in BP but epidermal predom in AD
-
BJD
@BrJDermatol
Catch us at #isid2023tokyo! Featuring @BrJDermatol Editorial Trainee @BeckyLMcCarthy with members of the lab of Deputy Editor Eleni Linos.
-
BJD reposted
Bernd Arents
@bernd_020
The Plain Language Summaries newsletter of the
@BrJDermatol has been sent. It contains the PLSs of the May 2023 issue. Link to the newsletter: mailchi.mp/a7cab3a76d82/bjd-plain-language-summaries-for-…
Subscribe: outlook.us4.list-manage.com/subscribe?u=e6aa83f73fd2a2d3a… -
BJD
@BrJDermatol
In this case study, the authors provide evidence for polymerase-δ-deficiency as a novel cause of inborn cancer predisposition associated with human papillomavirus infection. Read more below!
doi.org/10.1093/bjd/ljad021 -
BJD reposted
Werth Lab
@werthlab
In this study by @joshd102 and others from our group, we compare the #skindex 29 to the shorter, 16 question alternative for #dermatomyositis in @BrJDermatol #dermtwitter
academic.oup.com/bjd/advance-article/doi/10.1093/bjd/ljad… -
BJD
@BrJDermatol
Does acne-related post-inflammatory hyperpigmentation affect social perception and contribute to stigmatization of affected individuals?
Find out here 👇
doi.org/10.1093/bjd/ljad026 -
BJD reposted
John McGrath
@BJDEditor
Peristomal skin complications are a frequent issue tackled by this RCT of a novel ostomy baseplate: academic.oup.com/bjd/advance-article/doi/10.1093/bjd/ljac…
-
BJD reposted
Bernd Arents
@bernd_020
The Plain Language Summaries newsletter of the
@BrJDermatol has been sent. It contains the PLSs of the April 2023 issue. Link to the newsletter: mailchi.mp/dc93064006e5/bjd-plain-language-summaries-for-…
Subscribe: outlook.us4.list-manage.com/subscribe?u=e6aa83f73fd2a2d3a… -
BJD reposted
Rebecca McCarthy
@BeckyLMcCarthy
Delighted to be one of the new editorial trainees @BrJDermatol alongside @davidxzheng. Very exciting to see my name in the front of this month’s edition! Looking forward to showcasing evidence based dermatology and cutting edge research through social media!
-
BJD
@BrJDermatol
The complex clinical presentation of #hidradenitissuppurativa can lead to delayed diagnosis or misdiagnosis.
Imaging can help address these issues by detecting features of HS and accurately characterizing lesional morphology.
Read review: doi.org/10.1093/bjd/ljad028 -
BJD reposted
PeDRAResearch
@PeDRAResearch
New PeDRA publication in @BrJDermatol 👏
Direct Link ⬇️
pubmed.ncbi.nlm.nih.gov/37035904/
#pedra #pedraresearch #dermatology #pedsderm #dermresearch #academicdermatology #hidradenitis #hidradenitissuppurativa #hs #downsyndrome #brjdermatology #britishjournalofdermatology #dermtwitter -
BJD reposted
John McGrath
@BJDEditor
Lack of availability and/or lack of insurance cover for biologic therapy for #psoriasis affected 22% of patients requiring biologics in Brazil and 68% in Chile: academic.oup.com/bjd/advance-article/doi/10.1093/bjd/ljac…
-
BJD reposted
Claire fuller
@Clairefuller19
Great for @BrJDermatol to assist in amplifying the skin health issues facing displaced persons. Much was learned & shared at the first @IFDerm in person summit on Migrant Health Dermatology. @ILDSDerm
BJD
@BrJDermatol
Skin diseases are common health issues in refugee camps, yet lack of resources leads to poor care.
This article highlights the role of dermatologists in escalating care to migrants + displaced persons in humanitarian crises.
@pvaleska73 @DrEstherFreeman
doi.org/10.1093/bjd/ljad001 -
BJD
@BrJDermatol
Attending the BAD conference?
Catch us at the events below and see the attached posters for more details!
📣Meet the BAD Editors
🗓️Tuesday June 27th 11:00-11:45
🗓️Wednesday June 28th 12:30-13:30
🔍How to be a Peer Reviewer
🗓️Tuesday June 27th 10:30-11:00
@BJDEditor -
BJD
@BrJDermatol
🖼️Th BJD is encouraging authors submitting Original Articles and Review Articles to provide a Graphical Abstract.
🖌️Check out the link below for some guidance on how to create an effective Graphical Abstract!
academic.oup.com/bjd/pages/general-instructions -
BJD
@BrJDermatol
Is hydroxychloroquine an effective treatment for oral lichen planus?
Find out here👇
doi.org/10.1093/bjd/ljac113 -
BJD
@BrJDermatol
Skin diseases are common health issues in refugee camps, yet lack of resources leads to poor care.
This article highlights the role of dermatologists in escalating care to migrants + displaced persons in humanitarian crises.
@pvaleska73 @DrEstherFreeman
doi.org/10.1093/bjd/ljad001 -
BJD reposted
Werth Lab
@werthlab
Our latest article in the @BrJDermatol discusses the impact of the phase 3 trial of IVIG for DM, particularly for skin-predominant DM. @jkleitsch3 doi.org/10.1093/bjd/ljad044
-
BJD
@BrJDermatol
Check out the full paper here👇👇👇
doi.org/10.1093/bjd/ljad044 -
BJD
@BrJDermatol
In association with the Global Psoriasis Atlas (@PsoriasisAtlas), this cross-sectional survey study analysed the availability and insurance reimbursement of systemic treatments for adult patients with psoriasis in Brazil and Chile.
Read more: doi.org/10.1093/bjd/ljac128 -
BJD
@BrJDermatol
Are Janus kinase inhibitors an effective treatment for palmoplantar pustulosis? A critically appraised topic
doi.org/10.1093/bjd/ljac130 -
BJD
@BrJDermatol
This study investigated parents’ and children’s experiences of skin conditions, and the relevance of offering mindfulness-based interventions.
➡️Article: doi.org/10.1093/bjd/ljac129
➡️Plain Language Summary: doi.org/10.1093/bjd/ljad052 -
BJD
@BrJDermatol
This qualitative interview study explored the views and experiences of young people with eczema and parents/carers of children with eczema regarding eczemacareonline.org.uk.
doi.org/10.1093/bjd/ljac115
BJD
@BrJDermatol
Plain Language Summary: doi.org/10.1093/bjd/ljad048
Commentary:
doi.org/10.1093/bjd/ljac165 -
BJD reposted
John McGrath
@BJDEditor
Which factors increase the risk of depression and anxiety associated with #psoriasis and #eczema? Answers from a systematic review in the latest @BrJDermatol issue: academic.oup.com/bjd/advance-article/doi/10.1093/bjd/ljac…
-
BJD reposted
Jonny Guckian
@JonnyGucks
Junior Docs! This is a great suturing course by the BSDS, you don't want to miss out! Register below!
👇🏻👇🏻👇🏻 -
BJD reposted
Dominique du Crest
@ducrest
Sun protection: false beliefs and misguided advocacy
academic.oup.com/bjd/article/188/4/552/6880690?login=false
via @BrJDermatol
#dermtwitter -
BJD reposted
Soha Seddik
@SeddikSoha
We invite you all to watch our paper video @BrJDermatol YouTube channel
DLQI scores in Bangladeshi patients with AE, S. S. Tawfik et al. youtu.be/WX6gsJeWKME via @YouTube
@EdelOToole -
BJD reposted
John McGrath
@BJDEditor
Emerging data quantify higher infection risk, including COVID-19, in pemphigus patients associated with rituximab: academic.oup.com/bjd/advance-article/doi/10.1093/bjd/ljad…
-
BJD
@BrJDermatol
Age at symptom onset is an important factor associated with disease severity in older patients with hidradenitis suppurativa, and could indicate a patient’s prognosis.
doi.org/10.1093/bjd/ljac121 -
BJD reposted
William Damsky MD, PhD
@billdamsky
Congrats to lead author @SimonRoyMD on this work! @yalederm
BJD
@BrJDermatol
Inguinal patch in mpox (monkeypox) virus infection and eccrine syringometaplasia: report of two cases with in situ hybridization and electron microscopy findings
Read more: doi.org/10.1093/bjd/ljac146
@simonroymd @billdamsky @choateMD -
BJD
@BrJDermatol
Inguinal patch in mpox (monkeypox) virus infection and eccrine syringometaplasia: report of two cases with in situ hybridization and electron microscopy findings
Read more: doi.org/10.1093/bjd/ljac146
@simonroymd @billdamsky @choateMD -
BJD
@BrJDermatol
💊Antibiotic exposure during the prenatal period and infancy was associated with increased risk of atopic eczema.
🔬Further research is needed to clarify the causal mechanisms by which antibiotics may affect the risk of atopic eczema.
doi.org/10.1093/bjd/ljac108 -
BJD
@BrJDermatol
🔖Case report: severe tracheal involvement in type XVII collagen junctional epidermolysis bullosa
Read more: doi.org/10.1093/bjd/ljac135 -
BJD reposted
Integrating Genomics into Medicine
@IGM_group
Excited to share our new publication showing an interaction btwn MC1R red hair colour "R" and "r" variants, and MITF E318K. R and r are both well known to moderately > melanoma risk, but we found "r" does not > risk in E318K carriers! @BrJDermatol academic.oup.com/bjd/advance-article/doi/10.1093/bjd/ljad…
-
BJD reposted
Aideen McInerney-Leo she/her
@Amcinerneyleo
We knew that MC1R red hair colour variants (R & r) and MITF E318K independently increased melanoma risk
➡️Our international study showed an interactive effect - R increases risk in MITF carriers while r does not!
Thanks 🧵
@BrJDermatol @UQDRC @TRI_info
academic.oup.com/bjd/advance-article/doi/10.1093/bjd/ljad… -
BJD
@BrJDermatol
Quality-of-life questionnaires were originally designed and validated in Western English-speaking populations.
In under-represented groups in quality-of-life research, socioeconomic status and language barriers also influence the results.
doi.org/10.1093/bjd/ljac131
BJD
@BrJDermatol
➡️Plain Language Summary: doi.org/10.1093/bjd/ljad051
➡️Commentary: doi.org/10.1093/bjd/ljad015 -
BJD
@BrJDermatol
Higher concentrations of ambient air pollutants are associated with increased outpatient visits for psoriasis in Wuhan, China.
Air pollution control and exposure prevention may improve psoriasis symptoms among these patients.
doi.org/10.1093/bjd/ljac124
BJD
@BrJDermatol
Plain Language Summary: doi.org/10.1093/bjd/ljad050
-
BJD
@BrJDermatol
Peristomal skin complications are a common complication in people living with a stoma.
This randomized controlled trial shows that an ostomy baseplate with a skin-protective technology may be a new solution for peristomal skin complications.
doi.org/10.1093/bjd/ljac122
BJD
@BrJDermatol
➡️Plain Language Summary: doi.org/10.1093/bjd/ljad049
➡️Commentary: doi.org/10.1093/bjd/ljad006 -
BJD reposted
Hidradenitis Suppurativa (HS) Ireland
@hsireland1
#openaccess: understanding the #hidradenitissuppurativa #patient journey and unmet needs through #socialmedia #research:
academic.oup.com/bjd/advance-article/doi/10.1093/bjd/ljad… -
BJD reposted
Dr Olivia Hughes
@DrOliviaHughes
Watch our @BrJDermatol author video for our study investigating parent and child experiences of skin conditions, on YouTube!
youtu.be/kwmmXxEDWZ8 -
BJD reposted
Karen Alexander
@chemistrykaren
If you're in or near Edinburgh, this exhibition is sure to be fascinating. Free entry. Queen Street. Until 13 October. #dermatology #history #edinburgh @BrJDermatol @HealthySkin4All
Physicians' Gallery
@RCPEHeritage
Our exhibition is now open! ‘Skin: A Layered History' explores the complex history of the skin over 600 years - running until 13 Oct 2023 www.rcpe.ac.uk/heritage/skin-layered-history
-
BJD
@BrJDermatol
Previous research has found that people with eczema or psoriasis are more likely to experience mental health conditions.
What factors are associated with depression, anxiety and severe mental illness in adults with eczema or psoriasis?
doi.org/10.1093/bjd/ljac132
BJD
@BrJDermatol
Plain Language Summary: academic.oup.com/bjd/article/188/4/e27/7093715
Commentary: doi.org/10.1093/bjd/ljad009 -
BJD
@BrJDermatol
Patients with pemphigus treated with rituximab experienced an elevated risk of COVID-19, parasitic diseases and cytomegalovirus infections within the first year after treatment, as compared to those treated with azathioprine or MMF.
Read more: doi.org/10.1093/bjd/ljac118
BJD
@BrJDermatol
Commentary: doi.org/10.1093/bjd/ljad005
-
BJD
@BrJDermatol
Proton-pump inhibitors (PPIs) are often used by patients with melanoma receiving BRAF/MEK inhibitors.
Do PPIs reduce the absorption of oral anticancer treatments?
This study found that PPI use did not impact the efficacy of BRAF/MEK inhibitors.
doi.org/10.1093/bjd/ljac085
BJD
@BrJDermatol
Plain Language Summary:
academic.oup.com/bjd/article/188/4/e29/7093678 -
BJD
@BrJDermatol
🌼🌻Our April issue is now online!🌻🌼
academic.oup.com/bjd/issue/188/4 -
BJD reposted
John McGrath
@BJDEditor
Another HS article in this months @BrJDermatol. Is the association between hidradenitis suppurativa (HS) and obesity explained by increases in skin folds or do adipokines make adipose tissue more than an innocent bystander? academic.oup.com/bjd/advance-article/doi/10.1093/bjd/ljac…
-
BJD reposted
Hidradenitis Suppurativa (HS) Ireland
@hsireland1
This is an excellent #hidradenitissuppurativa #patient Information Leaflet, from the British Association of Dermatologists (@HealthySkin4All). It contains relevant and up-to-date information about causes, treatments, and management of HS.
www.skinhealthinfo.org.uk/condition/hidradenitis-suppurat… -
BJD
@BrJDermatol
Off-label use of spironolactone is an effective medication for female-pattern hair loss.
Spironolactone may increase serum potassium levels.
What is the risk of hyperkalemia in female patients >65 taking spironolactone for female-pattern hair loss?
academic.oup.com/bjd/article/188/3/429/6780311 -
BJD
@BrJDermatol
The process of laser hair reduction produces a visible plume, which can be harmful.
This study quantified laser-generated air particulate concentrations to understand the adequacy of current control methods.
doi.org/10.1093/bjd/ljac110 -
BJD reposted
Hidradenitis Suppurativa (HS) Ireland
@hsireland1
New findings about what drives inflammation in #hidradenitissuppurativa may lead to new treatments
academic.oup.com/bjd/article/188/3/e24/7050767 -
BJD reposted
Bernd Arents
@bernd_020
The Plain Language Summaries newsletter of the @BrJDermatol has been sent. It contains the PLSs of the March 2023 issue, and an interesting highlighted Perspectives article. Link: mailchi.mp/a1b0ac6c8723/bjd-plain-language-summaries-for-…
Subscribe: outlook.us4.list-manage.com/subscribe?u=e6aa83f73fd2a2d3a… -
BJD
@BrJDermatol
Comorbid diagnosis of systemic lupus erythematosus in vitiligo: a systematic review and meta-analysis
doi.org/10.1093/bjd/ljac038 -
BJD
@BrJDermatol
Proliferative actinic keratoses are associated with adverse clinical outcomes relative to actinic keratoses without a proliferative growth pattern
doi.org/10.1093/bjd/ljac098 -
BJD reposted
John McGrath
@BJDEditor
PASI 90 response rates after switching from another biologic to bimekizumab due to insufficient #psoriasis efficacy range from 79-91% after 48 weeks: academic.oup.com/bjd/advance-article/doi/10.1093/bjd/ljac…
-
BJD reposted
Ed Vital
@edvital
Our new paper in @BrJDermatol - resistant lupus is driven by target organ producing IFN-I, so fails all conventional imm supp. Switching to IFN blockade turns the most resistant lupus into remission, without needing to normalise blood biomarkers. academic.oup.com/bjd/advance-article/doi/10.1093/bjd/ljad…
-
BJD
@BrJDermatol
Itching and treatments in atopic dermatitis (AD): results from the German AD registry TREATgermany (www.treatgermany.org)
Read full article: doi.org/10.1093/bjd/ljac070 -
BJD
@BrJDermatol
5 reasons you should publish your research in the BJD
1⃣Leading derm journal
2⃣Global impact
3⃣Options to elevate your publication
4⃣Rapid+transparent editorial process with potential to Fast Track clinical trials
5⃣Open access options
Read more: academic.oup.com/bjd/pages/reasons-to-publish -
BJD reposted
Dominique du Crest
@ducrest
Atopic dermatitis epidemiology & disparities
academic.oup.com/bjd/advance-article/doi/10.1093/bjd/ljad…
by Anisa Mosam @BrJDermatol @WileyHealth
Interesting contribution
Guidelines and access to newer systemic agents are well established for the Global North but limited in South America and Africa
#dermtwitter 👇🏼 -
BJD reposted
Dr Sophia Quirke-McFarlane ☘️
@sophiaqmcf
Were depression and anxiety associated with treatment non-adherence in psoriasis during the first year of the COVID-19 pandemic? 🤔💊 Find out the answer by reading our latest #openaccess publication👇 academic.oup.com/bjd/advance-article/doi/10.1093/bjd/ljac… @BrJDermatol @PsoProtect @adherenceCARE
-
BJD reposted
NIHR Newcastle BRC
@NIHRNewcBRC
BRC emerging leader @derm_scientist talks about the ‘privilege and opportunity of working in partnership with patients’ to further research in skin disease.
@NCL_RareDisease -
BJD reposted
Andrew Proctor
@andy1online
Thank you BJD for publishing this piece highlighting the urgent need for clearer potency labelling to support safe and effective use of topical steroids for people with eczema.
BJD
@BrJDermatol
💬Perspective: potency of topical steroids should be clearly labelled on all packaging @eczemasociety
Read more: doi.org/10.1093/bjd/ljac104 -
BJD
@BrJDermatol
Case report: alopecia areata treated with the JAK1 inhibitor trial agent filgotinib
Read more: doi.org/10.1093/bjd/ljac103 -
BJD
@BrJDermatol
The Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI) assesses the extent of skin disease in dermatomyositis.
This study found excellent reliability between photos and in-person scoring of the CDASI activity score.
@werthlab @artmajormd
doi.org/10.1093/bjd/ljac091 -
BJD
@BrJDermatol
💬Perspective: potency of topical steroids should be clearly labelled on all packaging @eczemasociety
Read more: doi.org/10.1093/bjd/ljac104 -
BJD
@BrJDermatol
🔖Read the full letter here:
doi.org/10.1093/bjd/ljac065
Sidra Khan
@k_sidra
The results of our #skin #disease survey of the #maasai is now published in @BrJDermatol. This collaboration btwn @PsoriasisAtlas and @RDTCTZ demonstrated #fungal skin disease to be the most common dermatoses amongst the adults and that skin disease can impact their work & (1/2)
-
BJD reposted
John McGrath
@BJDEditor
Does the dermis or epidermis produce most TNFα in hidradenitis suppurativa (HS)? New research in the @BrJDermatol provides a paradigm shift in our thinking about HS inflammation: academic.oup.com/bjd/advance-article/doi/10.1093/bjd/ljac…
-
BJD
@BrJDermatol
Crisaborole has been used with success in atopic dermatitis and psoriasis.
This article reports two vitiligo patients successfully treated with crisaborole ointment.
Read more: doi.org/10.1093/bjd/ljac092 -
BJD
@BrJDermatol
☀️How much ultraviolet radiation (UVR) are you exposed to at work?
🚜This UVR exposure database provides exposure data for more than 250 occupations.
📖Read more: doi.org/10.1093/bjd/ljac093
BJD
@BrJDermatol
➡️Plain Language Summary:
doi.org/10.1093/bjd/ljad020
➡️Commentary:
doi.org/10.1093/bjd/ljac127 -
BJD
@BrJDermatol
🎉Check out the full article here: doi.org/10.1093/bjd/ljad036
Neil Rajan
Great work Bjorn!👏🏾👏🏾👏🏾 @BrJDermatol @EdelOToole @davidkelsell #dermtwitter
-
BJD
@BrJDermatol
The epidemiology, healthcare and societal burden of basal cell carcinoma in Wales
🔵Read article: doi.org/10.1093/bjd/ljac090 -
BJD
@BrJDermatol
This study identified the diagnoses that had a statistically significant association within 5 years (before or after) of a psoriasis diagnosis to create a comorbidity trajectory network.
Read more: doi.org/10.1093/bjd/ljac086
BJD
@BrJDermatol
➡️Plain Language Summary: doi.org/10.1093/bjd/ljad017
➡️Commentary: doi.org/10.1093/bjd/ljac126 -
BJD reposted
Neil Rajan
Excited to speak at the dermatology specialty and specialist doctors (SAS) development programme today on behalf of the BJD !
@HealthySkin4All @BrJDermatolThis media couldn't be displayed. See it on the original post. -
BJD reposted
John McGrath
@BJDEditor
Could having a youthful facial appearance reflect lower risks of systemic and cognitive aging and can this be observed by others? Find out more in this month's @BrJDermatol: academic.oup.com/bjd/advance-article/doi/10.1093/bjd/ljac…
-
BJD reposted
Werth Lab
@werthlab
Our latest research on validation of photography for use in #dermatomyositis by former fellow @artmajormd now at @UNMCDermatology using the #cdasi in @BrJDermatol academic.oup.com/bjd/article/188/3/434/6831695
-
BJD reposted
Global Parents for Eczema Research
@eczemaresearch
🧐New commentary by our executive director, Korey Capozza in the @BrJDermatol explains why patient reported outcomes are so important for assessing #atopicdermatitis and why we need better instruments for measuring PROs in non-English speaking populations.
academic.oup.com/bjd/advance-article/doi/10.1093/bjd/ljad… -
BJD
@BrJDermatol
Tofacitinib in recalcitrant bullous pemphigoid: a report of seven cases
academic.oup.com/bjd/article/188/3/432/6831704 -
BJD
@BrJDermatol
In this cross-sectional study, looking five years younger than the chronological age was associated with less age-related morbidities and better cognitive function.
academic.oup.com/bjd/article/188/3/390/6979846 -
BJD reposted
Psoriasis UK
@PsoriasisUK
February 2023's @BrJDermatol Plain Language Summaries are now available to view.
The summaries aim to make #dermatology research findings accessible to those without formal medical training.
We've linked to the summary that has a focus on #psoriasis below ⬇️ -
BJD
@BrJDermatol
Keratinocytes actively recruit immune cells to the epidermis in hidradenitis suppurativa (HS), driving inflammation.
Targeting epidermal inflammation in HS with topical treatments may be highly efficacious with reduced systemic side effects.
Article: doi.org/10.1093/bjd/ljac096
BJD
@BrJDermatol
➡️Plain Language Summary:
doi.org/10.1093/bjd/ljad019
➡️Commentary:
doi.org/10.1093/bjd/ljac164 -
BJD reposted
John McGrath
@BJDEditor
Mind the gap between development of a core outcome set (COS) and implementation – in #vitiligo only 10% of RCTs have used the full COS since publication: academic.oup.com/bjd/article/188/2/247/6774412
-
BJD
@BrJDermatol
Oral antibiotics are regularly used to treat moderate-to-severe acne vulgaris.
How long is the typical antibiotic treatment course and what proportion of people receive more than one course of treatment following a new acne diagnosis?
Article: doi.org/10.1093/bjd/ljac084 -
BJD reposted
Edel O'Toole
@EdelOToole
Thanks to Korey Capozza from @eczemaresearch for her thoughtful commentary on @SeddikSoha paper in @BrJDermatol doi.org/10.1093/bjd/ljac131 Lost in translation: understanding the experience of atopic eczema among non-English-speaking families academic.oup.com/bjd/advance-article/doi/10.1093/bjd/ljad… #eczema
-
BJD
@BrJDermatol
🚨See the full guideline here: doi.org/10.1093/bjd/ljac042
John McGrath
@BJDEditor
How might we choose between topical therapy, cryotherapy, curettage, surgery, PDT, laser or radiotherapy for Bowen’s disease? New BAD @HealthySkin4All guidelines are available. Image copyright: Cardiff & Vale University Health Board.
-
BJD
@BrJDermatol
This extension study of two pivotal phase III trials showed that treatment with secukinumab was effective through to year 5 and improved the quality of life of patients with moderate-to-severe plaque psoriasis.
Read more: doi.org/10.1093/bjd/ljac040 -
BJD
@BrJDermatol
Cobalt nanoparticles cause allergic contact dermatitis in humans
💠Article: doi.org/10.1093/bjd/ljac043
💠Plain Language Summary: doi.org/10.1093/bjd/ljac153 -
BJD reposted
John McGrath
@BJDEditor
In this month's @BrJDermatol, population-based data from England give insights into Merkel cell carcinoma epidemiology, remarkably collecting 3775 cases despite its rarity: academic.oup.com/bjd/article/188/2/228/6855420
-
BJD reposted
Dr Olivia Hughes
@DrOliviaHughes
Really pleased to have my first PhD study published in @BrJDermatol with @ProfARThompson @KSheltonCardiff and Helen Penny, investigating the relevance of mindfulness for families affected by skin conditions @PsychCardiffUni @DClinPsySWales @HEIW_NHS
doi.org/10.1093/bjd/ljac129 -
BJD reposted
Dominique du Crest
@ducrest
@BrJDermatol Plain Language Summaries Feb 2023. Review of the outcome measures used in clinical trials for vitiligo academic.oup.com/bjd/article/188/2/e17/7034266 "Our findings showed that only 10% RCT published b/w 2016-2021 reported on all 3 essential outcome domains"
#dermtwitter #vitiligoawareness -
BJD
@BrJDermatol
Are core outcome domain sets being used in vitiligo trials?
This study found that:
🔵only 10% of RCTs published between 2016 -2021 reported all 3 essential core outcome domains
🔵none reported both essential and recommended core outcome domains
doi.org/10.1093/bjd/ljac074
BJD
@BrJDermatol
🔵Plain Language Summary: doi.org/10.1093/bjd/ljac163
-
BJD
@BrJDermatol
Trends in incidence, treatment + survival of Merkel cell carcinoma (MCC) in England:
🟠the incidence of MCC ⬆️ by 3.9%/year between 2004-2018
🟠the incidence ⬆️ at 2x the rate in men than in women
🟠the greatest predictor of mortality was disease stage
🟠doi.org/10.1093/bjd/ljac044
BJD
@BrJDermatol
🟠Plain Language Summary: doi.org/10.1093/bjd/ljac157
🟠Commentary: doi.org/10.1093/bjd/ljac055 -
BJD reposted
John McGrath
@BJDEditor
Long-term safety data from the BRAVE-AA1 & 2 phase III trials of baricitinib for alopecia areata in this month’s @BrJDermatol : academic.oup.com/bjd/article/188/2/218/6821292
-
BJD
@BrJDermatol
🔖This review highlights the essential contribution of the unrecognized anatomical contacts between sensory neurons and epidermal cells.
Read more👇
doi.org/10.1093/bjd/ljac066 -
BJD
@BrJDermatol
Baricitinib has demonstrated long-term efficacy in moderate-to-severe atopic dermatitis.
This study found that downtitration of baricitinib after sustained disease control may maintain clinical efficacy in most patients.
Read more: doi.org/10.1093/bjd/ljac057
BJD
@BrJDermatol
🔴Plain Language Summary: doi.org/10.1093/bjd/ljac159
🔴Commentary: doi.org/10.1093/bjd/ljac082 -
BJD reposted
mySkin
@myskinstudy
One quarter of people who were prescribed a tablet or injection medication for their psoriasis reporting stopping or pausing this treatment during the pandemic.
Read the research paper from @BrJDermatol here academic.oup.com/bjd/advance-article/doi/10.1093/bjd/ljac… -
BJD
@BrJDermatol
Updated British Association of Dermatologists guidelines for the management of cutaneous squamous cell carcinoma in situ (Bowen disease).
Check out the flowchart below and read more here:
doi.org/10.1093/bjd/ljac042
BJD
@BrJDermatol
🔴Plain Language Summary: doi.org/10.1093/bjd/ljac160
-
BJD
@BrJDermatol
📢Our February issue is now online: academic.oup.com/bjd/issue/188/2
-
BJD
@BrJDermatol
This qualitative interview study explored the views and experiences of young people with #eczema and parents/carers of children with eczema regarding eczemacareonline.org.uk.
Read more: doi.org/10.1093/bjd/ljac115
Kate Greenwell
@kate_greenwell
So pleased that our qualitative process evaluation of www.eczemacareonline.org.uk has just been published in @BrJDermatol as part of the @ECO_eczema research programme academic.oup.com/bjd/advance-article/doi/10.1093/bjd/ljac… @UoS_PrimaryCare @PersonBased @CCCAHP_UoS @CebdNottm
-
BJD
@BrJDermatol
This review:
➡️illustrates #hidradenitissuppurativa-specific applications of 2 imaging modalities, ultrasound and MRI
➡️provides practical viewpoints on critical topics relating to the use of these imaging techniques in the management of HS
➡️read more: doi.org/10.1093/bjd/ljad028
Ximena Wortsman
@xworts
Check this in-depth @BJD open review of the role of #ultrasound (US) and #mri in #hidradenitissuppurativa (HS). US of HS lesions can support early diagnosis, staging, and management. #mri helps with dg deep perianal tunnels. More info at: pubmed.ncbi.nlm.nih.gov/36753411/ @xworts @sonoskin
-
BJD reposted
Shehnaz Ahmed
@Shehnaz27867450
This is a great piece on getting the word out about published #research! In @BrJDermatol we do that through our free plain language summaries, videos and podcasts.
National Institute for Health and Care Research
@NIHRresearch
How can we share our research with everyone? A new NIHR blog shares tips on how to share your research so that everyone can understand it and use the findings to improve their own health and care.
Find out more here: www.nihr.ac.uk/blog/getting-the-message-across-how-can-we… -
BJD reposted
Agingdoc🩺Dr David Barzilai🔔MD PhD MS MBA DipABLM
@agingdoc1
Younger facial looks are associate with a lower likelihood of several age-related morbidities in the middle-aged to elderly
"PA is associated with multiple morbidities and better cognitive function..."
academic.oup.com/bjd/advance-article/doi/10.1093/bjd/ljac…
@BrJDermatol -
BJD
@BrJDermatol
Check out the full article here👇
doi.org/10.1093/bjd/ljac014
The Skin Cancer Surgery PSP
@SkinSurgeryPsp
Great to see this in print @BrJDermatol @LindAlliance - top 10 priorities for skin cancer surgery! Well done everyone and thank you for your support. Time to start the research!
-
BJD reposted
Systems Biology Ire
@sysbioire
New publication in @BrJDermatol - a collaboration with Prof. Brian Kirby where we studied the potential for targeting B-cell & complement pathways in treating Hidradenitis suppurativa (HS).
@CharlesUCD @UCD_Conway @UCDMedicine
#skin #translationalresearch
academic.oup.com/bjd/article/188/1/52/6763723?login=true -
BJD reposted
Ketaki Bhate
@KetakiDerm
Thanks @DrJohnBarbieri. We also saw on average, courses of oral antibotic were prescribed for just two months, less than the recommended three, greater use and development of effective alternatives to oral antibiotics for acne are key! @stevesmithcam @BrJDermatol
John Barbieri, MD, MBA
@DrJohnBarbieri
Nice study led by @KetakiDerm evaluating patterns of antibiotic use for acne in the UK. Mean total exposure of 255 days with many getting repeated courses. Highlights why important to consider alternatives such as spironolactone, laser, isotretinoin, etc.
pubmed.ncbi.nlm.nih.gov/36670540/ -
BJD
@BrJDermatol
This qualitative study illustrates the impact of hidradenitis suppurativa-related pain on patients’ physical, psychological and social wellbeing.
🔴Article: doi.org/10.1093/bjd/ljac018
🔴Plain Language Summary: doi.org/10.1093/bjd/ljac162 -
BJD
@BrJDermatol
Adalimumab is effective in ~50% of patients with moderate-to-severe hidradenitis suppurativa.
Using RNA-seq, this study identified potential biomarkers + therapeutic targets for adalimumab non-responders.
Article: doi.org/10.1093/bjd/ljac007
Plain Language: doi.org/10.1093/bjd/ljac033 -
BJD reposted
Hidradenitis Suppurativa (HS) Ireland
@hsireland1
Living with and/or caring for someone with a #skin condition? Are you part of a skin-related #patient organisation? Willing to share your story?
BJD
@BrJDermatol
📣Are you a dermatology patient, carer, or patient society? We want to hear your perspectives!
🖌️Submissions can encompass a variety of formats and can be on any topic relevant to dermatology.
👇Check out the poster below for more details! -
BJD reposted
Pemfriends UK
@PemfriendsUk
Definitely for this. We patients are what it's all about.😊
BJD
@BrJDermatol
⭐️Our Patient Associate Editors play an integral role in the editorial process and producing Plain Language Summaries, making research more accessible to the public
⭐️Read more on the importance of patient engagement: doi.org/10.1111/bjd.21812
@OliviaHughes___ @bernd_020 -
BJD
@BrJDermatol
Does metformin improve survival in patients with cutaneous melanoma and type 2 diabetes?
This study found:
✅an association between metformin and improved overall survival
❌no association between metformin and melanoma-specific survival
Read more: doi.org/10.1093/bjd/ljac003
BJD
@BrJDermatol
🔴Plain Language Summary:
doi.org/10.1093/bjd/ljac150 -
BJD reposted
Emory Dept of Family & Preventive Medicine
@EmoryFamMed
New qualitative study on "Pain experiences among those living with hidradenitis suppurativa" by @EmoryFamMed faculty @curseen and @diokavalieratos in @BrJDermatol
pubmed.ncbi.nlm.nih.gov/36689519/
@EmoryMedicine #scholarlytuesday #medtwitter #palliativecare -
BJD reposted
Marit B. Veierød
@MaritBVeierod
We investigated the association between #physicalactivity and #melanoma thickness at diagnosis in a cohort of Norwegian women @BrJDermatol @eid_robsahm @RezaResearcher @kristinborch @IARC_DIR @CRueegg @OCBE_UniOslo @UniOslo_MED
academic.oup.com/bjd/advance-article/doi/10.1093/bjd/ljac… -
BJD reposted
Dermatology_UKDCTN
@UK_DCTN
All for this!
BJD
@BrJDermatol
⭐️Our Patient Associate Editors play an integral role in the editorial process and producing Plain Language Summaries, making research more accessible to the public
⭐️Read more on the importance of patient engagement: doi.org/10.1111/bjd.21812
@OliviaHughes___ @bernd_020 -
BJD reposted
Hidradenitis Suppurativa (HS) Ireland
@hsireland1
Lived experiences of patients with #hidradenitissuppurativa -related #pain academic.oup.com/bjd/article/188/1/e6/6998459
-
BJD reposted
Dominique du Crest
@ducrest
#hidradenitissuppurativa #hsawareness #hs
Lived experiences of patients with hidradenitis suppurativa-related pain academic.oup.com/bjd/article/188/1/e6/6998459
"In addition to treating this disease it is important to treat the symptom of pain" #dermatology #dermatologia #dermtwitter -
BJD reposted
Bernd Arents
@bernd_020
The Plain Language Summaries newsletter of the
@BrJDermatol has been sent. It contains the PLSs of January 2023. Apologies for the delay...
Link: mailchi.mp/c70c530c3704/bjd-plain-language-summaries-for-…
Subscribe: outlook.us4.list-manage.com/subscribe?u=e6aa83f73fd2a2d3a… -
BJD
@BrJDermatol
🧬How do genetic factors contribute to keloid development?
🔬This paper describes the molecular mechanism underlying a keloid-associated single nucleotide polymorphism.
Read more:
doi.org/10.1093/bjd/ljac025
BJD
@BrJDermatol
🔴Plain Language Summary: doi.org/10.1093/bjd/ljac154
🔴Commentary: doi.org/10.1093/bjd/ljac056 -
BJD reposted
BJD
@BrJDermatol
⭐️And make sure to check out this issue's Plain Language Summaries here👇
academic.oup.com/bjd/issue -
BJD
@BrJDermatol
⭐️Our Patient Associate Editors play an integral role in the editorial process and producing Plain Language Summaries, making research more accessible to the public
⭐️Read more on the importance of patient engagement: doi.org/10.1111/bjd.21812
@OliviaHughes___ @bernd_020
BJD
@BrJDermatol
⭐️And make sure to check out this issue's Plain Language Summaries here👇
academic.oup.com/bjd/issue -
BJD reposted
Dominique du Crest
@ducrest
Migrant skin health – Perspectives from the Migrant Health Summit, Malta, 2022
academic.oup.com/bjd/advance-article/doi/10.1093/bjd/ljad…
Via @BrJDermatol by @pvaleska73, @cemg70044533, Lucinda C Fuller, Toby Maurer and @DrEstherFreeman
#dermatology #dermtwitter
glodermalliance
@glodermalliance
The Migrant Health Summit 2022 starts TOMORROW! Join us as we discuss the development of dermatological solutions to the skin health needs of migrants, displaced people and refugees. Register vie e-mail to admin4@ilds.org #globalderm
#dermatology #dermed #dermtwitter -
BJD reposted
Dominique du Crest
@ducrest
#hidradenitissuppurativa devastating impairment- just 1 figure!
Unemployment rate of patients w/ HS was 12.6% vs. 5 – 6% in the general population. Thanks @hsireland1 for sharing.
#hsawareness Patients w/ #hs do not stay alone - there are patients groups
@BrJDermatol #dermtwitter
Hidradenitis Suppurativa (HS) Ireland
@hsireland1
#openaccess, the devastating impact of #hidradenitissuppurativa impact on employability.
Great to see studies such as this
academic.oup.com/bjd/article/188/1/9/6792791?login=false -
BJD reposted
William Fostier
@WFostier
Fantastic news! My first ever lead-authorship letter in dermatology has been published in the @BrJDermatol 🎉🔬 @derm_scientist @JamesSampson123 @georgieholt @BHD_Foundation @myrovlytis doi.org/10.1093/bjd/ljac138
-
BJD reposted
Steven Chen 陳持威, MD, MPH, MHPEd
@DrStevenTChen
DERMATOMYOSITIS (DM)
Let’s spend some time in this #tweetorial on the dermatologic manifestations of this potentially paraneoplastic disease!
First, a question: What is necessary to make a diagnosis of DM?
1/ -
BJD reposted
glodermalliance
@glodermalliance
Exciting news! 🎉 The deadline for the GLODERM Mentorship Program 2023 cohort has been extended till February 28th, 2023! This program is designed for dermatologists looking to become change-makers, and whose aim it is to improve access to skin health globally.
-
BJD reposted
Dario Balacco, PhD 🇮🇹🇬🇧🏳️🌈
@DarioBalacco
Progresses in the wound management and healing in EB. So exciting.
#fighteb
BJD
@BrJDermatol
🔵Epidermolysis bullosa (EB) is group of rare, inherited, skin disorders that causes fragile, blistering skin.
🔵Oleogel-S10 is the first therapy to demonstrate accelerated wound healing in EB.
🔵Oleogel-S10 was well tolerated.
doi.org/10.1093/bjd/ljac001 -
BJD
@BrJDermatol
🔖Research Letter
Patient perspectives on the lived experience of granuloma annulare
This survey of patients with granuloma annulare assessed:
➡️patient demographics
➡️granuloma annulare history
➡️symptoms
➡️treatments
➡️quality of life
doi.org/10.1093/bjd/ljac004 -
BJD
@BrJDermatol
🔵Epidermolysis bullosa (EB) is group of rare, inherited, skin disorders that causes fragile, blistering skin.
🔵Oleogel-S10 is the first therapy to demonstrate accelerated wound healing in EB.
🔵Oleogel-S10 was well tolerated.
doi.org/10.1093/bjd/ljac001 -
BJD reposted
AADmember
@AADmember
Authors of @BrJDermatol article explored how #cutaneous manifestations of COVID-19 have changed during Delta and Omicron waves of infection. Learn more in #dermworldweekly - assets.aad.org/html/ErrorPages/auth0_error.html?client_id…
-
BJD reposted
Dermatology_UKDCTN
@UK_DCTN
Brilliant to see a few familiar faces here. Great to share and collaborate Keep up the good work
Shehnaz Ahmed
@Shehnaz27867450
@BrJDermatol team day going on! We have over 40+ participants from around the world. It's so nice to discuss plans for the journal and also hear about latest cutting edge research in #skin by Prof Sabine Eming, President of @ESDRorg.
-
BJD reposted
Prof Andrew R Thompson 💙
@ProfARThompson
Lovely to see this editorial by @OliviaHughes___ et al. out on @BrJDermatol new OUP website.
-
BJD reposted
Prof Andrew R Thompson 💙
@ProfARThompson
It's great to be hearing about the work that has being going on at @BrJDermatol
Shehnaz Ahmed
@Shehnaz27867450
@BrJDermatol team day going on! We have over 40+ participants from around the world. It's so nice to discuss plans for the journal and also hear about latest cutting edge research in #skin by Prof Sabine Eming, President of @ESDRorg.
-
BJD reposted
Shehnaz Ahmed
@Shehnaz27867450
@BrJDermatol team day going on! We have over 40+ participants from around the world. It's so nice to discuss plans for the journal and also hear about latest cutting edge research in #skin by Prof Sabine Eming, President of @ESDRorg.
-
BJD
@BrJDermatol
Semi-virtual patch testing can be an excellent option for most patients, with high levels of patient satisfaction and reduced travel time. @rosievincent
🔴Read more: doi.org/10.1093/bjd/ljac013 -
BJD
@BrJDermatol
💬Perspective
What challenges do migrants in the USA face when in need of dermatological care and what can dermatologists do to improve migrant health?
Read more: doi.org/10.1093/bjd/ljac011 -
BJD reposted
Hidradenitis Suppurativa (HS) Ireland
@hsireland1
#openaccess, the devastating impact of #hidradenitissuppurativa impact on employability.
Great to see studies such as this
academic.oup.com/bjd/article/188/1/9/6792791?login=false -
BJD reposted
Hidradenitis Suppurativa (HS) Ireland
@hsireland1
Living with and/or caring for someone with a #skin condition? Are you part of a skin-related #patient organisation? Willing to share your story?
BJD
@BrJDermatol
📣Are you a dermatology patient, carer, or patient society? We want to hear your perspectives!
🖌️Submissions can encompass a variety of formats and can be on any topic relevant to dermatology.
👇Check out the poster below for more details! -
BJD
@BrJDermatol
🟡When would you recommend active surveillance for low-risk basal cell carcinoma?
🟢In this survey study of over 600 US dermatologists, most recommended active surveillance in situations of limited life expectancy and advanced age.
🔴Read more: doi.org/10.1093/bjd/ljac002 -
BJD
@BrJDermatol
What's new at the BJD?
For one, as part of our new publishing agreement with @OUPAcademic, authors of all BJD papers will retain copyright of their article🎉
Read more👇 doi.org/10.1093/bjd/ljac006 -
BJD
@BrJDermatol
Desmosomes are essential structures that provide strong adhesion between cells.
Tuftelin-1, encoded by TUFT1, has been implicated in desmosomal organization.
This study describes a novel TUFT1-related woolly hair and skin fragility syndrome.
doi.org/10.1093/bjd/ljac026 -
BJD reposted
Dr Carleen Walsh
@CARLEENWALGAL
📢Protocol Alert @BamfordCentre
Want to ID meaningful global patient/family health outcomes, develop and/or validate an outcome measure,check our #mixedmethod #novelconsensusapproach #inclusiveppi for dev #needsassessment #severityscale #raredisease
bmjopen.bmj.com/content/13/1/e068893
RT🙏 -
BJD
@BrJDermatol
Real‐world data on the effectiveness, safety and drug survival of dupilumab
doi.org/10.1111/bjd.21794 -
BJD
@BrJDermatol
A qualitative study of patients’ experiences of screening for psoriatic arthritis
doi.org/10.1111/bjd.21825 -
BJD reposted
AADmember
@AADmember
Authors of @BrJDermatol article explored how #cutaneous manifestations of COVID-19 have changed during Delta and Omicron waves of infection. Learn more in #dermworldweekly - assets.aad.org/html/ErrorPages/auth0_error.html?client_id…
-
BJD
@BrJDermatol
Mirikizumab is safe and works well in treating patients with moderate‐to‐severe plaque psoriasis.
Mirikizumab clears skin plaques in about 16 weeks and continues to do so up to 52 weeks.
🔴Article: doi.org/10.1111/bjd.21743
🔴Plain Language Summary: doi.org/10.1111/bjd.21895 -
BJD reposted
Hidradenitis Suppurativa (HS) Ireland
@hsireland1
Living with and/or caring for someone with a #skin condition? Are you part of a skin-related #patient organisation? Willing to share your story?
BJD
@BrJDermatol
📣Are you a dermatology patient, carer, or patient society? We want to hear your perspectives!
🖌️Submissions can encompass a variety of formats and can be on any topic relevant to dermatology.
👇Check out the poster below for more details! -
BJD reposted
Andrew Proctor
@andy1online
Great to see the BJD reaching out to patients, their carers and patient organisations in this way. We appreciate the journal being proactive and inclusive.
BJD
@BrJDermatol
📣Are you a dermatology patient, carer, or patient society? We want to hear your perspectives!
🖌️Submissions can encompass a variety of formats and can be on any topic relevant to dermatology.
👇Check out the poster below for more details! -
BJD
@BrJDermatol
📣Are you a dermatology patient, carer, or patient society? We want to hear your perspectives!
🖌️Submissions can encompass a variety of formats and can be on any topic relevant to dermatology.
👇Check out the poster below for more details! -
BJD
@BrJDermatol
Epoxy resin systems are a major cause of allergic contact dermatitis in the construction industry.
Despite skin protection, sensitization+dermatitis are prevalent among epoxy‐exposed workers.
🔴Article: doi.org/10.1111/bjd.21830
🔴Plain Language Summary: doi.org/10.1111/bjd.21898 -
BJD reposted
Shehnaz Ahmed
@Shehnaz27867450
A very happy new year to everyone! @BrJDermatol and @ced_journal are both available on @OUPAcademic. Visit: academic.oup.com/bjd/advance-articles and academic.oup.com/ced/advance-articles. All articles are free to view for some time - happy reading!
-
BJD
@BrJDermatol
In androgenetic alopecia, what are the genetic differences between hair follicles in the balding area (frontal and vertex regions) and nonbalding area (occipital region)?
Full article: onlinelibrary.wiley.com/doi/10.1111/bjd.21783
Plan Language Summary: onlinelibrary.wiley.com/doi/10.1111/bjd.21887 -
BJD
@BrJDermatol
🚨ATTN: clinically active medical students and dermatology specialist trainees/residents🚨
Applications are open to join the BJD as an Editorial Trainee! This is a wonderful opportunity for trainees to join our team.
👉For full details, click here: academic.oup.com/bjd/pages/vacancy-british-journal-of-der… -
BJD
@BrJDermatol
🔖Research Letter: progression of in situ and early invasive cutaneous squamous cell carcinomas concurrent with successful target tumour response to a programmed death-1 inhibitor
Read more: onlinelibrary.wiley.com/doi/10.1111/bjd.21831 -
BJD reposted
Esther Freeman MD PhD
@DrEstherFreeman
One of my goals as Section Editor for Global Health & Equity for @BrJDermatol is de-mystifying peer review & encouraging our trainees, esp. those often under-represented in medicine, to become part of the editorial process. Podcast: soundcloud.com/bjd_talks/bjd-talks-episode-9-peer-review #dermtwitter @BJDEditor
-
BJD reposted
Monty Junejo
@drmontynesss
Latest on quality of life in Bangladeshi patients with atopic eczema in E Ldn by the fab @EdelOToole & co. now in @BrJDermatol 👏🏽 #dermtwitter #poc #healthyequity
Soha Seddik
@SeddikSoha
Happy to share our work on Quality of life in Atopic Eczema patients in THEA study @EdelOToole Dermatology Quality of Life Indices in Bangladeshi Atopic Eczema Patients and Families in East London academic.oup.com/bjd/advance-article/doi/10.1093/bjd/ljac…
-
BJD reposted
Soha Seddik
@SeddikSoha
Happy to share our work on Quality of life in Atopic Eczema patients in THEA study @EdelOToole Dermatology Quality of Life Indices in Bangladeshi Atopic Eczema Patients and Families in East London academic.oup.com/bjd/advance-article/doi/10.1093/bjd/ljac…
-
BJD
@BrJDermatol
Nearly half of patients with #hidradenitissuppurativa are dissatisfied with their treatment.
What clinical/treatment-related characteristics are associated with high treatment satisfaction?
🔴Article: onlinelibrary.wiley.com/doi/10.1111/bjd.21798
🔴Plain Language Summary: onlinelibrary.wiley.com/doi/10.1111/bjd.21894 -
BJD
@BrJDermatol
This study summarized characteristics of checkpoint inhibitor associated blistering reactions:
🔴prolonged pruritus is frequently a prodromal symptom
🔴median time to onset: 12 months
🔴most patients had cutaneous melanoma
🔴Read more: onlinelibrary.wiley.com/doi/10.1111/bjd.21836
BJD
@BrJDermatol
Plain Language Summary: onlinelibrary.wiley.com/doi/10.1111/bjd.21890
-
BJD reposted
John Barbieri, MD, MBA
@DrJohnBarbieri
Also check out this thoughtful commentary by Jane Ravencroft and Lawrence Eichenfield describing that while we can be reassured at a population level, we should still closely monitor patients with acne for mental health comorbidities/side effects.
onlinelibrary.wiley.com/doi/full/10.1111/bjd.21596 -
BJD reposted
John Barbieri, MD, MBA
@DrJohnBarbieri
These findings are consistent with prior work in @BrJDermatol using the same dataset and add to the growing body of literature suggesting on a population level, isotretinoin is not associated with depression or other neuropsychiatric adverse events.
onlinelibrary.wiley.com/doi/10.1111/bjd.21049 -
BJD reposted
Roxana Daneshjou MD/PhD
@RoxanaDaneshjou
Who isn't represented in AI task design? Talented @StanfordMed student @mchen16 (Michael Chen) looked at the diseases represented in #dermatology AI tasks in our @BrJDermatol paper: academic.oup.com/bjd/advance-article/doi/10.1093/bjd/ljac…
-
BJD
@BrJDermatol
What is the most likely diagnosis in this 10-year old child based on the clinical appearance and associated Alcian blue staining ? #dermtwitter #pathtwitter #dermatology #dermpath



















































































































































































































































































































































































































































